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Abstract
Biology can achieve phenomenal information storage/processing capabilities from just
four hydrogen bonding molecules. The orthogonal self-sorting of these four hydrogen
bonding motifs is achieved alongside the hydrophobic collapse of the DNA backbone.
Orthogonal self-sorting without the aid of a polymer backbone is difficult to achieve, as
shown by the minimal examples of self-sorting hydrogen bonding motifs available in the
literature. This thesis describes the design, synthesis and binding studies of molecules
that are capable of orthogonal self-sorting, without a preorganising backbone and begins
to use them in a signalling cascade.
In Chapter 2 ureidoimidazole, a conformer independent triple hydrogen-bond array, is
introduced. Studies were carried out to investigate what effect, if any, preorganisation
using intramolecular hydrogen bonding had on the binding affinity of triply hydrogen
bonded complexes.
Chapter 3 investigates another factor that can effect the binding affinity of complexes,
the remote substituent effect. Two series of complementary molecules were synthesised
so that they contained a variety of electron donating/withdrawing groups and the effect
that these had on the binding affinity of the complex was measured.
Chapter 4 describes a novel quadruple hydrogen-bond array, which was designed to
interact strongly with its complementary partner. It was found that a combination of
effects (differences in geometry and undesired conformers being favoured) lead to a low
binding affinity being observed.
Chapter 5 begins to investigate non-linear arrays, however none of those proposed were
able to form heterodimers. Therefore a self-sorting system was assembled using a triple
and quadruple hydrogen-bonded array. High fidelity interactions were achieved, even
though it was possible to form undesired complexes. These undesired molecular inter-
actions were exploited in Chapter 5, where a signalling cascade is described. Careful
planning of the order in which to add the molecules can give different routes in which to
achieve the self-sorting system, each with it’s own fidelity trace. A photolabile tag was
introduced to one of the molecules so that a photosensitive system could be achieved.
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Chapter 1
Molecular Recognition and
Self-Assembly of Hydrogen
Bonding Motifs
Supramolecular chemistry is the chemistry of the intermolecular bond,1 allowing small
molecules to assemble into much larger, more complicated structures2 that would be
difficult to synthesise using covalent bond formations. Supramolecular chemistry has
been inspired by nature, where extensive examples of self-assembly using intermolecular
interactions can be found,3–5 for example protein folding6 and DNA duplex formation7,8
(Figure 1.1). In these examples, many weak, non-covalent interactions are used in con-
cert in order to obtain large, well-defined architectures.9
Figure 1.1: The DNA duplex is assembled using a combination of hydrophobic, pi-pi
stacking and hydrogen bond non-covalent interactions.
1
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Since intermolecular interactions are normally weaker than covalent bonds they can
be reversible. This allows supramolecular assemblies to be under equilibrium control,
resulting in the thermodynamic, not the kinetic, product being obtained (Figure 1.2).
For example, consider a system containing A and B; three species can exist (A, B,
and A ·B), but the most prevalent will be the component that is thermodynamically
favourable.
Figure 1.2: AB will be the major component of the mixture because it is thermodynam-
ically favoured.
Another advantage of using reversible intermolecular interactions is that they allow
supramolecular assemblies to be self-healing. If an assembly is formed that is higher
in energy than the thermodynamic product, it can dissociate to allow assembly of the
most stable, thermodynamic product. This is one of the reasons why nature uses lots
of weak interactions rather than using a few strong interactions. Since each individual
interaction is too weak to maintain the desired structure they must all be used in concert
to ensure that only the desired assemblies are formed.
The reversible nature of the non-covalent intermolecular interactions also allow supramo-
lecular assemblies to be stimuli responsive. Since the association constant (Ka) is propor-
tional to the concentration of bound material compared to unbound molecules (Equation
1.1), changing the position of equilibrium results in a change in Ka and can permit pre-
viously unfavoured assemblies to be the most prevalent.
Ka ∝ [A ·B][A][B] (1.1)
The equilibrium position of supramolecular systems can be changed by altering the pH,10
chemical environment,11 redox potential12,13 and by using light14–17 as a stimulus. Ka
Chapter 1 3
is related to free energy, ∆G◦ by the Equation 1.2 and ∆G◦ can also be expressed
by Equation 1.3. These two equations show that as well as changes in temperature,18
enthalpy and entropy can also affect the binding affinity of supramolecular assemblies.
This indicates that alterations to the individual components, along with changes to the
external environment can all influence interactions within supramolecular assemblies.
∆G◦ = −RTlnKa (1.2)
∆G◦ = ∆H◦ − T∆S◦ (1.3)
1.1 Hydrogen Bonds in Supramolecular Assemblies
There are many different types of non-covalent interaction (Table 1.1) available for use
by supramolecular chemists.19 Hydrogen bonds are commonly chosen because they can
be strong yet reversible, selective and directional20,21 and in addition, it is relatively
easy to manipulate the strength of binding. In principle, this makes it quite easy to
design complementary motifs and allows the strength of interaction to be manipulated,
according to the application that is required.
Selectivity arises because, for a hydrogen bond to form, an acceptor (A) must interact
with a donor (D). A’s are normally electronegative heteroatoms (e.g. O or N) and D’s
are normally hydrogens that are attached to an electronegative atom (Figure 1.3). The
electronegative atom removes electron density from the hydrogen atom, resulting in
Table 1.1: Examples of non-covalent interactions and their associated typical energies.19
Non-covalent Typical Energy
interaction Range (kJ mol−1)
Ion–Ion 50 – 400
Ion–dipole 50 – 200
Dipole – dipole 4 – 40
Hydrogen Bonding 4 – 120
Halogen Bonding 5 – 180
Cation–pi 5 – 80
pi-pi 4 – 20
Solvation 4 – 40
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Figure 1.3: A typical hydrogen bond between amide functionalities. NH acts as the
hydrogen bond donor and the carbonyl acts as the hydrogen bond acceptor.
a positive charge, which has attractive interactions towards the negatively charged A
atom. Directionality arises because hydrogen bonds are formed between dipoles. The
electronegative atoms position themselves as far apart as possible, resulting in a linear
alignment of the atoms involved in the hydrogen bond.
1.1.1 Strength of hydrogen bonds
The strength of hydrogen bonds can be altered by manipulating the acidity/basicity
of the hydrogen bonding atoms.22 The pKa equalisation principle23 shows that the
strongest hydrogen bonds are obtained when ∆pKa is zero (Equation 1.4). When ∆pKa
between A and D is zero the hydrogen bond can be considered as a three-centre-four-
electron covalent bond, so it becomes irreversible. In medium strength hydrogen bonds,
which are ideal for reversible interactions, ∆pKa should be ∼11–21.24 This is normally
achieved by using molecules where the pKa of the D is 11-21 and the pKa of the A is -7–3.
It has also been suggested that changing the pKa of the D can have a larger effect on the
strength of the hydrogen bond than changing the pKa of the A.25–27 Addition of electron
withdrawing acyl groups to diaminopyridine 1 gave the diamidopyridine 2.28 Stronger
Ka’s were obtained between 2 and the uracil derivative 3 (Ka = 800 M−1) compared to
1 (Ka = 84 M−1), presumably because the NH’s were more acidic (Figure 1.4).
∆pKa = pKa(D–H)− pKa(A–H+) (1.4)
Ordinarily, a single hydrogen bond does not have a strong enough Ka when used alone, so
multiple hydrogen bonds are used simultaneously as part of a hydrogen-bonding array. It
has been shown that large differences in binding affinity can be achieved by using different
numbers of hydrogen bonds.29,30 For example, three orders of magnitude difference in
Ka was measured between 4 ·5 and 4 ·6 where the only difference was the addition of
an extra hydrogen bond (Figure 1.5). Supramolecular homo- and heterodimers that
Chapter 1 5
1 ·3 2 ·3
Ka = 84 M−1 Ka = 800 M−1
Figure 1.4: The association constant of diaminopyridine 1 can be increased by adding
electron withdrawing groups to give diamidopyridine 2. Where R denotes generic alkyl
chain.
4 ·5 4 ·6
8× 104 M−1 2× 107 M−1
Figure 1.5: Large differences in binding affinity are seen between AA ·DDD and
AAA ·DDD hydrogen bond arrays.
interact using two,31 three,30,32,33 four34–40 and six41,42 hydrogen bonds have all been
described in the literature. It is generally accepted that using three or four intermolecular
hydrogen bonds gives the best properties for most supramolecular applications because
they assemble into strong, yet reversible complexes. Using less than three hydrogen
bonds does not give strong enough interactions, but using more than four intermolecular
hydrogen bonds can result in strong Ka’s that give essentially irreversible complexes.
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1.1.2 Secondary Elecrostatic Interactions
In addition to the number of hydrogen bonds used in the array, an important consider-
ation is the order in which the D’s and A’s are arranged. Large differences in binding
affinity have been obtained, simply by changing the order of the D’s and A’s in the
array,32,43,44 due to secondary electrostatic interactions.45 Secondary electrostatic inter-
actions can be constructive or destructive in nature, depending on the arrangement of
D’s and A’s in the array (Figure 1.6). Where triple hydrogen-bond arrays are concerned,
DDD ·AAA arrays normally have the strongest binding affinities (Ka≈ 105 M−1) because
they contain four attractive secondary electrostatic interactions. Conversely, DAD ·ADA
arrays normally have the weakest binding affinities (Ka≈ 102 M−1) because they contain
four repulsive secondary electrostatic interactions. Extremely strong binding affinities
were measured in the AAAA ·DDDD+ array 7 ·8 (Ka> 3× 1012 M−1) introduced by
Leigh et al. (Figure 1.7) because there are four primary hydrogen bonds and six at-
tractive secondary electrostatic interactions.35 The molecules in this complex were also
Ka≈ 105 M−1 Ka≈ 104 M−1 Ka≈ 102 M−1
Figure 1.6: Adjacent A and D can contribute positively or negatively to the binding
affinity of the complex allowing different association constants to be obtained.
7 ·8
Figure 1.7: Extremely strong binding affinities were obtained in this AAAA ·DDDD+
7 ·8 array because there are no repulsive secondary electrostatic interactions.
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designed so that they could be synthesised in just two steps, allowing complexes that
have exceptionally strong binding affinities to be readily accessible.
Since hydrogen bonds are additive, it is possible to predict the association constants of
dimers without having to synthesise and test each molecule.46 It was calculated that
primary hydrogen bonds increased the binding affinity by -7.9 kJ mol−1 and secondary
electrostatic interactions added ± 2.9 kJ mol−1 depending on whether they were con-
structive or destructive in nature.47 By adding spacers between the atoms involved
in hydrogen bonding the effects of secondary electrostatic interactions can be elimi-
nated.48–53 Gong et al. have designed a molecule (9) that is capable of self-recognition
(Kdim = 6× 104 M−1), but contains no secondary electrostatic interactions (Figure 1.8).54
This allows the binding affinity of the complex to be calculated based solely on the num-
ber of primary hydrogen bonds that are present, without interference from secondary
electrostatic interactions. Therefore the same binding affinities should be achieved, no
matter what order the hydrogen bond array is in.
9 ·9
Figure 1.8: Spacers in molecules allow the binding strength of dimers to remain the
same, no matter what order the array is in, because there are no secondary electrostatic
interactions present.
Spacers can not only negate secondary electrostatic interactions, allowing any combi-
nation of hydrogen-bond array to be used, but can also be used to prevent homod-
imerisation occurring.55 Where three hydrogen bonds are used, none of the arrays are
self-complementary (Figure 1.9a), but when four hydrogen bonds are present there are
two combinations (AADD and ADAD) that result in homocomplexes (Figure 1.9b). By
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(a) (b)
Figure 1.9: (a) Where three intermolecular hydrogen bonds are present six different ar-
rays are possible, none of them are self-complementary. (b) When four intermolecular hy-
drogen bonds are used there are ten possible arrays. Because two are self-complementary
six different complexes can be assembled.
10 ·11
Figure 1.10: Homodimerisation of AADD arrays can be prevented by using different
sized spacers.
altering the size of the spacer (10 and 11) AADD arrays (Ka = 2× 104 M−1) can be
synthesised that are not self-complementary (Figure 1.10).
1.1.3 Conformer Considerations
Amide/urea functionalities are a common feature of many hydrogen-bonding motifs
because they can act as both hydrogen bond D’s and A’s and they can normally be
synthesised relatively easily. A detrimental feature of these types of functional groups
however, is that they can adopt many alternative conformations, which can result in a
lower than expected binding affinity because of the loss of entropy that occurs when the
molecule adopts the correct binding conformation. One strategy to prevent molecules
from adopting alternative conformations, ensuring that the desired hydrogen-bond array
is always presented, has been to use covalent linkers.56,57 By forming a macrocycle, bonds
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are prevented from rotating, so undesired conformations cannot be adopted. Chang and
Hamilton58 showed the importance of preorganisation by measuring the differences in
Ka between a molecule that was free to adopt different conformers (12) and one that was
locked in a macrocyclic ring (13) with 5,5-diethylbarbital (DEB) 14. They found that
the Ka was increased by 100-fold, from 104 M−1 to 106 M−1 respectively (Figure 1.11),
simply by forcing all of the hydrogen bonding sites to be positioned in the desired
orientation.
12 ·14 13 ·14
Ka = 2.1× 104 M−1 Ka = 1.4× 106 M−1
Figure 1.11: Adding a covalent linker prevents different conformers being present, al-
lowing stronger interactions to be obtained.
In order to simplify the design and synthesis, hydrogen-bonding motifs often contain
a heteroaromatic ring, as well as amide/urea functionalities. Because heteroaromatic
rings are rigid and planar the position of the hydrogen-bonding atoms can be predicted,
allowing complementary partners to be designed. In addition to making the design
and synthesis easier, rigid molecules, if designed correctly, will have stronger binding
affinities than non-rigid molecules because the entropic penalties on binding are reduced
(Equation 1.3).
Although there are many advantages to using heteroaromatics, they can sometimes form
intramolecular hydrogen bonds with adjacent amide/urea functionalities. This can often
lead to undesired hydrogen-bond arrays being presented by the molecule, leading to the
assembly of undesired complexes. The most likely conformation of the molecule can be
predicted using Etter’s rules,59 which state that:
1. all good proton donors and acceptors are used in hydrogen bonding;
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2. six-membered-ring intramolecular hydrogen bonds form in preference to inter-
molecular hydrogen bonds;
3. the best proton donors and acceptors remaining after intramolecular hydrogen
bond formation form intermolecular hydrogen bonds to one another.
Phenylureidopyridine 15 was originally designed to present an ADD array 15i. However,
Etter’s rules predicted that an intramolecular hydrogen bond would form first and a DA
array 15ii would then be presented (Figure 1.12). This explains the lower than expected
binding affinity (Ka = 84 M−1)60 obtained between 15 and complementary arrays.61,62
15i 15ii
Figure 1.12: Intramolecular hydrogen bonding preorganises the molecule to present an
undesired array, so intermolecular hydrogen bonding is not possible.
Careful design of hydrogen-bonding motifs can allow intramolecular hydrogen bonds
to preorganise the motif for intermolecular interactions, rather than hinder them. The
Wilson group have designed two molecules that present the desired hydrogen-bond array
even when intramolecular hydrogen bonds are present.60,63 The first molecule exchanged
the pyridine ring in 15 for a pyrimidine to give phenylureidopyrimidine (PUPY) 16.63
The presence of two nitrogens in the ring allowed the desired ADA hydrogen-bond array
to be presented even when an intramolecular hydrogen bond was formed. Since either
nitrogen of the pyrimidine can form the intramolecular hydrogen bond (Figure 1.13),
PUPY 16 is a conformer independent array. A conformer independent array is one
that presents the desired hydrogen-bond array, no matter which conformer is adopted.
The second molecule designed by the Wilson group, where the pyridine ring in 15 was
16i 16ii
Figure 1.13: Exchanging pyridine ring with a pyrimidine allows an ADA array to be
permenantly presented.
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replaced with an imidazole to give phenylureidoimidazole (UIM) 17,60 is also a conformer
independent array (Figure 1.14). The Ka of UIM 17 with complementary arrays is
greatly increased when compared to that of phenylureidopyridine 15 (Ka = 8400 M−1 and
84 M−1 respectively) because it presents the desired DDA array in both conformations.
17i 17ii
Figure 1.14: Exchanging pyrimidine for an imidazole gives UIM 17 and allows a DDA
array to be presented in both conformations.
One exception to Etter’s rule is ureidocytosine (UCyt) 18 designed by Hailes et al.64
According to Etter’s rules, intramolecular hydrogen bonds should be formed first, before
intermolecular hydrogen bonds can form. However, it was found that UCyt 18 assembled
through the self-complementary AADD array, which did not contain any intramolecular
hydrogen bonds. It was proposed that even though both homodimers 18i and 18ii
contained four hydrogen bonds, the unfolded conformation 18i was preferred because it
formed four hydrogen bonds, plus two weak CH · · ·O interactions (Figure 1.15).
18i ·18i 18ii ·18ii
Figure 1.15: The two conformations that UCyt 18 can adopt. Both are self-
complementary, but the AADD array is favoured, probably due to the additional weak
CH · · ·O interaction that forms. R denotes generic alkyl chain.
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1.1.4 Tautomer Considerations
A further complication that can arise from using heteroaromatics is their ability to adopt
different tautomers, possibly preventing the desired hydrogen-bond array from being
presented. Ureidopyrimidine (UPy) 1934 was designed by Meijer et al. to self-associate
through an AADD array. However, it was found to adopt many other tautomeric states,
some of which did not present self-complementary arrays and one which self-associated
through an ADAD array (Figure 1.16). The AADD array was normally more preva-
lent than the ADAD array, probably because it contained fewer destructive secondary
electrostatic interactions than the ADAD array.34 It was possible to control which tau-
tomer was the most prevalent, simply by changing the electron donating/withdrawing
nature of the substituents (Figure 1.17).34 Careful choice of electron donating/with-
drawing groups made it possible to change the electron density of the atoms involved in
hydrogen bonding and so control which array was preferred.
Figure 1.16: All the possible tautomers and conformers that UPy 19 can adopt
whilst still maintaining an intramolecular hydrogen bond. Red molecules are self-
complementary and green present an ADDA array. R denotes generic alkyl chain.
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Figure 1.17: Changing the properties of the substituents can alter the preference of the
tautomer.
Although UPy 19 has a strong dimerisation constant (Kdim≈ 6× 107 M−1),65,66 it was
thought that it could be possible to increase it by ensuring that all possible tautomers
presented self-complementary arrays. Zimmerman et al. designed deazapterin (DeAP)
20 (Kdim = 9× 107 M−1) in an attempt to test this hypothesis,67 which does indeed have
a slightly stronger Kdim than UPy 19. Although more of the possible tautomer/conform-
ers presented self-complementary arrays in DeAP 20 than UPy 19, some tautomers still
presented undesired DAAD and AADA arrays (Figure 1.18) and these can be exploited
in order to form heterodimers.
Diamidonaphthalene (DAN) 21 was designed to form ADDA ·DAAD complexes with
both UPy 1968 and DeAP 2067 (Figure 1.19). It was found that, even though the
heterodimers contained more destructive secondary electrostatic interactions, they were
formed in preference to the homocomplexes. The rationale for this was that, even
though the strength of interaction was lower in the heterocomplexes compared to the
homocomplexes, more hydrogen bonds could be formed when the heterocomplexes were
assembled, making it thermodynamically favourable. For example, in the UPy 19 ho-
modimer there were six hydrogen bonds. When the UPy 19 dimer dissociated it could
assemble into two complexes with DAN 21, which each contained five hydrogen bonds.
So the system went from six hydrogen bonds in the homodimer, to ten hydrogen bonds
in the heterodimer.
Even though both UPy 19 and DeAP 20 interacted with high affinity to DAN 21, there
was a lack of fidelity69,70 due to the possibility of the formation of homodimers. In
order to make the heterocomplex with DAN 21 as favourable as possible, Park et al.
sought to design a molecule that presented the ADDA array through a tautomer that
was low in energy and the self-complementary AADD array through a tautomer that was
Chapter 1 14
Figure 1.18: All the possible tautomers and conformers that DeAP 20 can adopt whilst
still maintaining an intramolecular hydrogen bond. Molecules that are coloured red are
self-complementary and green coloured molecules present an ADDA array. R denotes
generic alkyl chain.
19 ·21 20 ·21
Figure 1.19: DAN 21 can form heterodimers with UPy 19 and DeAP 20. R denotes
generic alkyl chain.
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higher in energy.37 Using molecular modelling they designed ureidoguanine (UG) 22,
which presented the ADDA array in a tautomer that was 15 kcal mol−1 lower in energy
than the tautomer that presented an AADD array (Figure 1.20). Indeed, UG 22 has a
much lower dimerisation constant that UPy 19 (Kdim≈ 200 M−1 and Kdim≈ 6× 107 M−1
respectively). It was found that strong heterodimers (Ka≈ 5× 107 M−1) were formed
between UG 22 and DAN 21.
22 22
Low in energy High in energy
22 ·21 22 ·22
Ka≈ 5× 107 M−1 Kdim = 200 M−1
Figure 1.20: UG 22 presents an ADDA array through a low energy tautomer and the
AADD array in a tautomer that is high in energy. R denotes generic alkyl chain.
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1.2 Self-Assembly into Designed Architectures
The assembly of dimers is only part of the challenge. In order to obtain functionality,
molecules must be programmed so that higher order architectures can be assembled.
This can lead to applications such as; purification,71 detection of contaminants,72 cat-
alysts73–76 and in the recognition of DNA mismatches.77–83 Careful design of molecules
can allow them to assemble into two- and three-dimensional structures.84,85 The lit-
erature on hydrogen bond mediated assembly is already vast,86 hence only selected
examples that have relevance to the goals of this project will be discussed here.
1.2.1 Defined Two- and Three-Dimensional Architectures
It has been shown that guanosine 23 is templated by the addition of ions87 to form
macrocycles.88,89 Guanosine 23 alters its binding mode, switching from traditional Wat-
son and Crick interactions to Hoogsteen interactions, which results in the formation of a
2-D disk (Figure 1.21a). These 2-D disks then assemble, using hydrophobic interactions,
into 3-D stacks (Figure 1.21b). If hydrogen-bonding motifs can be designed so that they
have two hydrogen bonding faces then the ability to assemble into 2-D disks and pos-
sibly 3-D stacks should be possible. For 2-D disks to be formed the molecules must be
the correct shape and the correct hydrogen-bond array must be chosen so that only the
desired macrocycle is obtained. For example, when symmetrical DAD ·ADA arrays are
(a) (b)
234
Figure 1.21: (a) Guanosine 23 can assemble into macrocycles in the presence of ions. (b)
These two-dimensional disks can then form three-dimensional stacks using hydrophobic
interactions.
Chapter 1 17
used there is a possiblity of extended tapes being formed (Figure 1.22),90,91 but by using
unsymmetrical AAD ·DDA arrays, 2-D disks are the only product that can be assembled
(Figure 1.23).92 When the two arrays in a single molecule were complementary (24),
2-D disks were assembled that only contained one type of molecule (Figure 1.24a).92–94
However, when the two hydrogen-bond arrays were not complementary (25 and 26), a
second molecule had to be added, which allowed the formation of 2-D disks that con-
tained a mixture of molecules (Figure 1.24b).90 As in discrete linear arrays, the binding
affinity of 2-D disks has been increased by including additional secondary electrostatic
interactions 27 (Figure 1.25),95–97 or by increasing the number of intermolecular hydro-
gen bonds.98,99 Subtle changes in the shape of the motifs can change the assembly that
is obtained. Petersen et al. have shown that by using a mixture of six-membered (28)
and five-membered (29) rings, the assembly no longer formed 2-D disks, but instead
assembled into helical structures (Figure 1.26).100
Figure 1.22: An equilibrium between rings and tapes can be established if symmetrical
hydrogen-bond arrays are used.
Figure 1.23: Homo- and heterocomplementary hydrogen-bonding motifs can be designed
so that they can only form macrocycles.
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(a)
(24)6
(b)
(25 ·26)3
Figure 1.24: Macrocycles can be assembled using (a) homo or (b) hetero arrays.
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(27)6
Figure 1.25: The binding affinity of macrocycles can be increased by using additional
secondary electrostatic interactions.
28 29
Figure 1.26: Slightly changing the shape of the supramolecular motifs can result in a
dihelical assembly being obtained.
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In the previous examples, intermolecular hydrogen bonds were used to form the 2-D
disks, which could assemble into 3-D stacks using pi-pi interactions. By designing 2-D
molecules, 3-D stacks can be assembled where hydrogen bonds are formed between the
disks. These molecules must orientate hydrogen bond D’s and A’s above and below
the plane of the molecule. This can result in a self-complementary molecule that forms
3-D stacks, which can then self-assemble into larger architectures (Figure 1.27a). The
first examples of three-dimensional stacks had cyclohexane rings at their core 30 (Fig-
ure 1.27b),101 but these molecules required aromatic side chains to allow pi-pi stacking
to stabilise the assembly. More recently, phenyl rings have been used in the core 31
(Figure 1.27c) because they increase stack stability through pi-pi stacking in the core and
allow the side chains to be varied.102 By altering the side chains many new properties can
be obtained, for example different gelation properties,103,104 enhanced polymer forma-
tion105,106 and the ability to control the chirality of the self-assembled 3-D stack.107–114
(a)
(b) (c)
(30)n (31)n
Figure 1.27: (a) A cartoon representation of a 3D stack which can be built from (b) a
cyclohexane or (c) a benzene core.
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1.2.2 Polymer Assembly
If molecules are designed with two hydrogen bonding faces, which are not oriented to al-
low the assembly of 2-D disks, extended polymeric structures can be obtained. An early
example was from the Lehn group, where the two hydrogen bonding arrays were sepa-
rated by a rigid, aromatic core.115,116 Mixtures of two different molecules (32 and 33)
were made by ensuring that the individual molecules were not self-complementary (Fig-
ure 1.28). More recently flexible linkers have been used between the hydrogen bonding
motifs.84 Again, these arrays can have self-complementary hydrogen-bonding motifs at
each end of the ditopic array (Figure 1.29a),117 or they can be designed so that a comple-
mentary component must be added for polymerisation to occur (Figure 1.29b).118,119 Be-
cause the linker is flexible, a concentration dependent equilibrium between ring and chain
32 33
(32 ·33)n
Figure 1.28: Rigid rods designed by the Lehn group present two hydrogen-bond arrays
at either end of a rigid molecule.
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Figure 1.29: Cartoon representation of ditopic (a) homo and (b) hetero hydrogen-
bonding motifs.
34
35
(34 ·35)n
Figure 1.30: The ditopic triply hydrogen bonded heterodimers designed by the Wilson
group.
Chapter 1 23
formation is commonly established.120,121 The Wilson group have designed molecules 34
and 35 which can assemble into cyclic dimers and polymeric structures (Figure 1.30).122
Neither molecule was self-complementary, so they both had to be present in order to
form extended assemblies.
Hydrogen-bonding motifs have also been attached to the side chains of polymers (Fig-
ure 1.31).123 Appending the polymerising group to the hydrogen-bonding motif al-
lows it to be integrated into the polymer during polymerisation.124–128 The addition
of supramolecular motifs to the backbone of polymers can allow materials to have
new properties. Supramolecular polymers have self-healing properties,129 are stimuli
responsive,130 and often have lower melting temperatures than traditional covalent poly-
mers,131–133 which can be useful for some applications.
(a) (b)
Figure 1.31: Supramolecular polymers that are (a) stimuli responsive and (b) able to
form blends of polymers that are not normally miscible.
1.2.3 Self-Assembling Capsules
Careful integration of hydrogen-bonding motifs into rigid, 2D structures can allow the
assembly of 3D capsules.134 Rebek introduced the “tennis ball” capsule in 1993,135 which
was assembled from a self-complementary motif 36 (Figure 1.32). The existence of the
capsule was confirmed by vapour pressure osmometry (VPO), which calculated the mass
as being a dimer plus a solvent molecule, which was presumably trapped in the capsule.
A second capsule that can reversibly encapsulate guests136 is resorcinarene 37 (Fig-
ure 1.33),137 which assembles into a large capsule using 60 hydrogen bonds. Because
the resorcinarene capsules are quite large, they can accomodate large guest molecules.138
Another capsule, designed by Reinhoudt, appends hydrogen-bonding motifs to a cal-
ixarene to give 38.139 Because the hydrogen-bonding motif is not self-complementary,
capsules are only assembled when two equivalents of 5,5-diethylbarbituric acid (DEB) 14
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(a)
36
(b)
Figure 1.32: (a) The self-complementary hydrogen-bond motif 36 that assembles into
(b) the “tennis ball”.
37
Figure 1.33: The resorcinarene 37 which has been shown to assemble into large capsules
that can accomodate guest molecules.
(38)3 · (14)6
Figure 1.34: The capsule designed by Reinhoudt et al. that requires two complementary
partners to both be present in order for capsules to assemble.
are added (Figure 1.34). The result is a capsule that is assembled from three calixarene
38 molecules and six DEB 14 molecules.
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1.3 Self-Sorting in Hydrogen bonded Systems
Currently, only supramolecular assemblies constructed using one or two molecules have
been described. Although these small assemblies can enable materials to have new char-
acteristics, in order to obtain further new properties larger numbers of supramolecular
motifs must be used. Many different types of self-sorting systems have been described
in the literature,140 but this thesis will focus on nonintegrative,141 social self-sorting
systems,142 which use hydrogen bonds as the primary interaction. Nonintegrative sys-
tems are those that assemble into more than one architecture in solution, integrative
systems assemble all of the motifs into a single structure (Figure 1.35). A social self-
sorting system is one where molecules assemble into heterodimers and a narcissistic
self-sorting system is one where all molecules are self-complementary, so only homod-
imers are present.
Figure 1.35: A cartoon representation of integrative and nonintegrative, social and nar-
cissitic self-sorting systems.
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The previously described calixarene 38 was extended to give a double calixarene 39 ar-
chitecture, which could also interact with DEB 14 to give the (39)3 · (14)12 complex.143
On mixing of 38, 39 and DEB 14 it could be possible to obtain a number of different
homo- and heterocomplexes (Figure 1.36). However, it was found that no heterocom-
plexes were assembled, only the homocomplexes (38)3 · (14)6 and (39)3 · (14)12.143
38 39 14
(39)2 · (38)2 · (14)12 (39)1 · (38)4 · (14)12 (38)3 · (14)6 (39)3 · (14)12
Figure 1.36: Heterocomplexes containing both 38 and 39 are not assembled when 38, 39
and DEB 14 are mixed. Only the desired homocomplexes (38)3 · (14)6 and (39)3 · (14)12
are assembled.
Isaacs et al. have been able to obtain only homodimers from a mixture of two very similar
molecular clips (40 and 41). They found that along with differences in hydrogen-bond
arrays, shape complementarity and steric hindrances also prevented the assembly of the
undesired heterodimers.144 An extra molecule 42 could be added to this mixture, leading
to the narcissitic self-sorting145 of three very similar molecules (Figure 1.37).146
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40
41
42
Figure 1.37: The self-sorting mixture proposed by Isaacs et al. which assembles into
three homocomplexes. The assembly of heterocomplexes was not observed. R = CO2Et.
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The self-sorting of polymers is essential in biology for the replication and translation
of genetic material.147 To investigate whether self-sorting in synthetic polymers was
possible Burd and Weck incorporated two different recognition motifs into the polymer
backbone (Figure 1.38).147 The two molecules that were chosen were a thymine derivative
3, which interacts using a linear ADA hydrogen-bond array and cyanuric acid 14, which
interacts using a wedge-like ADAADA hydrogen-bond array. These two molecules have
very similar hydrogen-bond arrays, so could both interact with the same molecules,
preventing self-sorting processes from occurring. Nevertheless, it was found that on
addition of diamidopyridine 2 and isophthalic diamidopyridine 12, the self-sorting of
molecules attached to a polymer backbone was achieved.
2 ·3 14 ·12
Figure 1.38: Self-sorting of molecules attached to a polymer backbone is possible, even
when similar motifs are used.
Since all these examples appear to self-sort without requiring significantly different
hydrogen-bond arrays, Isaacs et al. were interested in investigating whether these rep-
resented special examples, or whether self-sorting was inherent in hydrogen bonded sys-
tems. It was found that nine molecules could be mixed, some of which had the potential
to assemble into undesired heterocomplexes, but only the desired homocomplexes were
obtained (Figure 1.39).70 All interactions could be broken and reformed by the addi-
tion/removal of DMSO, indicating that the thermodynamic, not the kinetic, product
was obtained each time. Investigation into how various stimuli (e.g. temperature, con-
centration, Ka) could affect the system was carried out. It was found that narcissitic
self-sorting can be robust to these external parameters, as long as the Ka of undesired
complexes is a factor of ten lower than the Kdim of the desired homodimers and equimo-
lar amounts of all components are present. It is expected that these general rules can
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43 44
45 38
14 19 41
36 40
Figure 1.39: The nine molecules that were used to assemble a self-sorting mixture.
(43)10 ·Ba2+ + 2Pic−, (44)16 · 2Ba2+ + 4Pic−, 45 ·45, (38)3 · (14)6, 19 ·19, 41 ·41,
40 ·40 and 36 ·36.
be reversed when heterocomplexes are desired over the formation of homocomplexes.
These self-sorted systems could lead to many polymer blends being made, allowing many
new materials properties to be realised. However, if it could be possible to manipulate
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the self-sorting system, allowing components to be altered using external stimuli, appli-
cations in information processing and molecular machines could be developed.148,149 An
example of a system that uses a controlled self-sorting system to carry out the desired
function has been described by Pe´rez et al.150 In this system the ring 46 can be shut-
tled to the desired position along the rod 47, using light as the stimulus (Figure 1.40).
When the olefin is in the Z-configuration the ring 46 selectively interacts at this posi-
tion; the peptide (red) preferentially adopts an alternative conformation, allowing the
formation of an intramolecular hydrogen bond, preventing the interaction of the ring
46. Converting the olefin to the E-configuration prevents the ring 46 from interacting
at this position, so it is shuttled along the rod 47 to interact with the peptide. The
isomerisation of the olefin is reversible, so the ring 46 can be shuttled along the rod 47
many times. Modification of the rod 47 into a macrocycle gives 48, which can act as
a molecular motor.151 In this system the direction that the ring 46 moves around the
macrocycle 48 can be controlled by using a combination of light and chemical stimuli
(Figure 1.41).
Figure 1.40: The ring 46 can be reversibly shuttled along the rod 47 using light as the
stimulus.
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Figure 1.41: A molecular motor 48 can be assembled by using a combination of light
and chemical stimuli.
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1.4 Project Aims
The above examples illustrate that synthetic molecules can be programmed so that they
only assemble into the desired structures, even in the presence of competing motifs.
However, the examples that are present in the literature tend to use shape comple-
mentarity, alongside different hydrogen-bonding arrays to aid self-sorting, and these
molecules can be difficult to synthesise. Ideally, self-sorting systems should be obtained
from simple, easy-to-synthesise molecules, allowing complexity to be achieved rapidly.
Generally, motifs with triple or quadruple linear hydrogen-bond arrays give strong Ka’s
and are easy-to-synthesise. However, when only linear arrays are present in a self-sorting
system there is the potential for many undesired complexes to be formed. In order to
use linear hydrogen-bond arrays in self-sorting systems greater understanding of the
fundamental features of hydrogen-bonding motifs is required. This thesis will focus on
the investigation of some of the fundamental features that can confirm the formation
of heterodimers; this increased understanding will enable a self-sorting system using
only linear hydrogen-bond arrays to be assembled. It has also been shown that external
stimuli, for example light, can be used to switch on and off the hydrogen bonding capa-
bilities of some molecules. Investigation into appending a photolabile group onto one of
the molecules, allowing a stimuli responsive self-sorting system to be obtained, is also
described.
Chapter 2
Effects of Preorganisation
An objective for supramolecular chemists is to obtain complex systems from simple
building blocks. Simple and easy-to-synthesise building blocks are desirable and there-
fore, all factors that can increase the binding affinity whilst keeping the molecules small
must be considered. Binding affinity, specifically the association constant (Ka) (Equa-
tion 1.2), is dependant on the contributions of enthalpy and entropy (Equation 1.3).
Therefore, in order to increase the binding affinity of supramolecular complexes, it is
not always necessary to add extra intermolecular hydrogen bonding groups, but simply
to rigidify the molecules so that they always present the desired hydrogen-bond array.
This should maximise affinities when low numbers of intermolecular hydrogen bonds are
used, which could also ease synthesis.
In complexes that interact using intermolecular hydrogen bonds there are many exam-
ples of how molecules have been preorganised.29,32,34,35,48,67,152–158 One strategy is to
use fused rings, forcing the molecules to present the desired array because they cannot
adopt alternative conformer states. The fused pyridine molecules (6 and 8), developed
by Leigh,29,35 participate in high affinity interactions (Figure 2.1). This strong binding
affinity is due to two reasons; there are no repulsive secondary electrostatic interac-
tions45 since the motifs present AAA 6 and AAAA 8 arrays and the molecules are fully
preorganised, minimising entropic loss on complex formation.
It is also possible to use intramolecular hydrogen bonds to preorganise molecules for com-
plex formation. There are many examples of molecules that are preorganised through a
combination of both rigid aromatic rings and intramolecular hydrogen bonds,32,34,48,67,152–157
33
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AAA ·DDD+ AAAA ·DDDD+
6 ·1 8 ·7
Ka = 3×1010 M−1 Ka> 3× 1012 M−1
Figure 2.1: Molecules that are preorganised by fused rings (red). No undesired hydrogen-
bond arrays can be presented because no alternative tautomer/conformer states can be
adopted. All association constants were determined in CH2Cl2.
some examples (20, 49, 50, 51 and 52) are shown in Figure 2.2. Care needs to be taken
when designing such molecules because they may have the ability to adopt undesired
conformer/tautomer states due to the nature of the heteroaromatic and amide/urea
functional groups that are used. There have also been examples of hydrogen-bonding
motifs that do not contain any aromatic rings. These molecules are preorganised by
using only intramolecular hydrogen bonds. This approach was used by Sanjayan et al.
in order to obtain self-complementary motifs 53 ·53 and 54 ·54 (Figure 2.3).158
There have been some previous studies on the effect that preorganisation using in-
tramolecular hydrogen bonds has on the binding affinity of complexes. Meijer et al. have
shown that the binding affinity of DADA ·ADAD arrays can be dramatically increased
by the addition of an intramolecular hydrogen bond (Figure 2.4).156 Diamidopyrimidine
55 does not contain any intramolecular hydrogen bonds and has a dimerisation con-
stant (Kdim) of 170 M−1. Switching one of the amide groups for urea functionality to
give 6-amido-2-ureidopyrimidine 56 allows for the formation of an intramolecular hy-
drogen bond. The self-association of 56 is dramatically increased (Kdim = 2× 105 M−1),
which is much higher than predicted by the rules set by Schneider.47 This strong bind-
ing affinity is probably because the intramolecular hydrogen bond not only preorganises
the pyrimidine 56 for interactions, but also because it alters the pKa of the hydrogen
bonding atoms through inductive effects. Electron density is removed from the NH’s
that form intermolecular hydrogen bonds, making them more acidic, allowing them to
form stronger interactions (Figure 2.4).
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20 49
50 51
52
Figure 2.2: Examples of self-complementary molecules that are preorganised using a
mixture of heteroaromatic rings and intramolecular hydrogen bonds. R denotes generic
alkyl group.
53 ·53 54 ·54
Figure 2.3: Self-complementary molecules that were introduced by Sanjayan et al. These
molecules are preorganised solely by the use of intramolecular hydrogen bonds. R de-
notes generic alkyl group.
55 ·55 56 ·56
Kdim = 170 M−1 Kdim = 2× 105 M−1
Figure 2.4: Addition of an intramolecular hydrogen bond dramatically increases the
self-association constant of the pyrimidines proposed by Meijer et al.
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Meijer et al. also introduced ureidopyrimidine (UPy) 19 as a self-complementary array
that can form homocomplexes with a strong dimerisation constant (Kdim = 2× 107 M−1).65
One issue is that UPy 19 can adopt different conformer/tautomer states (Figure 2.5),
of which some do not present self-complementary hydrogen-bond arrays, but are all
stabilised with an intramolecular hydrogen bond.34 Hailes et al. then introduced ureido-
cytosine (UCyt) 18,64 which can also form homodimers through the self-complementary
AADD array. One advantage of UCyt 18 over UPy 19 is that no alternative tautomers
can be adopted, reducing the number of available conformations. However, UCyt 18
does not contain an intramolecular hydrogen bond when the desired AADD array (18i)
is presented, but it can adopt a folded conformation (18ii), which does allow the forma-
tion of an intramolecular hydrogen bond (Figure 2.6). According to Etter’s rules,59 the
folded conformation that contains the intramolecular hydrogen bond should be favoured,
giving homodimers that interact through only two intermolecular hydrogen bonds, re-
sulting in a reduced binding affinity compared to UPy 19. However, because UCyt 18
forms strong homocomplexes (Kdim> 2× 105 M−1) it is most likely interacting through
the desired AADD array. Even though both complexes (18i and 18ii) contain a total of
four hydrogen bonds, it is possible that the unfolded AADD array is favoured because
it contains additional weak C–H · · ·O interactions to further stabilise the complex.36
Figure 2.5: The possible tautomer/conformers of UPy 19 that are all stabilised with an
intramolecular hydrogen bond. Only two (black) present self-complementary quadruple
hydrogen-bond arrays, the others (grey) do not self-associate.
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18i 18ii
Figure 2.6: Two possible conformers of UCyt 18. Although complexes with intramolec-
ular hydrogen bonds are normally considered favourable, here the additional weak C–
H · · ·O interactions favour self-assocation through the AADD array.
Currently, investigation of the effects of using intramolecular hydrogen bonding on bind-
ing affinity has only been carried out on self-complementary quadruple arrays. Further-
more, these effects are usually difficult to distinguish from other features; for example,
changes in pKa of the hydrogen bonding atoms due to inductive effects and preferential
tautomeric alternatives. The objective of this work was to investigate the effects of
preorganisation using triply hydrogen bonded heterocomplexes and has been published
in Chem. Eur. J.159 The phenylureidoimidazole (UIM) 17, previously reported by the
Wilson group,60 was chosen as the DDA array, which remained constant throughout
the study. It has been proposed that UIM 17 is a conformer independent DDA array
(Figure 2.7),60 which is important in this study because it remains constant, so must
have the same binding capabilities through all possible conformations. Further studies
were carried out in order to confirm that UIM 17 was conformer independent before
17i 17ii
17iii 17iv
Figure 2.7: Conformers/tautomers of UIM 17 that contain an intramolecular hydrogen
bond all present the desired hydrogen-bond array.
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investigation into the effects of preorganisation could be completed. The complemen-
tary AAD array was then systematically changed in order to investigate the effect that
intramolecular hydrogen bonds have on the binding affinity of AAD ·DDA heterocom-
plexes.
2.1 Conformer independent array
UIM 17 can only be truly conformer independent if all possible conformations can form
heterodimers with comparable binding affinities. In order to test this, a molecule that
presents the complementary AAD array had to be designed. Amidoisocytosine (AIC)
57 was chosen because of its similarities to UPy.65 AIC 57i contained an intramolec-
ular hydrogen bond which preorganised the molecule for binding, but AIC 57 could
also adopt an alternative tautomer which did not present the desired array 57ii, so it
was not a tautomer/conformer independent molecule (Figure 2.8a). Other tautomers
(e.g. pyrimidinol 57iii and 57iv) were not considered, even though they would nor-
mally be favoured due to aromaticity, because they did not contain an intramolecular
hydrogen bond. There were also additional steric and electrostatic repulsion between
the pyrimidine nitrogens and the amide group (Figure 2.8b) disfavouring formation of
the pyrimidinol tautomer. It was proposed that both conformers of UIM (17i and 17ii)
are able to interact with AIC 57 (Figure 2.9).
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(a)
57i 57ii
(b)
57iii 57iv
Figure 2.8: (a) There are two possible tautomers of AIC 57 that both contain an in-
tramolecular hydrogen bond, but only one presents the desired AAD array. (b) Other
possible tautomers do not allow the formation of an intramolecular hydrogen bond and
have steric/electrostatic interactions.
57 ·17i 57 ·17ii
Figure 2.9: Heterocomplexes that can be formed between AIC 57 and UIM 17.
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2.1.1 Synthesis of Molecules
Both UIM 17 and AIC 57 were synthesised following procedures developed within the
Wilson group. Boc protection of guanidine to give the boc-guanidine 58 followed by
cyclisation with 1-bromopinacolone gave the imidazole 59. Deprotection in acidic con-
ditions to obtain the free amine 60, followed by reaction with phenylisocyanate gave
the UIM 17 (Scheme 2.1). Separation of UIM 17 from the side product, diphenylurea,
was difficult and required multiple crystallisations. In the original paper60 these crys-
tallisations were not carried out and the measured association constants were lower than
reported here as a result of the small amounts of impurities that were present.160 AIC 57
was synthesised in a one step amide coupling between isocytosine and benzoyl chloride
(Scheme 2.2). A catalytic amount of DMAP was required to further activate the acyl
chloride because the amine is unreactive.
58 59
60 17
Scheme 2.1: Synthesis of UIM 17.
57
Scheme 2.2: Synthesis of AIC 57.
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Crystal structures of both AIC 57 and UIM 17 were obtained (Figure 2.10).161 The
crystal structure of AIC 57 does not present the desired hydrogen-bond array 57i, but
instead adopts the alternative tautomer 57ii. There are two possible reasons for this; the
tautomer found in the crystal structure could be the lowest energy conformation, or it
could be because this tautomer is able to pack better in the solid state. The desired AAD
array cannot self-associate, but the alternative tautomer presents a self-complementary
AD array. Conversely, the crystal structure of UIM 17 does present one of the desired
hydrogen-bond arrays. The required DDA array can be self-complementary through
bifurcated hydrogen bonds, and this is the case here; molecules are linked through
bridging methanol molecules (Figure 2.10c). Attempts were made to grow co-crystals of
AIC 57 and UIM 17, but these were all unsuccessful.
(a) (b)
(c)
Figure 2.10: Crystal structures of (a) AIC 57, (b) UIM 17 and (c) the packing structure
of UIM 17 showing the bridging methanol molecules that form bifurcated hydrogen
bonds between two UIM 17 molecules.
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2.1.2 Binding Studies
Before investigations could be carried out to establish whether UIM 17 is a conformer in-
dependent array it was confirmed that the UIM ·AIC 17 ·57 heterodimer can be formed
in solution. When molecules interact they become close in space and this change in
chemical environment can be followed by 1H NMR.162 Comparison of 1H NMR spec-
tra of the individual molecules with the 1:1 mixture shows that there are significant
complexation induced shifts (Figure 2.11). Any change in shift indicates that there are
interactions between the molecules because the chemical environment of some protons
has changed.
Figure 2.11: Typical 1H NMR spectra from the titration of UIM 17 into AIC 57 (CDCl3,
300 MHz, 6 mM). Ratio of AIC:UIM 57:17 (a) 1:0, (b) 1:0.5, (c) 1:1, (d) 1:2.
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To further confirm the formation of the complex in solution, diffusion ordered two-
dimensional NMR spectroscopy (DOSY) studies were carried out. DOSY can be used
to measure the size of components in solution. The speed with which they diffuse through
the solution is related to their size. Small components tumble much quicker than larger
ones, so formation of the complex can be observed by measuring the diffusion coefficient
of a 1:1 mixture compared to the individual molecules. Because the diffusion coefficient
is related to the size of the molecule, the size of the assembly that is formed in solu-
tion can be calculated using Equation 2.1.163 Dimerisation of the individual molecules
was established by measuring the diffusion coefficient at two extremes. For UIM 17,
diffusion coefficients of D = 7.092× 10−10 m2 s−1 and D = 5.247× 10−10 m2 s−1 at 10 and
100 mM respectively were measured. Using Equation 2.1 and assuming that dimeric
species (517 Da) is formed at high concentrations, it was calculated (210 Da) that the
species present at low concentrations is a monomer (actual mass 259 Da) of UIM 17.a
Similarly, AIC 57 gave D = 9.575× 10−10 m2 s−1 and D = 7.058× 10−10 m2 s−1 for 10
and 100 mM respectively. Assuming AIC 57 is only present as the homodimer (458 Da)
at the higher concentration, a mass of 182 Da is calculated for the low concentration,
corresponding to monomer (actual mass = 229 Da). Since UIM 17 and AIC 57 are
monomeric at 10 mM, this was the concentration of choice to study formation of the
heterocomplex. The methyl group of AIC 57 was followed, giving a diffusion coefficient
of D = 7.721× 10−10 m2 s−1. This corresponds to a mass of 493 Da, which suggests that
a heterodimer (actual mass = 488 Da) is present.
D[low]
D[high]
=
3
√
MW[high]
3
√
MW[low]
(2.1)
aThe calculated mass is lower than than the actual mass because the DOSY technique includes a
layer of solvent around the molecule when calculating the radius, which was not taken into account for
the MW[high].
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2.1.3 Measurement of Dimerisation
Having demonstrated that the complex does indeed form in solution it was necessary to
determine the binding affinity. There are many techniques available for measuring the
association constant (Ka) of complexes, including by 1H NMR titration. The change in
proton shift is proportional to the stength of the interaction, making it possible to use
this to calculate the strength of interaction in the complex. Firstly, dilution studies were
carried out in order to ascertain whether the individual components can self-associate.
If self-association is high it can impact upon the equilibrium position (Equation 2.2),164
resulting in a lower concentration of the desired complex being present. This in turn
impacts upon the Ka (Equation 2.3) because Ka is equal to the concentration of the
desired complex over the concentration of all other species that are present. If the
concentration of undesired species is high then Ka is lower as a result.
UIM ·UIM + AIC ·AIC
 UIM + AIC
 UIM ·AIC (2.2)
Ka =
[UIM ·AIC]
[UIM ·UIM][AIC ·AIC][UIM][AIC] (2.3)
Dimerisation constants (Kdim) for both UIM 17 and AIC 57 were found to be negligible
(10± 2 M−1 and 4± 1 M−1 respectively) by 1H NMR dilutions and were therefore, not
included in any of the calculations for Ka. The titrations to obtain Ka were then carried
out; a solution of UIM 17 containing some AIC 57 was titrated into a solution of AIC
57. After each aliquot of UIM 17 was added a 1H NMR spectrum was recorded and the
change in shift was plotted against the equivalents of UIM 17 (Figure 2.12). HypNMR165
was used to calculate the Ka of the complex, which was found to be 33000± 16000 M−1.
The titration was carried out in triplicate and the mean average taken as the association
constant and the reported error is the standard deviation of the three measurements.
Since error(Ka) and eerror(ln(Ka)) are not comparable, the average and error of Ka could
not simply be converted to ∆G.b ∆G was then calculated for each individual titration
using Equation 1.2, where R is the Boltzmann gas constant (8.314 J K−1 mol−1) and T
is temperature (298 K), and the mean value taken as the ∆G and the error was the
bGuidance from Dr. Matthew Greenwood-Nimmo, Lecturer in Applied Econometrics at the Univer-
sity of Leeds, was taken for calculation of average ∆G’s.
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standard deviation of the converted ∆G’s. This gave ∆G =−25.6± 1.2 kJ mol−1. It was
not possible to carry out the reverse titration (where AIC 57 was titrated into UIM
17) because of solubility restrictions. The results obtained here were much higher than
reported in the original paper,60 probably due to the more rigorous purification of the
UIM 17 to remove any trace impurities which could interfere with interactions.
Figure 2.12: Typical titration graph obtained from HypNMR for the titration of UIM
17 into AIC 57 (0.006 M).
When molecules interact there is normally a change in enthalpy and entropy, which can
result in a release of energy. This release of energy can be measured using isothermal
titration calorimetry (ITC).166 ITC measures any changes in temperature by maintain-
ing a standard cell at the same temperature as the experimental cell. As molecules are
titrated into the experimental cell, energy must be added or removed from the standard
cell, ensuring that it remains at the same temperature as the experimental cell. This
energy correlates to the energy released by the molecules when they interact. Because
ITC can be carried out at lower concentrations than 1H NMR, it was possible to perform
the titration in both directions (i.e. UIM 17 into AIC 57 and AIC 57 into UIM 17)
(Figure 2.13). Titrations between UIM 17 and AIC 57 provided usable endotherms for
curve fitting; however, since ITC measures a combination of hetero and homodimerisa-
tion, dilution studies were carried out as well as the normal titrations. It was shown that
AIC 57 did not self-associate because there was no change in heat release throughout
the dilution experiment. UIM 17 has a different dilution curve which shows that as
it becomes more concentrated it releases more heat, indicating that self-association is
occurring. Figure 2.13 shows the titration and dilution curves for the titration of UIM
17 into AIC 57 alongside the reverse experiment (i.e. AIC 57 into UIM 17). Standard
analysis of the data by subtraction of dilution curves from titration curves gave data
that could not be fitted with standard MicroCal models available in the Origin software.
Therefore, a global analysis of all titration and UIM 17 dilution data, using a mixed
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(a)
(b)
Figure 2.13: ITC titrations (black) and dilutions (grey) for (a) AIC 57 in the cell and
(b) UIM 17 in the cell.
association model, that allows for UIM 17 dimerisation coupled to AIC ·UIM 57 ·17
binding was carried outc using the SEDPHAT software programme.167 This data analysis
provided a rigorous determination of the binding parameters for the interaction of UIM
17 with AIC 57, giving values of Ka = 24700± 3800 M−1, ∆Ha =−41.9± 2.1 kJ mol−1
and Kdim = 520± 70 M−1, ∆Hdim =−28.3± 1.3 kJ mol−1. The association constant cor-
responds to ∆Ga =−24.6 kJ mol−1, ∆Sa = 58.9 J K−1 mol−1. The analysis reveals, as ex-
pected, an enthalpy driven process. Furthermore, the association constant obtained us-
ing ITC is comparable to that determined by 1H NMR spectroscopy. The self-association
constant that is extracted for UIM 17 however, is one order of magnitude different be-
tween ITC and 1H NMR (Kdim = 520 M−1 and Kdim = 11 M−1 respectively). This may
cAnalysis was carried out with the guidance of Dr. Bruce Turnbull.
Chapter 2 47
reflect the small signal changes observed and limited concentration range accessible in
the 1H NMR experiment due to solubility limitations.
2.1.4 Confirmation of Conformer Independence
Although extensive studies on the dimerisation of AIC ·UIM 57 ·17 have been carried
out, it has still not been confirmed whether UIM 17 is conformer independent. The 1H
NMR spectra illustrate that UIM 17 interacts with AIC 57 because of the large changes
in shift seen between the individual components and the mixture. However, there is
only one signal present for each proton of the UIM 17, which can mean two things.
Firstly, it could be that only one conformer/tautomer is present in solution and this is
the one that interacts. Secondly, it could be that all conformers/tautomers interconvert
and the signals that are seen are an average of all of tautomer/conformer states that are
present in solution. The second option is most likely because each conformer/tautomer
is stabilised by only one intramolecular hydrogen bond, so should be easily broken. 1H-
1H NOESY gives evidence that both conformations of UIM 17 can interact with AIC
57 (Figure 2.14) however, it is difficult to differentiate between the tautomers because
the resonances corresponding to these are not resolved. It is likely that because of the
bulk of the tBu group only two of the tautomers (17i and 17ii) can interact because the
other two (17iii and 17iv) are sterically hindered.
Chapter 2 48
Figure 2.14: 1H-1H NOESY of AIC ·UIM 57 ·17 shows that two conformers of UIM 17
can interact.
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A low temperature 1H NMR spectrum (400 MHz, CDCl3, 213 K, 40 mM) of a 1:1 mixture
of UIM ·AIC 17 ·57 shows that more than one conformer/tautomer of UIM 17 is present
(Figure 2.15). As the sample is cooled, exchange between the different confomer/tau-
tomer states is slowed. Since each conformer/tautomer places protons in different chem-
ical environments and exchange is sufficiently slow at low temperatures, they can be
distinguished by 1H NMR. There are three visible tBu peaks, with one more prevalent
than the others. However, it was not possible to assign the peaks to particular conform-
ers because the sample precipitated when it was cooled down for extended periods of
time required to perform 1H-1H NOESY experiments.
Figure 2.15: As the sample is cooled, exchange between the different tautomer/conformer
states slows, meaning that the peaks resolve, allowing the different tautomers to be
observed. (400 MHz, CDCl3, 213 K, 40 mM)
Although 1H-1H NOESY and low temperature 1H NMR spectra confirmed that different
conformations of UIM 17 were present in the AIC ·UIM 57 ·17 complex, neither could
conclude what ratios each conformer were in. It was necessary to turn to molecular
modelling in order to ascertain the binding affinity of each conformer of UIM 17. If the
two conformers were found to have similar binding affinities by molecular modelling then
it could be assumed that UIM 17 is a conformer independent array. DFT calculations
were carried out using Gaussian 03,168 which is the program of choice because it can
accurately predict hydrogen bonds. However, the molecules and complexes are large,
which led to long calculation times when the desired, global basis set (6-311++G**)
was used. This required new basis sets to be written so that hydrogen bonds could be
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accurately predicted using a large basis set, whilst the rest of the molecule was calculated
using a smaller basis set, decreasing the calculation time. All calculations were carried
out using the B3LYP level of theory in the gas phase. The basis set that was chosen for
calculations was C, 6-31G, N/O, 6-31G*, H, 6-31++G**; this includes polarisation169
and diffusion170 functions on hydrogen-bonding atoms, but keeps the calculation of non-
hydrogen-bonding atoms simple. It is important to include polarisation and diffusion
functions on the hydrogen-bonding atoms because they share electron density, so their
orbitals become distorted as the hydrogen bond is formed. Results using this basis set
were compared to those of a larger basis set (C/N/O, 6-311G*; H, 6-311++G**) and
were found to be quite similar (Table 2.1). The individual molecules (17 and 57) and
the complex 17 ·57 was calculated using both basis sets. Subtraction of the energy of
the individual molecules from that of the complex gave the energy from intermolecular
interactions. A difference of only 10 kJ mol−1 was obtained between the two basis sets,
which is a relatively small difference in energy. Since the purpose of molecular modelling
in this study was not to obtain absolute binding affinities, but simply to observe trends,
the smaller basis set was able to calculate the binding affinities to the required accuracy.
Table 2.1: Comparison of the basis sets. Small; C, 6-31G, N/O, 6-31G*, H, 6-31++G**.
Large; C/N/O, 6-311G*, H, 6-311++G**.
Small Big
(Hartrees) (Hartrees)
UIM 17 −681.243 −681.524
AIC 57 −778.527 −778.849
AIC ·UIM 57 ·17 −1459.822 −1460.421
∆G (kJ mol−1) −136.9 −126.8
Firstly, the energies of the possible conformers and tautomers of UIM 17 and AIC
57 were calculated. It was found that for UIM 17,d both conformers that contain an
intramolecular hydrogen bond have very similar energies (Figure 2.16). A difference of
only ∼2 kJ mol−1 was calculated. AIC 57 was different, the tautomer that presents the
desired hydrogen-bond array (57i) is ∼ 30 kJ mol−1 higher in energy than the alternative
tautomer (57ii), found in the crystal structure (Figure 2.17).
dThe tBu group was removed for two reasons. 1, to simplify the calculations and 2, to reduce the
number of conformer/tautomer possibilities.
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17i 17ii
−681.243 Hartrees −681.242 Hartrees
∆E = 1.863 kJ mol−1
Figure 2.16: The energies of UIM 17i and 17ii that were obtained using B3LYP/C,
6-31G; N/O, 6-31G*; H, 6-31++G**.
(a) (b)
57i 57ii
−778.527 Hartrees −778.539 Hartrees
∆E = 30.756 kJ mol−1
Figure 2.17: The energies of AIC 57i and 57ii that were obtained using B3LYP/C,
6-31G; N/O, 6-31G*; H, 6-31++G**.
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Even though both conformers of UIM 17 are similar in energy, it still does not necessar-
ily mean that they both interact with similar binding affinities. The energies of the two
possible complexes (57 ·17i and 57 ·17ii) were calculated using the same basis set as for
the individual motifs (Figure 2.18), but with counterpoise171,172 included. Counterpoise
allows the basis set superposition error (BSSE) to be calculated. As molecules approach
one another their basis functions overlap, resulting in each molecule increasing its basis
set. This results in a higher energy being calculated and using counterpoise allows this
error to be removed. Counterpoise runs five calculations for each complex; the energy
of each molecule in their own basis set, the energy of each molecule using the global
basis set and the energy of the complex. The BSSE can be calculated by addition of the
errors in calculating the individual molecules, which is the difference in energy for the
molecules calculated using the individual and global basis set. The strength of the in-
termolecular interactions can be calculated by subtracting the energies of the molecules
calculated in their own basis sets from the counterpoise corrected complex. This energy
is higher than the energy measured experimentally because it does not include the en-
tropic loss that occurs when the molecules twist out of their favoured, planar geometry,
57 ·17i 57 ·17ii
−110.3 kJ mol−1 −115.4 kJ mol−1
Figure 2.18: Molecular modelling of the AIC ·UIM 57 ·17 complex.
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Table 2.2: Molecular modelling of the complexes shows that both complexes have
similar binding affinities.
AIC ·UIM AIC ·UIM
57 ·17i (Hartrees) 57 ·17ii (Hartrees)
AIC ·UIM 57 ·17 a −1459.822 −1459.824
AIC ·UIM 57 ·17 b −1459.812 −1459.813
AIC 57 c −778.529 −778.530
AIC 57 d −778.522 −778.523
AIC 57 e −778.527 −778.527
UIM 17 c −681.244 −681.244
UIM 17 d −681.241 −681.239
UIM 17 e −681.243 −681.242
Intermolecular interactions −127.2 f −133.0 f
Measured intermolecular interactions −110.3 f −115.4 f
a Without counterpoise correction.
b With counterpoise correction
c Using the global basis set.
d Using the basis set for the individual molecule.
e The planar molecule calculated alone.
f kJ mol−1.
in order to reduce steric hindrance in the complex. To include this change in geometry
to the calculation of the binding affinity, the energy of the molecules calculated in their
planar geometry is subtracted from the counterpoise corrected complex. A summary of
the results obtained for the AIC ·UIM 57 ·17 complex can be found in Table 2.2. Both
conformers of UIM 17 gave similar results, with UIM 17ii having slightly stronger inter-
molecular interactions (−115.4 kJ mol−1) than 17i (−110.3 kJ mol−1).e This is probably
because, in the unfolded UIM 17i, steric interactions between the phenyl ring of AIC
57 and the imidazole of UIM 17 mean that the phenyl ring has to twist further out of
the plane (27.6 ◦), resulting in a loss of conjugation.
In summary, it has been shown that the UIM ·AIC 17 ·57 complex forms in solution and
the measured Ka using different methods, provides consistent results. 1H NMR studies
confirmed that UIM 17 can interact through two possible conformers and molecular
eThe binding affinities obtained from molecular modelling are much higher than the experimental
results because the calculations are carried out in the gas phase, so solvation is not taken into account.
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modelling has shown that the binding affinity of these two conformers is similar. These
results confirm that UIM 17 is a conformer independent array.
2.2 Effects of preorganisation in AAD · DDA arrays
Throughout the study described below, UIM 17 remained constant and the comple-
mentary partner was changed to different molecules that present an AAD array, but
with different degrees of preorganisation and steric hindrance. Two new molecules were
designed (61 and 62) that both present an AAD array, but do not contain a preor-
ganising intramolecular hydrogen bond. n-Hexylbenzamidocytosine (HAC) 61 shows
similarities to the UCyt 18 that was introduced by Hailes.64 The benzamidonaphthyri-
dine (ANT) 62 is similar to the naphthyridine described by Corbin et al.61 however,
it has an extra methyl group which could interfere with the binding affinity because of
steric interactions.
57 61
62 17
2.2.1 Synthesis of Molecules
For the synthesis of UIM 17 and AIC 57 see Section 2.1.1. HAC 61 was synthesised in
two steps (Scheme 2.3). Firstly, amide coupling between cytosine and benzoyl chloride
in the presence of base and catalytic DMAP gave the insoluble amidocytosine 63. To
aid solubility an alkyl chain was added via an SN2 reaction to give the HAC 61. The
alkylation was low yielding, because there are other possible alkylation sites in the
molecule and a mixture of all these products was obtained.173 A crystal structure of
HAC 61 was obtained from the slow addition of hexane into a CHCl3 solution of HAC 61
(Figure 2.19). In the crystal structure the desired AAD hydrogen-bond array is presented
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63
61
Scheme 2.3: Synthesis of HAC 61.
(a)
61
(b) (c)
Figure 2.19: The crystal structure of (a) HAC 61 with (b) the packing structure from
(c) different views.
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and the molecules interact through two of these hydrogen bonds in the extended packing
structure. The molecules are assembled into rows however, it does not appear that they
interact through pi-pi stacking because the molecules are not aligned correctly. ANT 62
was synthesised (Scheme 2.4) following minor modifications to a literature procedure.43
Diamidopyridine was dissolved in hot phosphoric acid, before dimethoxy-2-butanone was
added dropwise, to give the aminonaphthyridine 64. Reaction with benzoyl chloride in
the presence of NEt3 gave the ANT 62. Multiple crystallisations were necessary in order
to obtain material that was pure enough to aquire accurate results from the 1H NMR
titration experiments.
64
62
Scheme 2.4: Synthesis of ANT 62.
2.2.2 1H NMR Titrations
It was expected that AIC 57 would have the strongest binding affinity towards UIM 17
because it is preorganised for interactions by the intramolecular hydrogen bond, which
may also increase binding affinity through inductive effects. ANT 62 was predicted to
have the lowest binding affinity because it does not contain a preorganising intramolec-
ular hydrogen bond and also has a sterically hindering methyl group. HAC 61 was
expected to have an association constant inbetween that of the other two complexes.
1H NMR titrations were carried out for each of the complexes and data was processed
using HypNMR165 to give Ka and ∆G. It was found that ANT 62 had the lowest bind-
ing affinity for UIM 17 (∆G =−19.3± 0.4 kJ mol−1), but the binding affinities of AIC
57 and HAC 61 with UIM 17 (∆G =−25.6± 1.2 and −24.2± 0.3 kJ mol−1 respectively)
were both similar. This result shows that preorganisation of AIC 57 with an intramolec-
ular hydrogen bond does not dramatically increase its binding affinity towards UIM 17.
The reasons for this were not immediately obvious, so conformational analysis of the
individual components and their complexes was carried out.
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2.2.3 NMR Studies of Compounds and Complexes
1H-1H NOESY spectra of the individual components UIM 17 and AIC 57, did not give
good structural information because all of the NH protons were broadened. This is
presumably because they are in rapid exchange, so are not visible by 1H NMR. For the
other molecules, HAC 61 and ANT 62, the NH protons were visible in the 1H NMR
spectra, making it possible to gain more information. It was found that no correlations
between the NH and other protons were observed in HAC 61, but only one conformation
was visible in the 1H-1H NOESY spectrum for ANT 62 (Figure 2.20). Only correlations
between the NH and He were observed. Correlations between the NH and Hd, which
Figure 2.20: 1H-1H NOESY of ANT 62 shows that the desired conformation is the only
one that is present in solution.
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could arise from the molecule being in an alternative conformation, were not seen. This
suggests that ANT 62 presents the desired hydrogen-bond array in solution. 1H-1H
NOESY spectra were also obtained for the mixtures of HAC 61 and ANT 62 with UIM
17. These however, only showed evidence that one conformer of UIM 17 was interacting.
This could either mean that the second conformer does not form complexes or that it
does not show up in the 1H-1H NOESY spectra because non-covalently bound species
can give weak nOe’s. Since the binding array in AIC 57 and HAC 61 is very similar it
is unlikely that both conformations of UIM 17 will interact with AIC 57, but not HAC
61. For ANT 62 the binding face is more hindered because of the methyl group, which
could block the approach of one of the conformers of UIM 17.
2.2.4 Molecular Modelling
Since no useful structural information was obtained for the individual molecules and
complexes using 1H NMR studies, molecular modelling was carried out. Firstly, the
energy of four possible rotamers of HAC 61 (Figure 2.21) and ANT 62 (Figure 2.22)
were calculated, using the same level of theory and basis set as described in Section 2.1.4.
These four rotamers were chosen because they are likely to be the most stable. They
can adopt a planar structure, allowing the sp2 orbitals to align, so that delocalisation
of the p-electrons can occur throughout the entire molecule. It was found that the
rotamers that present the desired hydrogen-bond array were the lowest in energy for
both molecules, which is presumably because of unfavourable steric/electronic clashes
in the alternative rotamers. This is the opposite to AIC 57, where the lowest energy
tautomer presented an undesired hydrogen-bond array.
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61i 61ii
+ 31.5 kJ mol−1
61iii 61iv
+ 37.5 kJ mol−1 + 45.0 kJ mol−1
Figure 2.21: Molecular modelling of HAC 61 revealed that the conformer that presents
the desired hydrogen-bond array (61i), is lowest in energy. Energies show how much
higher in energy each conformer (61ii, 61iii and 61iv) is than the ground state molecule
(61i).
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62i 62ii
+ 31.5 kJ mol−1
62iii 62iv
+ 38.2 kJ mol−1 + 43.4 kJ mol−1
Figure 2.22: Molecular modelling of ANT 62 revealed that the conformer that presents
the desired hydrogen-bond array (62i), is lowest in energy. Energies show how much
higher in energy each conformer (62ii, 62iii and 62iv) is than the ground state molecule
(62i).
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The energy of the conformer/tautomer that presents the desired hydrogen-bond array
of AIC 57 (Figure 2.18), HAC 61 (Figure 2.23) and ANT 62 (Figure 2.24a) with both
conformers of UIM 17 were then calculated, using the same level of theory and basis
set as described previously. It was shown that the AIC ·UIM 57 ·17 complex had the
strongest binding affinity (∆G =−110.3 and −115.4 kJ mol−1) and HAC ·UIM 61 ·17
had a lower binding affinity (∆G =−92.5 and −95.9 kJ mol−1). This does not agree with
the experimental values, where AIC 57 and HAC 61 had similar binding affinities to UIM
17 (∆G =−25.6±1.2 and−24.2±0.3 kJ mol−1 respectively). A likely explanation for this
is that the lowest energy conformer of HAC 61 presents the desired hydrogen-bond array,
so it does not have to change conformer in order to form complexes. AIC 57 on the
other hand, possibly presents an undesired hydrogen-bond array. Therefore, in order to
interact with UIM 17, AIC 57 must change tautomer/conformer, losing energy, before
it can form the heterocomplex and this is not accounted for in the calculations. This loss
in energy means that, although molecular modelling indicated that the intermolecular
hydrogen bonds were stronger in the AIC ·UIM 57 ·17 complex, the measured binding
affinities of AIC 57 and HAC 61 were very similar. ANT ·UIM 62 ·17 had the lowest
binding affinity (∆G =−70.9 and−76.5 kJ mol−1), which was because of steric hindrance
from the methyl group, which can be seen when viewed from the side (Figure 2.24b).
The methyl group of ANT 62 blocks the approach of both conformations of UIM 17,
61 ·17i 61 ·17ii
−92.5 kJ mol−1 −95.9 kJ mol−1
Figure 2.23: Molecular modelling for the HAC ·UIM 61 ·17 complex.
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(a)
62 ·17i 62 ·17ii
−70.9 kJ mol−1 −76.5 kJ mol−1
(b)
Figure 2.24: (a) Molecular modelling for the ANT ·UIM 62 ·17 complex and (b) the
side views showing how the methyl group of ANT 62 sterically hinders the approach
of UIM 17 in both conformations, preventing strong intermolecular interactions from
forming.
meaning that all the hydrogen bonds are longer and therefore weaker as a result.
2.3 Conclusions
It has been shown that UIM 17 is a conformer independent array that can interact
with similar energies through both conformations. This makes it ideal for use in studies
that compare the binding affinities of AAD arrays because it does not matter which
conformer of UIM 17 interacts, they both give the same results. Therefore, sterics
should not affect the results because both conformers have similar binding affinities.
Intramolecular hydrogen bonding, tautomeric preferences and electrostatic and steric
interactions all play important roles in determining the preferred conformation of the
individual molecules. It is important to ensure that the lowest energy conformation
presents the desired hydrogen-bond array in order to obtain the highest possible binding
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affinities. For the molecules used in this study it was found that preorganisation using
hydrogen bonds did not dramatically increase the binding affinity of the complexes, as
had been predicted. However, the molecular modelling results suggest that, if molecules
containing intramoleuclar hydrogen bonds could be designed so that they present the
desired AAD array in the lowest energy tautomer/conformer, then binding affinities
could be increased.

Chapter 3
Remote Substituent Effect and
Applications in Supramolecular
Polymer Assembly
It was shown in Chapter 2 that the binding affinity of hydrogen-bonding motifs can
be modulated by changing the extent to which molecules are preorganised using in-
tramolecular hydrogen bonds.159 There are many other factors that can also affect the
stability of supramolecular complexes including the conformer/tautomer preference,60,63
the number of hydrogen bonds,174 the arrangement of the hydrogen bonds45 and the
strength of the individual hydrogen bonds.24 The strength of the individual hydrogen
bonds is controlled by the pKa of the atoms involved, which can be modulated by chang-
ing the electron donating/withdrawing nature of adjacent substituents. The substituent
effect could then be used in supramolecular polymers as a simple way to access different
binding properties, without having to redesign the hydrogen-bonding motif in order to
obtain the desired binding affinity for the chosen application.
65
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There have been attempts to quantify the effect that electron donating/withdrawing
substituents have on the binding affinity of hydrogen-bonding arrays.28,175,176 In order
to study the binding affinity of the DNA bases in non-aqueous solvent, Kyogoku et al.
made some modifications to the bases (65 and 66) using electron donating/withdrawing
substituents (Figure 3.1).175 They found that, in general, binding affinities increased
with electron withdrawing substituents. This is most likely because electron withdraw-
ing groups remove electron density from the NH of uracil, making it more acidic and
therefore better at forming strong hydrogen bonds (Table 3.1) However, the measured
differences are small and no errors were reported, indicating that the measured differ-
ences represent an insignificant change in the binding affinity.
(a) (b)
65iv 66 65 66iv
66i X = CH3 Y = O Z = H 65i X’ = N(CH3)2 Y’ = H Z’ = H
66ii X = H Y = O Z = H2 65ii X’ = N(CH3)H Y’ = H Z’ = H
66iii X = H Y = S Z = H 65iii X’ = NH2 Y’ = H Z’ = H
66iv X = H Y = O Z = H 65iv X’ = H Y’ = H Z’ = NH2
66v X = H Y = O Z = CH3 65v X’ = NH2 Y’ = H Z’ = NH2
66vi X = H Y = O Z = Br 65vi X’ = NH2 Y’ = H Z’ = Br
66vii X = H Y = O Z = I
Figure 3.1: DNA base derivatives 65 and 66 designed by Kyogoku.
Table 3.1: Table to show the binding affinities of complexes in the study by Kyogoku.
Complex Ka (M−1) Complex Ka (M−1)
65iii ·66i <1 65i ·66iv 1.5
65iii ·66ii 30 65ii ·66iv 50
65iii ·66iii 90 65iii ·66iv 100
65iii ·66iv 100 65iv ·66iv 45
65iii ·66v 130 65v ·66iv 170
65iii ·66vi 240 65vi ·66iv 140
65iii ·66vii 220
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Another study of the effect that substituents can have on the binding affinity of com-
plexes was carried out by Deans et al.,176 who designed a receptor 67 for flavin 68.
Again, a correlation between binding affinity and the substituent was found (Figure 3.2),
but the differences were small and there were some anomolies that did not fit the
trend. The strongest interactions were obtained when electron withdrawing groups were
present, presumably because they decreased the electron density of the two NH protons,
affording stronger hydrogen-bonding atoms. Weaker interactions were obtained when
electron donating groups were present because, although they increased the electron den-
sity of the triazine nitrogen, the binding capabilities of both NH’s was reduced, making
the overall binding affinity weaker as a result. It would normally be expected that,
when hydrogen is the substituent, a binding affinity between that of electron donating
and withdrawing groups would be obtained. In this example however, the hydrogen
substituent had the lowest binding affinity, probably because it did not enhance or re-
duce the binding affinity of any of the hydrogen-bonding atoms. Therefore, although
this study showed that there was a correlation between electron donating/withdrawing
groups and the binding affinity of the complexes, it was difficult to predict the binding
affinity of substituents that were not included in the experiment.
67 ·68
Molecule Substituent (X) Binding affinity (Ka)
67a OMe 44 M−1
67b Me 53 M−1
67c H 24 M−1
67d CF3 63 M
−1
67e NO2 97 M
−1
Figure 3.2: Binding affinity of 67 to 68 could be modulated by changing the electron
donating/withdrawing nature of the substituent.
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3.1 Substituent Control over the Binding Affinity of
DDA · AAD Arrays
Although the studies described above showed that differences in binding affinity can
be obtained by changing the electron donating/withdrawing nature of the substituent,
the differences were small and it was difficult to predict what binding affinity untested
molecules would have. For the substituent effect to be quantified, molecules with stronger
binding affinities should be used, allowing any effects to be magnified. In order to ensure
that a trend without anomolies can be observed, the substituent should be appended
to the terminus of the array, which should allow each atom to be affected equally. This
should also prevent steric interactions and the conformer preference of the molecules from
changing, no matter which substituent was present. UIM 17 and AIC 57,60 described
in Chapter 2, were chosen for this study because they interacted through an ADD ·DAA
array and both contained a phenyl ring appended to the end of the hydrogen-bond array,
which was easy to functionalise (57a-f and 17a-i). Because remote substituents were
used a difference in binding affinity between electron donating and electron withdrawing
groups was observed without interference from sterics and undesired conformations. This
work was published in Org. Lett.177
57 ·17
57a X = H 17a Y = H 17e Y = Me
57b X = MeO 17b Y = CF3 17f Y = Cl
57c X = CO2Me 17c Y = MeO 17g Y = F
57d X = tBu 17d Y = CO2Et 17h Y =
tBu
57e X = Cl
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3.1.1 Synthesis of the Molecules
Both series of molecules were synthesiseda using methods that had previously been devel-
oped within the Wilson group.60 Compounds in the AIC series 57a-e were synthesised
in one step, which was amide coupling of the chosen benzoic acid 69 with isocytosine,
using EDCI and DMAP as the activating agents (Scheme 3.1). A crystal structure of
AIC 57d was obtained by the slow evaporation of MeOH (Figure 3.3) and it was found
to be in the same, undesired conformation as the crystal structure of AIC 57a (Fig-
ure 2.10a). The second series (UIM 17a-h) was synthesised in four steps (Scheme 3.2).
Guanidine hydrochloride was protected to give Boc-guanidine 58 before cyclisation us-
ing 1-bromopinacolone was carried out to give the imidazole 59. The next step was
deprotection of the imidazole 59 to give the free amine 60, which was reacted with
the chosen isocyanate in the presence of NEt3, to give the desired UIM 17. The final
step was low yielding because it was difficult to separate the desired UIM 17 from the
biproduct, diphenyl urea, leading to significant loss of product during purification.
69a X = H 57a X = H 33%
69d X = tBu 57d X = tBu 83%
69e X = Cl 57e X = Cl 40%
Scheme 3.1: Synthesis of the AIC 57 series. Molecules shown were synthesised by myself,
others were synthesised by Andrea McGhee and Adam Gooch.
57d
Figure 3.3: The crystal structure of AIC 57d shows that an alternative conformation,
which does not present the desired AAD array, is presented in the solid state.
aAndrea McGhee, Adam Gooch and myself were all involved in the synthesis of the compounds.
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58 59
60 17a Y = H 29%
17e Y = Me 46%
Scheme 3.2: Synthesis of the UIM 17 series. Molecules shown were synthesised by
myself, others were synthesised by Andrea McGhee and Adam Gooch.
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3.1.2 1H NMR Titration Experiments
The self-association of UIM 17 and AIC 57 had already been studied60 but dimerisation
constants (Kdim) were required for the remaining molecules in each series to ensure that
they would not impact on the association constants of the heterocomplexes. It was
found that Kdim was negligible for all of the molecules (Table 3.2), so was not included
in any of the calculations for association constants of the heterodimers. The Ka’s were
measuredb for AIC 57a with all of the UIM’s 17a-h and for UIM 17a with all of the
AIC’s 57a-e (Table 3.3). Each titration was carried out in triplicate in order to obtain
more accurate results and attempts were made to remove human error from the results
by using more than one person. Ka’s were then converted to ∆G’s and Hammett plots
(Figure 3.4) were generated by plotting the sigma (σ) value178 of the substituent against
the measured ∆G for the given complex over ∆G for 57a ·17a (∆GX or Y/∆GH). Errors
were calculated (Equation 3.1) to show the standard deviation of the measurements.
Table 3.2: Table to show the dimerisation constants (Kdim) measured for each
molecule.
Molecule Kdim (M−1) Molecule Kdim (M−1)
57a 3.6± 0.3 17a 10.6± 2.2
57b 1.5± 0.3 17c 25.2± 1.0
57d < 1 * 17e 2.0± 0.1
57f < 1 * 17h < 1 *
57c 4.7± 1.1 17f < 1 *
17g < 1 *
17d 12.5± 2.4
17b 10.9± 1.8
* Negligible change in shift was observed for these molecules, this equates to negligible
dimerisation constants.
bAll 1H NMR titrations were carried out by myself and Adam Gooch, a former PhD student in the
Wilson group.
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Table 3.3: Table to show the binding constants for substituents throughout both series
and how these relate to their sigma values.
57-X 17-Y σ Ka ∆G
(× 103 M−1) (kJ mol−1)
CO2Me H 0.44 10± 7.9 −22.4± 1.6
Cl H 0.24 18± 13 −23.4± 2.8
H H 0.00 33± 16 −25.6± 1.2
tBu H -0.15 25± 20 −23.6± 4.2
OMe H -0.27 41± 3.9 −26.3± 0.2
H CF3 0.53 86± 34 −28.0± 0.9
H CO2Et 0.44 84± 22 −28.0± 0.6
H Cl 0.24 11± 8.4 −22.4± 2.6
H F 0.24 8.1± 2.8 −22.2± 1.0
H H 0.00 33± 16 −25.6± 1.2
H tBu -0.15 1.9± 0.8 −18.5± 1.0
H Me -0.14 3.7± 2.2 −20.2± 1.3
H OMe -0.27 3.8± 2.2 −20.1± 1.6
(a) (b)
Figure 3.4: Hammett plots to show the correlation between the association constants
and substituent effect for (a) the AIC 57 series and (b) the UIM 17 series.
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A2e
A2
=
B2e
B2
+
C2e
C2
(3.1)
A =
∆GX or Y
∆GH
,Ae = SDX or Y
H
B = ∆GX or Y,Be = SDX or Y
C = ∆GH,Ce = SDH
In the AIC 57 series, a four fold difference in Ka was measured between the strongest and
weakest interactions (57c 10100± 7900 M−1 → 57b 40900± 3900 M−1), which does not
represent a significant effect. This was not surprising because, as has previously been sug-
gested,179 the carbonyl group can insulate against any effects that the substituent might
have on the hydrogen-bonding atoms. It seems that, in this case, electron-withdrawing
groups stabilise negative charge development on the NH nitrogen (Figure 3.5a), making
it a better hydrogen bond donor. At the same time positive charge on the carbonyl
carbon is destabilised, furnishing a weaker intramolecular hydrogen bond. The opposite
was observed for electron donating groups; positive charge build-up on the carbonyl
is stabilised, allowing stronger intramolecular hydrogen bonds to form. This gave a
slightly stronger association constant when electron donating groups were present, even
though the electron density of the NH increased. It was proposed that the increased
binding affinity due to the stronger intramolecular hydrogen bond was cancelled out
by the weakening of the NH hydrogen bond, leading to only a small change in the
Ka as substituents were changed from electron-withdrawing to electron-donating. Con-
versely, there was nearly two orders of magnitude difference in the UIM 17 series (17h
1900± 800 M−1 → 17b 86200± 33800 M−1). There were no insulating groups present
57 17
Figure 3.5: The proposed reasons for the observed differences in binding affinities for
the AIC 57 and the UIM 17 series.
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in this series, allowing the substituent to have a direct effect on the hydrogen-bonding
atoms. Electron withdrawing groups could stabilise negative charge on the nitrogen
(Figure 3.5b), making the hydrogen more acidic, allowing it to form stronger hydrogen
bonds. The opposite was true for electron donating groups, electron density increased
at the NH’s, affording weaker hydrogen bonds.
3.1.3 Molecular Modelling
Since the NH’s did not appear in the 1H NMR spectra of either series of compounds it was
difficult to obtain structural information on the individual molecules and complexes using
1H NMR techniques. Because of this, molecular modelling was used to provide further
insight into the differences in binding affinities that had been measured. Following
protocol from Jorgensen and Pranata,45 DFT calculations at the B3LYP/6-31G* level
of theory were carried out to obtain the geometry of each individual molecule using
Gaussian03.168 For the AIC 57 series, when the desired DAA array was presented,
the phenyl ring was slightly twisted to prevent steric interactions between the ArCH
and NH protons (Figure 3.6a). In contrast, the UIM 17 series could take on a planar
geometry (Figure 3.6b) when the desired DDA binding array was presented, whichever
conformation was adopted.
In order to compare the hydrogen bonding abilities of each molecule, the Mulliken val-
ues180 were obtained for each atom involved in intermolecular hydrogen bonding (Ta-
ble 3.4). Mulliken values are a measure of the electronegativity of atoms; stronger
(a) (b) (c)
57a 17a 17a
Figure 3.6: Figure showing (a) the steric interactions in AIC 57 that force the phenyl
ring to twist and lose conjugation and (b) the planar structure of UIM 17 in (c) both
conformations.
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Table 3.4: Table to show how the Mulliken Values of the atoms involved in
hydrogen bonding change as the strength of the interaction changes.
57-X A B C
OMe 0.368025 -0.556871 -0.526338
Me 0.369315 -0.556096 -0.525138
H 0.369957 -0.555439 -0.524308
Cl 0.363866 -0.556925 -0.511179
CO2Me 0.370544 -0.554845 -0.523051
17-Y D E F
CF3 0.328203 0.341659 -0.537103
CO2Me 0.328262 0.341585 -0.537178
Cl 0.327507 0.341435 -0.357374
H 0.324916 0.339929 -0.538526
Me 0.323865 0.339470 -0.538972
OMe 0.324071 0.339681 -0.538843
17-Y G H I
CF3 0.337946 0.346312 -0.588508
CO2Me 0.338111 0.346750 -0.586609
Cl 0.337779 0.345982 -0.590288
H 0.336564 0.343734 -0.590287
Me 0.336272 0.343162 -0.591346
OMe 0.336860 0.344270 -0.591015
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hydrogen bonds are formed when hydrogens are more acidic, with low electron density.
Therefore, a more positive Mulliken value indicates that strong interactions should oc-
cur. For hydrogen bond acceptors (e.g. O and N) a more negative value leads to stronger
interactions because this indicates that the atom has a higher electron density. 1H NMR
titration experiments showed that, for the AIC 57 series, electron donating groups gave
the strongest binding affinities and the same trend was observed from the Mulliken values
(Table 3.4). When electron donating groups were present, the hydrogen bond acceptors
B and C became more negative. The hydrogen bond donor A however, became less
positive, indicating that weaker hydrogen bonds could be formed. So, even though one
hydrogen bond had weaker interactions, two increased their hydrogen bonding ability,
which gave an overall gain in binding affinity. The UIM 17 series gave a similar result
for both conformations. Two of the atoms (D,E and G,H) became stronger hydrogen
bond donors, whilst the third (F and I) became weaker hydrogen-bonding atoms as the
binding affinity increased.
This same effect could be visualised using electron density maps (Figure 3.7). Red
shows areas of high electron density, allowing hydrogen-bond acceptors to form stronger
intermolecular interactions. Blue shows areas of low electron density, allowing hydrogen-
bond donors to form stronger intermolecular interactions. For the UIM 17 series the
NH’s became more blue (Figure 3.7a) when an electron withdrawing group was present.
For the AIC 57 series the O and N became more red (Figure 3.7b) when an electron
donating group was present. This result was in agreement with the 1H NMR titration
results.
Chapter 3 77
(a)
17c 17b
-20.4 kJ mol−1 -28.2 kJ mol−1
-5.000e−2 7.500e−2
(b)
57c 57b
-22.9 kJ mol−1 -26.3 kJ mol−1
-8.000e−2 7.000e−2
Figure 3.7: Electron density maps of the molecules that form the strongest and weakest
interactions for (a) UIM 17 and (b) AIC 57.
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3.2 Substituent Effect in Supramolecular Polymers
It was proposed that the substituent effect described above can be applicable to many
hydrogen-bonding motifs. The substituents are appended to the end of the hydrogen-
bond array, so should not interfere sterically or conformationally. Currently, a popular
area of research is in supramolecular polymers84 because of their ease-of-synthesis, facile
handling and new materials properties when compared to covalent polymers.181 A com-
mon supramolecular polymer monomer is the ditopic UPy 19 unit (Figure 3.8a),156
which can assemble into polymers (Figure 3.8b) because UPy 19 is self-complementary.
Figure 3.8: (a) The monomer building block. Self-complementary UPy can form (b)
supramolecular polymers when linked together.
There are many examples of UPy 19 polymers in the literature. Short alkyl link-
ers65,117,182,183 have been used in order to study the ring/chain equilibrium of supramolec-
ular polymers.120,184–186 In order to more easily obtain the desired materials properties
the linker was extended so that it was a UPy 19 capped polymer chain.187–189 It can
also be made so that the UPy 19 moiety is placed within the polymer chain,190 allowing
many contacts to be made between chains, making the assembly much stronger. The
fact that UPy 19 can form strong interactions to DAN 21 can allow two different types
of polymers to be mixed,191,192 enabling new materials properties to be made.
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All of these examples use alkyl linkers between the UPy 19 units, but in order to study
the remote substituent effect in supramolecular polymers, the UPy 19 units must be
linked together through a phenyl ring (Figure 3.9). Using isoelectronic esters allows
the desired electron donating/withdrawing properties to be obtained, whilst keeping
the linkers the same, so that interactions between the linking groups should remain the
same in both cases.193 Although there it could be possible for the two isoelectronic
supramolecular polymers to have different crystallisation/packing properties, they are
as similar as possible, so any differences in the material properties can be assumed to
be due to differences in their hydrogen bonding capabilities. By changing the electron
donating/withdrawing nature of the linker it should be possible to change the strength
of the intramolecular interactions and hence change the degree of polymerisation (DP).
Since the remote substituent in the UPy molecules is attached to the hydrogen-bond
array through the urea functionality, its binding properties should be analogous to the
UIM 17 series. Electron withdrawing groups should afford more acidic NH’s, making
them better at forming hydrogen bonds, allowing large assemblies to accumulate. An
electron donating group should have the opposite effect, increasing electron density at
the urea NH’s, affording a lower association constant, which should be visible by the
formation of smaller assemblies in solution (Figure 3.9).
Figure 3.9: The two self-complementary polymers that were designed, with (a) electron
withdrawing and (b) electron donating substituents. According to the substituent effect
described in Section 3.1, when applied to the hydrogen-bonding motifs here, n>m is
predicted.
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3.2.1 Synthesis of polymers
The monomer building block that was first proposed for the synthesis of both electron
withdrawing and electron donating supramolecular polymers had a methyl group ap-
pended to the isocytosine functionality and a short, six-carbon linker (EWG 70 and
EDG 71).
70
71
Investigation into the addition of the linker was tested using benzoyl chloride and phenol
as mimics for the UPy functionality to give molecules 72 and 73 (Scheme 3.3). Because
these reactions were successful, synthesis of the ditopic UPy’s was attempted. Reaction
of 2-amino-6-methylpyrimidin-4-ol with the desired isocyanate gave UPy-CO2Et 74 and
UPy-OMe 75. UPy-CO2Et 74 was then hydrolysed
194 using NaOH to give the UPy-
COOH 76 (Scheme 3.4), which was insoluble, so further reactions could not be carried
out. Demethylation of UPy-OMe 75 with boron tribromide,195 to give the UPy-OH 77
(Scheme 3.5), also gave an insoluble material, which would not undergo further reactions.
A different route was required so that the desired monomers could be synthesised.
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72
73
Scheme 3.3: Synthesis of the short linkers using benzoyl chloride and phenol.
74
76
Scheme 3.4: Synthesis of the insoluble UPy derivative 76.
75
77
Scheme 3.5: Synthesis of the insoluble UPy derivative 77.
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It was reasoned that addition of a long, solubilising alkyl chain to the UPy derivatives
could make the precursor molecules more soluble, allowing further reactions to be carried
out. Firstly isocytosine with a long alkyl chain 78 was synthesised (Scheme 3.6) by
reaction of myristoyl chloride with potassium malonate to give ethyl 3-oxohexadecanoate
79, which was cyclised by reaction with guanidinium carbonate to give the isocytosine
78.193 The isocytosine 78 was reacted with the chosen isocyanate to give the desired
molecules, UPy-CO2Et 80 (Scheme 3.7) and UPy-OMe 81 (Scheme 3.8). Hydrolysis of
UPy-CO2Et 80 was carried out in the presence of NaOH
194 to give UPy-COOH 82 and
demethylation of UPy-OMe 81 was carried out in the presence of BBr3 to give UPy-OH
83.195 Several attempts were made to synthesise the ditopic units with a short linker
however, the desired products were never isolated.
79 78
Scheme 3.6: Synthesis of the isocytosine 78 with a long alkyl chain.
78
80 82
Scheme 3.7: Synthesis of electron withdrawing UPy.
78
81 83
Scheme 3.8: Synthesis of electron donating UPy.
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It could be that the ditopic UPy’s with a 6-carbon linker were not isolated because
the direct difunctionalisation was not possible. Addition of a longer linker which con-
tained a terminal alkene was first tested on benzoic acid (Scheme 3.9) to give 84. The
terminal alkene was present so that two molecules could be joined using metathesis to
give the desired difunctionalised molecule. The mechanism164 for the cross metathesis
(Figure 3.10) is firstly a [2+2] cycloaddition between the carbene and the alkene to give
a metallocyclobutane. This reaction then occurs in reverse, leaving the alkene attached
to the Ru. A further [2+2] cycloaddition between another alkene in solution and the Ru
carbene gives another 4-membered ring containing both functional groups. The reverse
reaction can release the product, regenerating the catalyst.
84
Scheme 3.9: Synthesis of benzoic acid derivative 84 functionalised with a long alkyl
chain with a terminal alkene.
Figure 3.10: Cross metathesis mechanism.
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The strategy of esterification followed by metathesis was then used in the synthesis of
both UPy-EWG 85 and UPy-EDG 86 (Scheme 3.10 and Scheme 3.11). Esterification
was carried out between the acid and alcohol precursors using DMAP and EDCI as the
coupling reagents to give the UPy esters 87 and 88. The metathesis reaction could
then be carried out using the first generation of Grubbs catalyst.196 The solvent was
degassed for 1 hr before the alkene precursor was charged to the flask. The catalyst
was then added dropwise over 10 hrs before the reactions mixture was left to stir for a
further 12 hrs. The ditopic UPy’s 85 and 86 were both obtained as a mixture of cis-
and trans-alkene, but since they were probably both obtained in the same ratio (difficult
to ascertain from the broad 1H NMR spectra) in both polymers they were taken on as a
mixture. Since such a long flexible linker was used it should not cause problems having
both cis- and trans-alkene present because they should both have the same binding
properties.
82
87
85
Scheme 3.10: Synthesis of UPy-EWG 85.
83
88
86
Scheme 3.11: Synthesis of UPy-EDG 86.
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3.2.2 Self-Assembly into Polymers
There are many different materials properties that can be measured, but to measure
the differences between 85 and 86 the size of the assemblies and melting temperatures
are important factors. Differential scanning calorimetry (DSC) is a technique that mea-
sures melting transitions of polymers and it was thought that if the strength of the
intermolecular hydrogen bonds in 85 and 86 was different, then different melting tem-
peratures would be obtained. Although a transition was observed for UPy-EWG 85
at about 70 ◦C, no transition was observed for UPy-EDG 86 (Figure 3.11). This could
be because there are no transitions, but it could also be because the transition is very
broad, so cannot be detected. These initial results indicated that DSC was not a suit-
able technique for the study of these types of supramolecular polymers, so no further
experiments were carried out.
Figure 3.11: DSC experiment for both UPy-EWG 85 and UPy-EDG 86 indicates that
there is a transition at ∼70 ◦C for 85, but that there is no transition for 86.
Because interactions between these ditopic molecules can result in polymer networks
being assembled, the viscosity of the solution can be changed when different concentra-
tions of monomer are present and also when different types of monomer are present. It
is possible to measure the viscosity of the solution using a viscometer (Figure 3.12); the
time taken for the solution to travel between two lines is measured and compared to that
of the solvent alone. Differences between chloroform and the supramolecular polymer
solutions at different concentrations were measured (Table 3.5) however, the differences
between the two polymers were found to be negligible. There are possibly two reasons
for this: (1) the travel time was too short, making it difficult to know if differences are
real, or measurement errors and (2) the solubility of the polymers was poor, resulting
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Figure 3.12: A cartoon representation of the viscometer that was used in these experi-
ments. The solution was sucked up the right hand tube before the time taken for it to
travel between the lines under gravity control was measured.
Table 3.5: Table to show the measured values for different concentrations of both
supramolecular polymers.
Polymer (Conc mM) Run 1 (s) Run 2 (s) Run 3 (s) Average (s)
(0) 45.30 45.50 45.94 45.58± 0.33
85 (10.42) 48.25 48.40 48.33 48.33± 0.08
85 (8.34) 47.79 48.08 47.86 47.91± 0.15
85 (6.95) 47.61 48.15 47.82 47.86± 0.27
86 (12.59) 51.89 51.94 51.95 51.93± 0.03
86 (10.07) 50.31 50.52 50.35 50.39± 0.11
86 (8.40) 50.05 49.90 50.42 50.12± 0.27
86 (7.20) 49.40 49.81 50.01 49.74± 0.31
86 (6.30) 49.57 50.66 50.16 50.13± 0.55
in the capilliary tube getting blocked which made measurements unreliable. These re-
sults indicated that viscometry was not sensitive enough to measure differences in the
assembly properties of these similar supramolecular polymers.
Since the polymers did not stay in solution during the viscometry experiment, gela-
tion was also attempted in order to detect differences between these two supramolecular
polymers. It was thought that UPy-EWG 85 would form gels at lower concentrations
than UPy-EDG 86 because of it’s predicted stronger hydrogen bond interactions, allow-
ing larger polymer networks to assemble. It was found that the only solvent that the
polymers would dissolve in was chloroform and gels were formed by 85 at 40 mM after
40 days, whereas no gelation was observed in the 40 mM solution of 86. Although this
does represent a difference in the two supramolecular polymers, the long time taken for
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the gel to form is not viable as a form of testing the differences in these polymers. It
could be that gelation only occurred because some chloroform evaporated resulting in a
higher concentration of polymer, or that the concentration of H2O increased over time,
resulting in a solvent conformation that the supramolecular polymer would not dissolve
in.
DOSY can be used to measure the size of the assemblies that are present in solution, so
could be used to see if there are differences in the DP of the 85 and 86 supramolecular
polymers at different concentrations. As the concentration was decreased it was found
that the 1H NMR peaks sharpened for both polymers, which was indicative of smaller
assemblies being present in solution. The smaller the assemblies, the quicker they tumble
through solution and so faster diffusion coefficients (D) are measured. D was measured
for both UPy polymers (85 and 86) at 30, 20, 10 and 1 mM concentrations (Table 3.6).
Because D was very similar for 10 and 1 mM in both polymers it was reasoned that
this was the smallest assembly that could be formed in solution; probably representing
a single molecule. For UPy-EWG 85, D for 1 and 10 mM were similar, but when
higher concentrations were tested D began to decrease, indicating that larger assemblies
were formed. For UPy-EDG 86, the 20 mM solution had a similar D to the 1 and
10 mM solutions and D only began to decrease at 30 mM concentrations. Assuming that
the quickest D represented a single monomer at low concentrations, the DP could be
calculated. Firstly the molecular weights (MW) of the assemblies at each concentration
were calculated (Equation 3.2) where D[low] was the D for 1 mM solutions and MW[low]
was assumed to be the monomer. The DP was then calculated by dividing the weight
of the polymer assembly by the weight of the monomer units (Equation 3.3). Plotting
the DP results against concentration (Figure 3.13) showed that the EWG 85 began
to polymerise at lower concentrations than the EDG 86. This showed that higher
concentrations of UPy-EDG 86 were required to initiate polymer assembly, indicating
Table 3.6: Diffusion coefficients and the DP that these correlate to for the polymers at
different concentrations.
UPy-EWG 85 UPy-EDG 86
Conc. D
DP
D
DP
(mM) (× 10−10 m2 s−1) (× 10−10 m2 s−1)
30 2.315± 0.005 16.58± 0.48 2.089± 0.010 12.57± 0.29
20 3.652± 0.016 4.22± 0.09 4.470± 0.120 1.28± 0.06
10 5.817± 0.007 1.05± 0.03 5.040± 0.025 0.90± 0.02
1 5.903± 0.070 1.00 4.858± 0.060 1.00
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Figure 3.13: Graph to show the correlation between the concentration and DP for both
polymers, UPy-EWG 85 and UPy-EDG 86. Lines serve to guide the eye.
that weaker interactions were present compared to UPy-EWG 85, which is in agreement
with the predictions from earlier experiments (Section 3.1).
D[low]
D[high]
=
3
√
MW[high]
3
√
MW[low]
(3.2)
DP =
MWpolymer
MWmonomer
(3.3)
3.3 Conclusions
It has been shown that the binding affinity of supramolecular complexes can be modu-
lated, simply by changing the electron donating/withdrawing nature of the substituent.
By using remote substituents, connected to the end of the linear hydrogen-bond array
through conjugation, it was possible to alter the binding affinities without favouring
alternative conformations or sterically hindering the binding face of the molecules. The
substituent effect was then applied to other hydrogen-bonding motifs that are commonly
used in the assembly of supramolecular polymers. Although differences in the size of the
assembly were observed using DOSY, the other techniques were not sensitive enough
to measure differences between the two supramolecular polymers. This could indicate
that using the remote substituent effect to modulate the properties of supramolecular
polymers should only be used to fine tune the characteristics, not to make large changes.
Chapter 4
A Novel ADDA Quadruple
Hydrogen-Bond Array
As shown in Chapters 2 and 3, the binding affinity of molecules can be manipulated by
altering molecular features (e.g. conformation and electronics) that are not directly in-
volved in hydrogen bonding. However, simply changing the strength of interactions will
probably not allow the assembly of a high fidelity self-sorting system. New hydrogen-
bonding motifs which interact using different arrays must be designed in order to achieve
the desired high affinity and high fidelity systems. There are examples of hydrogen-
bonding motifs that present ADDA arrays, allowing them to interact with the com-
plementary DAAD array diamidonaphthalene (DAN) 21; however there is an ongoing
requirement for molecules that can achieve high affinity interactions to DAN 21 without
competition from homodimerisation.
21
Diphenylurea (DPU) 89 dimerises with DAN 21 with a low association constant (Ka
= 103 M−1).152,197 The reason for this low association constant has been attributed
to DPU 89 being preferentially in the folded state,59 to allow the formation of an in-
tramolecular hydrogen bond (Figure 4.1). This results in a self-complementary AD array
being presented, allowing DPU 89 to weakly self-associate (Kdim = 5 M−1 at 50 ◦C).61
Ditriazoleurea (DTU) 90 has recently been introduced by Hisamatsu et al. (Figure 4.1).
89
Chapter 4 90
Although DTU 90, like DPU 89, can fold so that an intramolecular hydrogen bond is
formed allowing self-association to occur (Kdim = 102 M−1), it forms strong interactions
with DAN 21 (Ka = 105 M−1).40 The difference in binding affinities between DPU 89
and DTU 90 with DAN 21 has been attributed to steric hindrance between the car-
bonyl oxygen and aromatic protons in the unfolded conformers. In DPU 89 there is
a short distance between the oxygen and proton, disfavouring the unfolded conformer.
For DTU 90 the distance between the oxygen and proton is greater because of the size
and shape of the five-membered-ring, allowing the unfolded conformer to be adopted
with less steric hindrance.
89 89
90 90
Figure 4.1: The two conformers of DPU 89 and DTU 90 which present the desired
ADDA and self-complementary AD arrays. Steric hindrance in DPU 89 favours the
folded conformation, preventing formation of the heterodimer.
Other hydrogen-bonding motifs that have been shown to interact with DAN 21 can
also adopt alternative tautomeric states, allowing them to present self-complementary
hydrogen-bonding arrays. Ureidopyrimidine (UPy) 19, introduced by Meijer, forms a
strong homodimer66 (Kdim> 105 M−1) but on addition of DAN 21 this homodimer dis-
sociates in favour of formation of the heterodimer (Ka> 105 M−1) (Figure 4.2).68,198,199
Although both the homo- (19 ·19) and heterocomplex (21 ·19) have strong association
constants, formation of the heterocomplex is preferred, presumably because it allows
the largest number of hydrogen bonds to be formed. There are six hydrogen bonds in
the UPy homodimer, but this dissociates in order to form two UPy ·DAN 19 ·21 com-
plexes, which contain ten hydrogen bonds altogether. Zimmerman has also designed
molecules that can self-associate and interact with DAN 21. Deazapterin (DeAP) 20,
like UPy 19, self-associates strongly (Kdim> 105 M−1) but can also interact with DAN
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21 (Ka> 105 M−1). In an attempt to increase the fidelity of molecular association with
DAN 21, Zimmerman et al. designed ureidoguanosine (UG) 22, which presents the de-
sired ADDA array when the lowest energy tautomer is adopted.37 The association con-
stant of UG ·DAN 22 ·21 complex is still high (Ka = 108 M−1) but the self-association
of UG 22 (Kdim = 102 M−1) is much lower than that of UPy 19 and DeAP 20.200 This
means that the fidelity of the UG ·DAN 22 ·21 system is high, but there still remains
a requirement for molecules that form strong interactions to DAN 21 with even lower
dimerisation constants than UG 22. The design, synthesis and molecular recognition
properties of one possible molecule is described below; this work has been submitted to
Org. Biomol. Chem.201
19 ·19 21 ·19
Figure 4.2: The UPy dimer 19 ·19 dissociates on addition of DAN 21 to preferentially
form the heterodimer 21 ·19.
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4.1 Design and Synthesis of UDIM and DAN
Extension of the previously studied UIM 17 ADD array with a second imidazole gave
the ureidodiimidazole (UDIM) 91, which presents an ADDA array when it is in the
unfolded conformation. As in UIM 17, UDIM 91 can adopt two different conformers
(Figure 4.3), along with several different tautomers. It was reasoned that the desired
conformer would be easily adopted because it contained two stabilising intramolecular
hydrogen bonds, the same as the undesired folded conformer, and none of the alternative
conformer/tautomer states presented self-complementary hydrogen-bond arrays.
91i 91ii
Figure 4.3: The two possible conformations that UDIM 91 could adopt whilst retaining
two intramolecular hydrogen bonds.
UDIM 91 was synthesised (Scheme 4.1) following a similar procedure to that of UIM 17
(see Section 2.1.1). Protection of guanidine to give the boc-guanidine 58, followed by
cyclisation with 1-bromopinacolone gave the boc-imidazole 59 which was deprotected us-
ing 1 M HCl in EtOH to give the aminoimidazole 60. Initial reactions to form the UDIM
91 were all unsuccessful, so the synthesis was optimised using 2-aminobenzimidazole to
give the ureidodibenzimidazole 92. 1,1-Carbonyldiimidazole (CDI) was reacted with 2-
aminobenzimidazole and a range of solvents were tested (Scheme 4.2). It was found that
THF was the solvent of choice for the reaction because it gave the largest conversion to
the product which could be collected simply by filtration of the reaction mixture. Be-
cause the aminoimidazole 60 is present as the hydrochloride salt a base must be added to
the reaction mixture in order to reveal the free amine. The addition of NEt3 was tested
59 91
Scheme 4.1: The synthesis of UDIM 91.
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in the reaction of 2-aminobenzimidazole with CDI in THF to investigate whether the
addition of NEt3 could be tolerated. Similar conversion rates were observed with and
without NEt3, indicating that it was not a problem for it to be present. The aminoim-
idazole 60 was then reacted with 1,1-carbonyldiimidazole in the presence of NEt3 to
give the UDIM 91. Although this final step was low yielding no attempts were made to
optimise the reaction because enough material was obtained in order to carry out the
desired experiments.
(a)
92
(b)
92
Scheme 4.2: The synthesis of ureidodibenzimidazole 92 was used to test the formation
of the urea. Firstly (a) the ideal solvent was found and secondly (b) the addition of
NEt3 to the reaction was tested.
DAN 93 was synthesised (Scheme 4.3) using a modified literature route.191,202 Reaction
of 2,6-diaminopyridine and malic acid gave the aminohydroxy naphthalene 94. The
aminohydroxy naphthalene 94 was then reacted with valeroyl chloride in pyridine to give
the naphthalamide 95 which was converted to the chloride 96 using POCl3. Addition
of valeramide was then carried out in the presence of catalytic palladium to give DAN
93.
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95 96
93
Scheme 4.3: The synthesis of DAN 93.
4.2 Conformational Studies of UDIM
Since UDIM 91 is symmetrical it should have four (broad) signals in the 1H NMR spec-
trum, if rapid exchange between the different conformer/tautomer states occurs. How-
ever, the 1H NMR spectrum of UDIM 91 at room temperature contained more than
four signals (Figure 4.4a), which indicated that slow exchange between the different tau-
tomer/conformer states occured on the NMR timescale. The 13C NMR spectrum also
indicated that slow exchange was occuring because there were many more signals than
would normally be expected (Figure 4.4b). Cold temperature 1H NMR (Figure 4.4c)
confirmed that many conformer/tautomer states were present in solution, with some
being more prevalent than others. On heating (Figure 4.4d and e) the signals began to
converge into four broad NH signals, which indicated that exchange between conformer-
s/tautomers had become more rapid, but since they had not completely converged into
the expected two NH signals this exchange was still quite slow.
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91i 91ii
Figure 4.4: (a) 1H NMR spectra of UDIM 91 (40 mM, 300 MHz, CDCl3) and (b)
13C
NMR spectra of UDIM 91 confirm that slow exchange between tautomer/conformer
states occur allowing many states to be observed (40 mM, 125 MHz, CDCl3). Variable
temperature 1H NMR shows that at high temperatures the signals converge to give a
more symmetrical spectra. (c) 213 K, (d) 293 K (e) 333 K (40 mM, 500 MHz, CDCl3).
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Ideally, in order for the strongest possible interactions to be formed the unfolded con-
former of UDIM 91 must be the most prevalent in solution. However, the folded con-
former has the potential to assemble into heterodimers, through bifurcated hydrogen
bonds (Figure 4.5), so it could be possible that the folded conformer is favoured over
the desired unfolded conformer. 2D NMR experiments were carried out in order to
investigate which conformer of UDIM 91 was the most prevalent in solution. HMQC
(Figure 4.6) showed that Hf was in two different environments within the molecule.
There were correlations to two different carbon atoms from the ArCH proton, which
confirmed that the molecule was not symmetrical in solution. However, this could arise
from either conformation being present (Figure 4.6), so could not establish the structure
of UDIM 91.
91ii ·91ii
Figure 4.5: The folded conformer of UDIM 91ii has the potential to assemble into
homodimers through a bifurcated hydrogen-bond array.
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91i 91ii
Figure 4.6: HMQC of UDIM 91 shows that Hf is in two different environments.
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1H-1H NOESY (Figure 4.7) showed that every proton was correlated to all of the other
protons. However, this could have been obtained from either conformer state, because
they can both place all protons within close proximity of all the other protons. One
problem with this experiment is that it was not possible to distinguish between through-
space correlations and proton exchange peaks, so many of the observed interactions may
simply be exchange peaks.
91ii 91ii 91i
Figure 4.7: 1H-1H NOESY of UDIM 91 shows that each proton is coupled to all of the
other protons, but this could arise from either conformation.
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Since the 2D NMR experiments could not confirm which conformer UDIM 91 adopted
in solution it was not possible to predict whether it was monomeric, or present in larger
assemblies. In order to measure the self-dimerisation of UDIM 91, some dilution and
co-solvent experiments were carried out. Firstly, a solution of UDIM 91 in CDCl3 was
diluted from 113 mM to 12 mM (Figure 4.8). No change in shift of any of the proton
signals was observed, indicating that either UDIM 91 was monomeric, even at very high
concentrations, or that it was bound strongly in assemblies, even when the concentration
was reduced. To confirm whether UDIM 91 was present in larger assemblies, DMSO-d6
was added to a solution of UDIM 91 in CDCl3 (Figure 4.9). Even at very low concen-
trations of DMSO-d6 the NH’s began to converge and broaden, which indicated that
either exchange between conformer/tautomer states occured more rapidly with an in-
creasing concentration of DMSO-d6, or that the equilibrium distribution of conformers
had changed. At 4% DMSO the proton at 6 ppm had become sharp, indicating that
exchange between the conformer/tautomer states was increasing. Although some of the
proton peaks shifted as the concentration of DMSO-d6 increased, this was not necessarily
due to a complex induced shift, but because the composition of the solvent was different
and protons can have different chemical shifts in different solvents. A solution of UDIM
91 in 5% DMSO-d6–CDCl3 was then diluted from 100 mM to 0.5 mM (Figure 4.10).
Again, there was no change in the chemical shift of any of the protons, which indicated
Figure 4.8: A solution of UDIM 91 was diluted (300 MHz, CDCl3). (a) 113 mM, (b)
46 mM, (c) 19 mM, (d) 12 mM.
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that UDIM 91 was monomeric because DMSO-d6 is a very strong hydrogen bond accep-
tor and normally interferes with the assembly of hydrogen-bonded complexes as their
concentration is decreased. This indicated that UDIM 91 was monomeric in CDCl3
solutions, but it was not possible to distinguish what the most prevalent conformer was.
Figure 4.9: DMSO was added to a solution of UDIM 91 (10 mM, 300 MHz, CDCl3). (a)
0.00%, (b) 1.64%, (c) 4.00%, (d) 10.45%, (e) 20.00%.
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Figure 4.10: A solution of UDIM 91 in 5% DMSO:CDCl3 was diluted (a) 96.9 mM, (b)
48.5 mM, (c) 9.7 mM, (d) 1.0 mM, (e) 0.5 mM.
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4.3 Heterodimerisation Studies of UDIM · DAN
Since it had been shown that UDIM 91 was monomeric in solution, its interactions
with DAN 93 could be studied. Comparison of the 1H NMR spectra of DAN 93 and
UDIM 91 with the 1:1 mixture indicated that there was some complex formation (Fig-
ure 4.11). The NH of DAN 93 shifts from ∼ 8 ppm to ∼ 9 ppm and a new signal appears
just downfield of the UDIM 91 ArCH proton. This new signal is most likely from the
unfolded conformation of UDIM 91i interacting with DAN 93. Strongly bound quadru-
ple hydrogen-bond motifs should be nearly 100% bound at 10 mM, so the fact that it
appeared that only about a third of UDIM 91 was in the complex at 10 mM gave an
early indication that this motif did not behave as expected. Confirmation that the new
93 ·91
Figure 4.11: The NHC of DAN 93 shifts downfield by ∼ 1 ppm (10 mM, 300 MHz,
CDCl3). (a) UDIM 91, (b) DAN 93, (c) UDIM ·DAN 91 ·93, (d) UDIM ·DAN 91 ·93
after 3 days. No extra complexation was observed. New signal integrates to 13 and the
original ArCH signal integrates to 23 .
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signal at ∼6 ppm was attributed to bound UDIM 91 was found from 1H-1H NOESY and
ROESY experiments. The 1H-1H NOESY (Figure 4.12) showed that all NH’s correlated
with all other NH’s but, as was the case in UDIM 91, differentiating between exchange
and through-space correlations was not possible. For this reason a 1H-1H ROESY (Fig-
ure 4.13) was carried out which showed that only the new UDIM 91 signal interacted
with DAN 93. This indicated that it was only the unfolded conformer that formed
complexes because the new signal was a singlet, which should only be obtained from a
symmetrical molecule.
93 ·91 93 ·91
Figure 4.12: 1H-1H NOESY of the DAN ·UDIM 93 ·91 complex (10 mM, 500 MHz,
CDCl3).
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93 ·91
Figure 4.13: 1H-1H ROESY of the DAN ·UDIM 93 ·91 complex (10 mM, 500 MHz,
CDCl3).
Since the DAN ·UDIM 93 ·91 complex had been shown to exist in solution a 1H NMR
titration was carried out in order to quantify the strength of interaction. Aliquots of
UDIM 91, containing a small amount of DAN 93, were added to a solution of DAN
93. After each addition of UDIM 91 a 1H NMR spectrum was taken and the change
in shift of the NH of DAN 93 was plotted against the concentration of UDIM 91. Be-
cause neither DAN 93 or UDIM 91 strongly self-associate, a simple 1:1 association
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model in HypNMR165 was used to fit the data, giving a Ka of 825± 16 M−1. This as-
sociation constant was much lower than expected for quadruple hydrogen-bonded com-
plexes, so DOSY NMR experiments were carried out in order to verify the 1H NMR
titration results. Diffusion coefficients were measured on 3.6 mM solutions at 20 ◦C in
CDCl3. The diffusion coefficients for DAN 93 and UDIM 91 alone were 10.613 and
9.332 m2 s−1× 10−10 respectively. The diffusion coefficients of the 1:1 mixture were dif-
ferent to those of the individual samples (10.057 and 8.671 m2 s−1× 10−10 respectively),
showing that larger assemblies were present in the mixture compared to the individual
samples. In strongly bound species it is normally expected that the diffusion coefficients
are coincident, so obtaining two sets of diffusion coefficients from the mixture indicated
that a weakly bound complex was present. In order to calculate the association constant,
the mole fraction (χ) must first be obtained. Calculation of χ can be carried out using
Equation 4.1 and this was used to calculate the association constant using Equation 4.2.
An association constant of 834 M−1 was calculated, which is in agreement with the 1H
NMR titrations (825±16 M−1).
χDAN ·UDIM = Dobs −DUDIMDDAN −DUDIM (4.1)
χDAN ·UDIM = 10.057− 9.33210.613− 9.332
χDAN ·UDIM = 0.566
Ka =
χDAN ·UDIM[DAN]
((1− χDAN ·UDIM)[DAN])2 (4.2)
Ka =
0.566× 3.6× 10−3M−1
(0.434× 3.6× 10−3M−1)2
Ka = 834M−1
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4.4 Comparison of the Binding Properties of a Triple Hydrogen-
Bond Array
It has been suggested that sometimes triply hydrogen-bonding motifs can form stronger
interactions than quadruply hydrogen-bonding motifs with the same complementary
partner.203 Because UDIM 91 was an extended version of UIM 17, which interacts
through an ADD triple hydrogen-bond array, it was hypothesised that UIM 17 might
form stronger interactions with DAN 93 than UDIM 91 did. A 1:1 1H NMR spectra
of UIM ·DAN 17 ·93 confirmed that they interact because of the complexation induced
shifts that were observed (Figure 4.14). Indeed, the NH of DAN 93 shifted further down-
field when UIM 17 was present than when UDIM 91 was. 1H-1H NOESY (Figure 4.15)
confirmed that the molecules were close in space and formed a complex in solution.
93 ·17
Figure 4.14: The NHC of DAN 93 shifts downfield by ∼ 1.5 ppm (10 mM, 300 MHz,
CDCl3). (a) UIM 17, (b) DAN 93, (c) UIM ·DAN 17 ·93.
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93 ·17
Figure 4.15: Correlations observed between DAN 93 and UIM 17 in the 1H-1H NOESY
of a 1:1 mixture (10 mM, 500 MHz, CDCl3).
1H NMR titrations were then performed, again following the shift of the NH of DAN 93.
It was found that the Ka of the UIM ·DAN 17 ·93 complex was 2140± 40 M−1, which is
significantly stronger than the DAN ·UDIM 93 ·91 complex (825± 16 M−1). In order to
rationalise the differences in binding affinity observed between the triple and quadruple
hydrogen-bond arrays, molecular modelling studies were carried out.
It could be possible that the tautomer required for UDIM 91 to interact with DAN 93
cannot be easily adopted due to steric hindrance (Figure 4.16). To investigate this the
energies of all possible conformer/tautomer combinations were calculated (Figure 4.17).a
It was found that there was only ∼9 kJ mol−1 energy difference between the lowest
and highest energy conformer/tautomers, so it should be possible for all of them to
be presented in solution. The conformer/tautomer that presents the desired hydrogen-
bonding array with the tBu groups pointing away from the interaction face is 5.4 kJ mol−1
higher in energy than the lowest energy tautomer/conformer. This should not be a large
enough energy difference to prevent the desired conformer being present in solution,
especially when the complementary binding partner is present. However, solvation was
91i
Figure 4.16: Steric hindrance between the two tBu groups could prevent the desired
hydrogen-bond array from being adopted.
aThe B3LYP/C, 6-31G; N/O, 6-31G*; H, 6-31++G** basis set was used for all the calculations shown
in this chapter.
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Lowest energy conformer + 1.8 kJ mol−1 + 2.8 kJ mol−1
91i 91ii 91i
+ 4.6 kJ mol−1 + 5.4 kJ mol−1 + 5.5 kJ mol−1
91ii 91i 91ii
+ 8.7 kJ mol−1
91ii
Figure 4.17: The energies of the lowest and highest energy conformer/tautomer combi-
nations and the energy of the desired conformer/tautomer. All other combinations have
energies inbetween the lowest and highest energy conformations. Values show how much
higher in energy each conformer/tautomer is than the lowest energy conformer.
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not taken into account in these gas phase calculations and in addition the energy of the
transition states were unknown. It could take a lot of energy to change transition and
desolvate the new hydrogen-bonding atoms.
Since the desired conformer of UDIM 91i can probably exist in solution there must
be other factors that prevent it from interacting with DAN 93. The binding affini-
ties of DAN 93 were calculated with both conformers of UDIM 91 (Figure 4.18).b It
was found that the conformer that interacts with an ADDA array (91i) had a binding
affinity of −104 kJ mol−1 and the folded conformer (91ii), which only interacts through
three hydrogen bonds, had a lower binding affinity of −76 kJ mol−1. Although the triply
hydrogen-bonded complex had a lower binding affinity, it was found that the molecules
did not have to alter their geometry so much in order to assemble, so there was less
entropic loss. For the quadruple UDIM ·DAN 91i ·93 complex the ArCH · · ·O=C
distance has to become shorter (2.20–2.10 A˚) to form interactions. The intramolecu-
lar hydrogen bonds in UDIM 91i also have to become shorter (2.09–2.01 A˚) to allow
the intermolecular hydrogen-bonding atoms to align. For the triply hydrogen-bonded
UDIM ·DAN 91ii ·93 complex only one of the ArCH · · ·O=C has to become shorter
(2.20–2.11 A˚ and 2.20–2.18 A˚) and the intramolecular hydrogen bonds both remain to
about the same length (2.05–2.06A˚ and 1.93–1.91A˚).
The binding affinities of the two possible conformers of UIM 17, which can both interact
with DAN 93 using three hydrogen bonds, were also calculated (Figure 4.19). It was
found that they both had higher calculated binding affinities to DAN 93 (−78 and
−79 kJ mol−1) than the folded UDIM 91ii (−76 kJ mol−1), even though they all interact
with the same hydrogen-bonding array. This higher binding affinity was attributed to the
fact that UDIM 91ii had an extra intramolecular hydrogen bond which removed electron
density from the carbonyl oxygen, rendering it a weaker hydrogen bond acceptor. It
was again noted that, in order for the complex to form, in both cases neither of the
intramolecular hydrogen bonds in UIM 17 had to change length (2.07–2.01A˚ and 1.91–
1.89A˚) as much as they did in UDIM 91 and also only one of the ArCH · · ·O=C had
to change length (2.20–2.12A˚ and 2.20–2.11A˚).
It appears that the subtle geometry mismatch between the unfolded UDIM 91i and
DAN 93 molecules could be the main reason for the low binding affinities that were
bFor these calculations the tBu groups were removed in order to reduce the time required for the
calculation to be completed.
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(a)
−104 kJ mol−1
93 91i 93 ·91i
(b)
−76 kJ mol−1
93 91ii 93 ·91ii
Figure 4.18: The structures and binding energies of the two possible DAN ·UDIM 93 ·91
complexes.
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(a)
−78 kJ mol−1
93 17i 93 ·17i
(b)
−79 kJ mol−1
93 17ii 93 ·17ii
Figure 4.19: The structures and binding energies of the two possible DAN ·UIM 93 ·17
complexes.
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measured for this complex. Both DAN 93 and UDIM 91 have to change geometry
in order to interact using four hydrogen bonds, leading to a loss of entropy, reducing
the binding affinity. When the folded conformer is present there is less loss of entropy,
which helps to keep the binding affinity as high as possible. Solvation can also play a
part in controlling which conformer interacts and it could be that desolvation of the
fourth hydrogen bonding atom requires more energy than is gained from it interacting,
which would result in a thermodynamically unfavoured process.
4.5 Conclusions
The design and synthesis of a novel quadruple ADDA hydrogen-bonding motif (UDIM
91) has been described. Lower than expected binding affinities with the complementary
partner, DAN 93, were observed and extensive studies to probe the reasons for this
were performed. It was found that the reason for the low association constant was most
likely due to a combination of subtle effects. These included the desired conformer of
UDIM 91 not being the lowest energy conformer, possible problems with high solvation
energies and entropic loss on binding due to differences in shape complementarity. The
differences in shape complementarity arose because DAN 93 is not a linear array, but
slightly curved, because C-N bonds are shorter than C-C bonds.203 This study has
highlighted that highly preorganised hydrogen-bonding motifs, which present the desired
array and do not self-associate, will not necessarily have high association constants
with complementary motifs. All of the factors discussed above must be taken into
consideration in order to obtain motifs that can interact with high binding affinities.
Chapter 5
Novel Arrays for Self-Sorting
Assemblies
Since many of the fundamental features of hydrogen-bonding motifs have now been in-
vestigated it was possible to look towards the study of self-sorting systems.140 Ideally,
self-sorting systems are assembled using high affinity and high fidelity interactions. A
high fidelity system is defined as one where only the desired complexes, and no unde-
sired complexes, are assembled. The assembly of a self-sorting system using orthogonal
hydrogen-bonding motifs could lead to many applications, for example supramolecu-
lar polymers and supramolecular switches/devices.204 There are many examples of self-
sorting in biological systems;6 for example, substrates interacting with proteins, proteins
interacting with proteins and the assembly of the DNA double helix. Unfortunately, bi-
ological molecules cannot simply be mimicked in synthetic systems because they are too
large. Many of the atoms that are present in proteins and DNA are not involved in in-
tramolecular interactions, but are used to preorganise the molecule. Ideal molecules for
synthetic systems are small and easy-to-synthesise, allowing complexity to be obtained
relatively quickly and cheaply.
Synthetic hydrogen-bonding motifs normally contain heteroaromatic and amide/urea
functionalities, which have the potential to interact indiscriminately when there are
many molecules present, leading to the formation of undesired complexes. If different
types of linear arrays of hydrogen bonds are used, there is the possiblity of undesired
arrays being formed; for example, in Chapter 4 it was shown that DAN 93, a quadruple
113
Chapter 5 114
hydrogen-bond array, can form interactions with UIM 17, a triply hydrogen-bonded
motif. It was therefore proposed that, if hydrogen-bonding motifs could be designed so
that they interact through different types of non-linear arrays, the chance of undesired
complexes being formed would be reduced allowing high fidelity systems to be obtained.
Three new pairs of motifs were proposed (Figure 5.1) for the synthetic self-sorting sys-
tem. The first (Figure 5.1a) was between diamidopyridine (DAP) 97 and oxazolidinone
98, which were proposed to interact through a bifurcated enol array. The second (Fig-
ure 5.1b) was between the pyrrole 99 and its complementary piperidinone 100, which
were proposed to interact through a bifurcated hydrogen-bond array. The final array
(Figure 5.1c) that was proposed for the synthetic self-sorting system was a 3D array,
which was assembled using two 2D motifs 101 and 102. Because all these complexes
were designed to interact through different types of hydrogen-bond array, the forma-
tion of undesired complexes should be prevented when they are mixed, leading to the
assembly of a high fidelity204 self-sorting system.
(a) (b)
97 ·98 99 ·100
(c)
101 ·102
Figure 5.1: Three new motifs that were proposed for the synthetic self-sorting system
(a) enol, (b) bifurcated and (c) 3D arrays.
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5.1 Enol Array
When carbonyls are placed at the one and three positions along an alkyl chain there is
the possibility for a six-membered intramolecular hydrogen bond ring to form when an
enol is present. This results in an ADA array being presented, which should interact
with a complementary DAD array. Diamidopyridine (DAP) 97 has been previously
studied by the Wilson group,63 so it was chosen as the DAD array for this study.
5.1.1 Synthesis and Binding Studies
Synthesis of DAP 97 (Scheme 5.1) was carried out in one step, reaction of valeroyl
chloride with 2,6-diaminopyridine gave DAP 97.63 The complementary oxazolidinones
were then synthesised. Reaction of the commercially available phenylacetyl chloride with
deprotonated 2-oxozolidinone gave the phenyl oxazolidinone 98a (Scheme 5.2).205 It was
reasoned that an electron withdrawing group on the phenyl ring could make the benzyl
protons more acidic, enabling the enol to form more easily, so a second oxazolidinone was
synthesised (Scheme 5.3) with an electron withdrawing nitro group. Formation of the
acid chloride 103 was carried out in the presence of thionyl chloride206 before addition
of 2-oxazolidinone gave the nitrophenyl oxazolidinone 98b.205
97
Scheme 5.1: The synthesis of DAP 97.
98a
Scheme 5.2: The synthesis of the enol array 98a.
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103
98b
Scheme 5.3: Synthesis of the enol array 98b with an electron withdrawing group ap-
pended to it.
A crystal structure of the enol array with a nitro group 98b was obtained by the slow
evaporation of a solution of 98b in CH2Cl2–Et2O. For interactions to be possible be-
tween 98b and complementary motifs the carbonyl groups must be pointing in the same
direction however, in the crystal structure of 98b the carbonyl groups are orientated
away from each other. This is probably because there are electrostatic interactions be-
tween the two oxygen atoms, preventing them from being on the same face when the
enol form is not present.
Figure 5.2: A crystal structure of the enol array 98b was obtained.
Interactions between DAP 97 and the enol arrays 98a and 98b were tested by comparing
the individual 1H NMR spectra to that of a 1:1 mixture (Figure 5.3 and Figure 5.4).
No complexation induced shifts were observed and the benzyl protons integrated to
two throughout, indicating no conversion to enol. This showed that there were no
interactions between 97 and 98a or 98b and the enol was never present.
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97 98a
Figure 5.3: 1H NMR spectra of (a) DAP 97, (b) 98a and (c) a 1:1 mixture of DAP 97
and 98a (10 mM, 300 MHz, CDCl3).
97 98b
Figure 5.4: 1H NMR spectra of (a) DAP 97, (b) 98b and (c) a 1:1 mixture of DAP 97
and 98b (10 mM, 300 MHz, CDCl3).
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Since neither 98a or 98b could interact with DAP 97, ethylacetoacetate 104 was tested
because it has been shown that it can exist in the enol form.207 Unfortunately, no
interactions between 104 and DAP 97 were observed (Figure 5.5), indicating that it
is not possible to form complexes between DAP 97 and enols. This could be because
protons can only form one hydrogen bond at a time and intramolecular hydrogen bonds
are normally formed in favour of intermolecular hydrogen bonds.59 So, even if the enol
is formed, it is unlikely that the desired heterocomplex will be formed.
97 104
Figure 5.5: 1H NMR spectra of (a) 97, (b) 104 and (c) a 1:1 mixture of 97 and 104
(400 MHz, CDCl3, 10 mM)
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5.2 Bifurcated Array
Since carbonyl oxygens have two lone pairs of electrons they can act as the acceptor of
two hydrogen bonds and this is known as a bifurcated array. Using bifurcated hydrogen
bonds can allow small numbers of hydrogen bonding atoms to form many interactions.22
This can increase the binding affinity whilst keeping the molecule small, which normally
makes the synthesis easier. Two carbonyls can form up to four hydrogen bonds and it
was proposed that the 2,5-diamidopyrrole 99 would present the complementary DDD
array (Figure 5.1b).
5.2.1 Synthesis and Binding Studies
Many different routes were attempted towards the synthesis of the 2,5-diamidopyrrole
99. Firstly, to enable an unsymmetrical molecule to be obtained (Scheme 5.4), func-
tionality was added to ethyl pyrrole-2-carboxylate via a Vilsmeier reaction to give the
aldehyde 105.208 Deprotection of the ester in the presence of potassium hydroxide,
followed by amide coupling using EDCI and HOBT gave the amide pyrrole 106. Oxida-
tion of the aldehyde in the presence of potassium permanganate did not give the desired
acid pyrrole 107 and this route was abandoned in favour of the synthesis of symmet-
rical pyrroles. The second route that was attempted was the oxidation of 2,5-dimethyl
pyrrole, to obtain the diacid pyrrole 108 (Scheme 5.5) however, this reaction was not
105
106 107
Scheme 5.4: The first route that was attempted for the synthesis of pyrroles.
108
Scheme 5.5: Attempts to synthesise the diacid pyrrole 108 via oxidation of the 2,5-
dimethyl pyrrole were all unsuccessful.
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successful. The reason for this could be because the 3- and 4-positions were not substi-
tuted and there were no electron withdrawing groups present.209 The third route that
was attempted (Scheme 5.6) involved functionalisation of the boc-pyrrole 109 via depro-
tonation of the 2- and 5-positions using n-BuLi before addition of methyl chloroformate
gave the 2,5-diester pyrrole 110.210 Hydrolysis in the presence of sodium hydroxide,
followed by removal of the protecting group with hydrochloric acid gave the 2,5-diacid
pyrrole 108. Amide coupling was carried out by preparation of the acid chloride with
thionyl chloride followed by addition of propyl amine in the presence of pyridine to give
the 2,5-diamidopyrrole 99.
109 110
108 99
Scheme 5.6: Synthesis of the diamide pyrrole 99.
Two complementary partners for the 2,5-diamidopyrrole 99 were synthesised. The first
was the benzoylpiperidinone 100 which was synthesised (Scheme 5.7) by deprotonation
of piperidinone using n-BuLi followed by addition of benzoyl chloride. Synthesis of the
benzyl diacetamide 114 was first attempted by the reaction of diacetamide and benzyl
bromide in the presence of both NaH and K2CO3
211 however, no product was isolated.
The second route (Scheme 5.8) involved amide coupling between benzyl amine and
100
Scheme 5.7: Synthesis of the benzoylpiperidinone 100.
111 112 113 114
Scheme 5.8: Synthesis of the acetylbenzylacetamide 114.
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methyl acetate using a catalytic amount of triazabicyclodecene (TBD) 115 in solvent
free conditions to obtain the benzyl acetamide 113.212 TBD 115 can catalyse the amide
coupling of esters 112 and amines 111 (Scheme 5.9)213 by first reacting with the ester
112 to give the TBD amide 116 and alcohol. The amine 111 can then interact with the
TBD-amide 116 through an intermolecular hydrogen bond, which places the nitrogen in
the desired position for amide formation to occur. TBD 115 is then regenerated along
with formation of the desired amide 113. Deprotonation of the benzyl acetamide 113
using n-BuLi followed by the addition of acetic anhydride gave the benzyl diacetamide
114.
115 112 116 111 115 113
Scheme 5.9: The proposed reaction mechanism of TBD 115 with the ester 112 and
amine 111 to give the amide 113.
1H NMR was used to investigate the binding properties of the 2,5-diamidopyrrole 99
to the piperidinone 100 (Figure 5.6) and the diacetamide 114 (Figure 5.7). No inter-
actions were observed and this was probably due to a combination of reasons. Firstly,
it is likely that there were unfavourable electrostatic interactions between the two car-
bonyl oxygens. This would hinder interactions between the pyrrole 99 and piperidinone
100/diacetamide 114 because it would prevent the piperidinone 100 and the diac-
etamide 114 from adopting the desired conformation. Secondly, a derivative of the
pyrrole 117 has previously been used to interact with just one oxygen atom214 (Fig-
ure 5.8) and this could indicate that there is not enough space within the array for two
oxygens to interact.
Chapter 5 122
99 100
Figure 5.6: 1H NMR spectra of (a) 99, (b) 100 and (c) a 1:1 mixture of 99 and 100
(300 MHz, CDCl3, 10 mM).
99 114
Figure 5.7: 1H NMR spectra of (a) 99, (b) 114 and (c) a 1:1 mixture of 99 and 114
(300 MHz, CDCl3, 10 mM).
Chapter 5 123
117
Figure 5.8: The pyrrole 117 that interacts with just one oxygen.
5.3 Three Dimensional Array
Benzene-1,3,5-triamides have been used to assemble three-dimensional (3-D) stacks;102,105,106
the amide functional group allows two-dimensional (2-D) molecules to be self-complementary,
leading to the formation of 3-D stacks. By removing either the donor or acceptor from the
molecule it was proposed that these molecules would no longer be self-complementary.
This would prevent the assembly of 3-D stacks, allowing discrete complexes to be formed,
but only when both complementary molecules were present.
5.3.1 Synthesis and Binding Studies
Benzene-1,3,5-tricarbonyltrichloride was reacted with the chosen amine to give the trip-
iperidine amide 102 (Scheme 5.10) and trioctyl amide 119 (Scheme 5.11).215 Because
the tripiperidine amide 102 is a tertiary amide it does not contain any protons that can
act as hydrogen bond donors, so should not form 3-D stacks.107,108 The trioctyl amide
119 however, is self-complementary and the hydrogen bond acceptors must be removed
to prevent it from assembling into 3-D stacks. The oxygen atoms were exchanged for
sulphur atoms because soft sulphur atoms are not as strong hydrogen bond acceptors as
102 118
Scheme 5.10: Synthesis of the tripiperidine amide 102 and the trithioamide 118.
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119 101
Scheme 5.11: Synthesis of the trioctyl thioamide 101.
hard oxygen atoms.216 Reaction of the trioctyl amide 119 with Lawesson’s Reagent217
gave the trioctyl thioamide 101
Crystals of 119 (Figure 5.9a), the precursor of the 1,3,5-trioctyl thioamide 101, were
obtained by the slow evaporation of a DMF–Et2O solution. The phenyl ring appears to
be in conjugation with the amide bonds because they are planar. For intermolecular in-
teractions to form the conjugation would have to be broken and the amide bonds twisted
out of the plane of the phenyl ring. The structure of 102 (Figure 5.9b), obtained by
the slow evaporation of MeOH, is very different. The large piperidine groups sterically
hinder the conjugated conformation, leading to a structure where the carbonyl groups
are orientated away from the plane of the phenyl ring. This is ideal for intramolecular
hydrogen bonds to form because the carbonyl groups are already in the correct orien-
tation, so there will be less loss of entropy on binding. For heterodimers to be formed
(a) (b) (c)
119 102 118
Figure 5.9: Crystal structures of 119, 102 and 118.
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between 102 and 101 the hydrogen bonding atoms must all be on the same face of the
phenyl ring. In the crystal structure of the tripiperidine 102 only two are on the same
face, with the third being on the opposite face. This could indicate that there is steric
hindrance between the piperidine rings, preventing them from all being on the same
face, which would give lower than expected binding affinities between 102 and comple-
mentary motifs. The crystal structure of 1,3,5-tripiperidine trithioamide 118 was also
obtained (Figure 5.9c) and in this structure the piperidines are all on the same face.
This indicates that there is enough space for all of the piperidines to be on the same
face of the molecule and presumably 102 can also adopt this conformation.
1H NMR of the 1:1 mixture of 102 and 101 gives a very broad spectrum (Figure 5.10)
which sharpens as the temperature is increased. It was found that at low temperatures a
broad spectrum was obtained, which could indicate that weak interactions were occurring
and an equilibrium between bound and unbound 102 and 101 had been established.
As the temperature was increased the spectrum became more defined, which showed
that the molecules were most likely present as monomers. Although it was shown that
the 102 ·101 complex was probably forming in solution the association constant could
not be obtained using 1H NMR titrations because the spectra were too broad. Other
techniques (e.g. ITC or DOSY) could have been used to obtain the binding affinity
however, 1H NMR was the technique of choice with which to study the self-sorting
system, so it was decided that the 102 ·101 heterodimer was not a suitable candidate
for the self-sorting system.
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102 101
Figure 5.10: 1H NMR spectra (300 MHz, CDCl3, 10 mM) of (a) 102 (293 K), (b) 101
(293 K) and the 1:1 mixtures of 102 and 101 at (c) 223 K, (d) 293 K, and 333 K.
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5.4 A Self-Sorting System
Because it was not possible to form complexes using novel hydrogen-bonding arrays
a different approach was required to assemble an orthogonal self-sorting system. The
DAN ·UPy 21 ·19 complex has been used in a self-sorting system along with two hy-
drazide derivatives 120 and 121.218 The desired outcome of this system was the 21 ·19
and 120 ·121 pairs (Figure 5.11) however, by 1H NMR it was possible to see that UPy
19 was present as both the homo- and heterodimer (at a ratio of 4:6 respectively). This
suggested that the system had a low fidelity, possibly because both desired complexes
interact using the same ADDA ·ADDA array, so there was no chemical discrimination
between the pairs.
21 ·19 120 ·121
Figure 5.11: The self-sorting system proposed by Zhao et al. that includes DAN 21 and
UPy 19. R denotes generic alkyl chain.
By using different types of linear array the binding affinity of the desired complexes
should be much higher than the undesired complexes, which should allow a high affin-
ity, high fidelity system to be obtained. The previously studied AIC ·UIM 57 ·17
triply hydrogen-bonded array was chosen along with the DAN ·UPy 93 ·80 quadru-
ple hydrogen-bond array (Figure 5.12). Since hydrogen bonded systems assemble into
the thermodynamic product, using different types of array should give a high fidelity
system because the maximum number of hydrogen bonds can only be present when the
desired complexes are assembled.
Before this self-sorting system could be assembled the association constants of all possible
dimers had to be measured. The self-association of all four molecules was already known;
the homodimerisation of DAN 93 was found to be negligible (Kdim< 5 M−1) by Corbin et
al.61 and the homodimerisation of UPy 80 is known to be high (Kdim = 6×107 M−1).156
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93 ·80 57 ·17
Figure 5.12: The proposed self-sorting system that uses different types of linear
hydrogen-bond array.
Homodimerisation constants of UIM 17 and AIC 57 were measured in Section 2.1.3
and were found to be Kdim = 10.6± 2.2 and 3.6± 0.3 M−1 respectively. The association
constant of the DAN ·UPy 93 ·80 heterodimer has been found to be191 4× 105 M−1
and the association constant of the AIC ·UIM 57 ·17 was measured in Chapter 2 to be
3×104 M−1.
It was found in Chapter 4 that undesired interactions are formed between DAN 93 and
UIM 17 (Ka = 2140± 40 M−1). To investigate whether there were interactions between
DAN 93 and AIC 57 the 1H NMR spectra of the individual molecules was compared
to that of the 1:1 mixture (Figure 5.13). There were no complexation induced shifts,
indicating that there were no intermolecular interactions between the molecules.
A 1:1 mixture of UPy 80 and UIM 17 (Figure 5.14) showed that interactions were
formed between these two molecules. 1H NMR titrations were carried out in order
to obtain the association constant of the UPy ·UIM 80 ·17 complex. By fixing the
homodimerisation of UPy 80 at 6× 107 M−1 in HypNMR165 an association constant
of 68000± 9600 M−1 was obtained for the UPy ·UIM 80 ·17 complex, which is much
stronger than the DAN ·UIM 93 ·17 complex. This was thought to be due to secondary
electrostatic interactions,45 DAN ·UIM 93 ·17 has an additional destructive interaction,
whereas UPy ·UIM 80 ·17 has an additional constructive interaction (Figure 5.15).
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93 57
Figure 5.13: 1H NMR spectra (10 mM, 300 MHz, CDCl3) of the DAN 93 and AIC 57
molecules (a) DAN 93, (b) AIC 57 and (c) a 1:1 mixture of DAN 93 and AIC 57.
80 17
Figure 5.14: 1H NMR spectra (10 mM, 300 MHz, CDCl3) of the UPy 80 and UIM 17
molecules (a) UPy 80, (b) UIM 17 and (c) a 1:1 mixture of UPy 80 and UIM 17.
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93 ·17 80 ·17
Ka = 2140± 40 M−1 Ka = 68000± 9600 M−1
Figure 5.15: The additional secondary electrostatic interactions can have a dramatic
effect over the stability of the complex.
The final possible dimer was between the UPy 80 and AIC 57. Comparison of the
1H NMR spectra of the individual molecules to a 1:1 mixture (Figure 5.16) indicated
that there were no interactions between these molecules. All of the association constant
results have been collated into Table 5.1. Although some undesired complexes can be
formed it should be noted that AIC 57 only forms complexes with UIM 17 and it was
predicted that this would drive self-sorting towards the desired complexes, along with
the fact that formation of the desired complexes gives the maximum number of hydrogen
80 57
Figure 5.16: 1H NMR spectra (10 mM, 300 MHz, CDCl3) of the UPy 80 and AIC 57
molecules (a) UPy 80, (b) AIC 57 and (c) a 1:1 mixture of UPy 80 and AIC 57.
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Table 5.1: The association constants of all possible homo- and heterodimers that can be
formed between the four molecules.
Complex Ka/Kdim (M−1)
UPy ·UPy 80 ·80 6× 107
DAN ·DAN 93 ·93 5
AIC ·AIC 57 ·57 3.6± 0.3
UIM ·UIM 17 ·17 10± 2.2
UPy ·DAN 80 ·93 4× 105
AIC ·UIM 57 ·17 33400± 16100
AIC ·UPy 57 ·80 < 1
AIC ·DAN 57 ·93 < 1
UIM ·UPy 17 ·80 68000± 9600
UIM ·DAN 17 ·93 2140± 40
bonds, so should therefore be thermodynamically favourable.
The 1H NMR spectra of the 1:1:1:1 mixture at 10, 5 and 1 mM confirmed that a high
fidelity system had been established; the 1H NMR spectrum of the mixture was an
overlay of the desired pairs (Figure 5.17) at all concentrations. There were some small
differences in the NH region which could indicate that there was not 100% formation
of the desired complexes. One of the UPy 80 NH’s does not appear in the self-sorting
mixture and the DAN 93 NH moved as the concentration was decreased. At 10 mM
there was some evidence of a small amount of an undesired component being present
because there were some broad peaks at ∼ 10.5, 7.8 and 6.4 ppm which were not present
in the individual heterodimers. At lower concentrations these undesired components are
not visible, even though the fidelity of the desired complexes is probably lower. This
could be because, even though the relative concentration of the undesired components
is higher compared to the desired complexes, it is too low to be detectable by 1H NMR.
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93 ·80 57 ·17
Figure 5.17: 1H NMR spectra of the self-sorting mixture UPy ·DAN 80 ·93 and
AIC ·UIM 57 ·17. (a) UPy ·DAN 80 ·93 (5 mM, 300 MHz, CDCl3), (b) AIC ·UIM
57 ·17 (5 mM, 300 MHz, CDCl3), (c) UPy ·DAN 80 ·93 and AIC ·UIM 57 ·17 (10 mM,
300 MHz, CDCl3), (d) UPy ·DAN 80 ·93 and AIC ·UIM 57 ·17 (5 mM, 300 MHz,
CDCl3) and (e) UPy ·DAN 80 ·93 and AIC ·UIM 57 ·17 (1 mM, 300 MHz, CDCl3).
Red boxes indicate where there is evidence of undesired components being present.
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The fidelity of self-sorting systems can be caculated by dividing the sum of the con-
centration of the desired complexes by the sum of the concentration of all other com-
ponents (Equation 5.1).204 In the proposed DAN ·UPy 93 ·80, AIC ·UIM 57 ·17 self-
sorting system there is the possibility for all four monomers and homodimers to be
present along with the six possible heterodimers (DAN ·UPy, DAN ·UIM, DAN ·AIC,
UPy ·UIM, UPy ·AIC and UIM ·AIC).
Fidelity =
total concentration of desired complexes
total concentration of all complexes
(5.1)
Fidelity = [DAN ·UPy] + [AIC ·UIM]
[DAN] + [UPy] + [UIM] + [AIC] +
[UPy ·UPy] + [DAN ·DAN] + [AIC ·AIC] + [UIM ·UIM]
+ [DAN ·UPy] + [DAN ·UIM] + [DAN ·AIC] + [UPy ·UIM]
+ [UPy ·AIC] + [UIM ·AIC]
Since the association constants of all possible dimers was known it was possible to
estimate the concentration of each component in solution and hence the fidelity of the
system. The concentration of all possible components in a 1:1:1:1 mixture of DAN 93,
UPy 80, AIC 57 and UIM 17 was calculated as the concentration of all components was
increased using the HySS program.219 It was possible to see that the concentration of the
desired components (AIC ·UIM 57 ·17 and UPy ·DAN 80 ·93) was significantly higher
than the other components throughout (Figure 5.18a). AIC ·UIM 57 ·17 had a higher
concentration than UPy ·DAN 80 ·93, presumably because AIC 57 and UIM 17 have
low dimerisation constants, so there is less competition for assembly of the heterodimer.
The fidelity of the system at different concentrations was then calculated (Figure 5.18b)
(a) (b)
Figure 5.18: The fidelity of the self-sorting DAN ·UPy 93 ·91, AIC ·UIM 57 ·17 system
changes as the concentration is altered. High concentrations lead to higher fidelities
being obtained.
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and it was found that as the concentration increased the fidelity increased, to a maximum
of ∼ 0.7 at 50 mM. The low fidelity at low concentrations was presumably because at low
concentrations there was a comparatively high concentration of the individual monomers,
increasing the concentration of the undesired components. The fidelity curve begins to
plateau at ∼ 10 mM, which is the concentration that was chosen for these experiments
to be carried out at.
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5.5 Signalling Cascade
Biology uses signalling cascades in order to carry out a desired process.220 The binding
of one molecule to a protein can alter the tertiary structure of the protein, revealing a
second binding site where other molecules can interact, resulting in the desired output
signal being released. Alternatively, the output obtained from the formation of the first
complex can be stopped by the addition of a competing molecule, allowing the biological
processes to be switched on and off.
In the self-sorting system that was described in the previous section many undesired
complexes can be formed. These undesired interactions can be exploited in a signalling
cascade if the order of addition of the molecules is carefully considered. Because UIM
17 can interact with both UPy 80 and DAN 93, as well as AIC 57, three signalling
cascades could be envisioned (Figure 5.19) where UPy ·UPy 80 ·80 was the starting
point.
Figure 5.19: Some of the different signalling cascades that are possible using AIC 57,
UIM 17, UPy 80 and DAN 93.
The first that was investigated began with the UPy ·UPy 80 ·80 homodimer, which
was broken by the addition of UIM 17. Addition of AIC 57 regenerated the UPy
80 homodimer along with the UIM ·AIC 17 ·57 heterodimer and finally, addition of
DAN 93 resulted in the self-sorting system being assembled. The 1H NMR spectra
(Figure 5.20) confirmed that the presence of the UPy 80 homodimer could be switched
on and off by the presence (Figure 5.20a and c) and disapperance (Figure 5.20b and d)
of the UPy 80 NH signals.
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Figure 5.20: The signalling system (a) UPy ·UPy 80 ·80, (b) UPy ·UIM 80 ·17, (c)
UPy ·UPy 80 ·80 + UIM ·AIC 17 ·57, (d) UPy ·DAN 80 ·93 + UIM ·AIC 17 ·57
(10 mM, 300 MHz, CDCl3).
The composition of the mixture at each stage of the signalling cascade was calculated
using HySS.219 The concentration of all molecules already present was set to 10 mM
and the concentration of the molecule being added was increased from 0 – 50 mM (Fig-
ure 5.21). The fidelity of each step of the signalling cascade during addition of the new
molecule was calculated using Equation 5.1. It was found that in all cases the fidelity
was at a maximum when an equimolar amount of all molecules were present, which
was not surprising because if there is an excess of one of the components present then
the concentration of undesired components will begin to increase. The fidelity of the
UPy ·UIM 80 ·17 complex (Figure 5.21a) is quite low (0.24), probably because the UPy
80 dimer has a much stronger association constant than the UPy ·UIM 80 ·17 het-
erodimer, so UIM 17 cannot compete and dissociate the UPy 80 homodimer. The next
step, addition of AIC 57 (Figure 5.21b), had a very high fidelity (0.91), which is most
likely because AIC 57 only interacts with UIM 17, leaving UPy 80 free to assemble into
strong homodimers. The final step was addition of DAN 93 (Figure 5.21c), which was
found to have a moderate fidelity of 0.67 at equimolar concentrations.
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(a)
(b)
(c)
Figure 5.21: The concentration of all components of the mixture was calculated as
one molecule was added. (a) UPy ·UPy → UPy ·UIM, (b) UPy ·UIM → UPy ·UPy +
UIM ·AIC and (c) UPy ·UPy + UIM ·AIC → UPy ·DAN + UIM ·AIC. All mixtures
begin at 10 mM.
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The second signalling cascade began the same as the first, by the formation of the
UPy ·UIM 80 ·17 complex (fidelity = 0.24). The next step was the addition of DAN
93 with the aim of reforming the UPy 80 homodimer along with the assembly of the
DAN ·UIM 93 ·17 heterodimer. The final step was addition of AIC 57 to give the
original self-sorting system once more. The 1H NMR spectra (Figure 5.22) for this
signalling cascade indicated that there was a low fidelity for some of the steps. In the
third step (Figure 5.22c) there was evidence for the presence of the undesired UPy ·DAN
80 ·93 complex. This was most likely because this undesired heterocomplex had a higher
association constant than the desired DAN ·UIM 93 ·17 complex. Calculation of the
fidelity of each of the steps (Figure 5.23), using the same protocol as described above,
confirmed that the fidelity was low for this signalling cascade. Addition of DAN 93 to
the UPy ·UIM 80 ·17 mixture only had a fidelity of 0.53.
Figure 5.22: The signalling system (a) UPy ·UPy 80 ·80, (b) UPy ·UIM 80 ·17, (c)
UPy ·UPy 80 ·80 + UIM ·DAN 17 ·93, (d) UPy ·DAN 80 ·93 + UIM ·AIC 17 ·57
(10 mM, 300 MHz, CDCl3).
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(a)
(b)
(c)
Figure 5.23: The concentration of all components of the mixture was calculated as
one molecule was added. (a) UPy ·UPy → UPy ·UIM, (b) UPy ·UIM → UPy ·UPy +
UIM ·DAN and (c) UPy ·UPy + UIM ·DAN → UPy ·DAN + UIM ·AIC. All mixtures
begin at 10 mM.
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The third possible signalling cascade began with the addition of DAN 93 to a solution
of UPy 80, followed by addition of UIM 17 to give UPy ·UPy 80 ·80 and DAN ·UIM
93 ·17 and finally addition of AIC 57 to return to the self-sorting system. The 1H NMR
spectra (Figure 5.24) were obtained for each stage of this cascade and again the third
step (UPy ·UPy 80 ·80 and DAN ·UIM 93 ·17) appeared to have a low fidelity due to
the presence of two species of UPy 80. The fidelity of each step was then calculated and
it was found that the UPy ·DAN 80 ·93 heterodimer had a fidelity of 0.58. The addition
of UIM 17 gave the same, low fidelity (0.53) mixture that was obtained between UPy
80, DAN 93 and UIM 17 in the previous cascade. Finally, addition of AIC 57 resulted
in the self-sorting system being obtained with the same fidelity (0.67) that had been
previously obtained.
Figure 5.24: The signalling system (a) UPy ·UPy 80 ·80, (b) UPy ·DAN 80 ·93, (c)
UPy ·UPy 80 ·80 + UIM ·DAN 17 ·93, (d) UPy ·DAN 80 ·93 + UIM ·AIC 17 ·57
(10 mM, 300 MHz, CDCl3).
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(a)
(b)
(c)
Figure 5.25: The concentration of all components of the mixture was calculated as one
molecule was added. (a) UPy ·UPy → UPy ·DAN, (b) UPy ·DAN → UPy ·UPy +
UIM ·DAN and (c) UPy ·UPy + UIM ·DAN → UPy ·DAN + UIM ·AIC. All mixtures
begin at 10 mM.
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5.6 Photosensitive signalling cascade
Attachment of a photolabile group to one of the molecules would result in a photosen-
sitive signalling cascade, allowing interactions to be switched on and off by light. Pho-
tolabile protecting groups are often favoured over chemically labile protecting groups,
especially in supramolecular systems, because they can be removed without having to
add extra reagents and can often have 100% cleavage yields. There are vast exam-
ples of photolabile protecting groups in the literature,221 many of which have been
used in supramolecular systems.15,222 Some molecules can use photoswitchable groups,
which change the conformation of the molecule, often using steric hindrance to block
the hydrogen-bonding array from making interactions.223–227 Azobenzene can reversibly
switch conformation using UV and Vis light. If large groups are appended to the azoben-
zene functionality then the hydrogen-bonding atoms can be sterically hindered to inter-
act with complementary molecules (Figure 5.26). Other systems have used ring for-
mation to turn interactions on and off.228,229 In these systems it is the modulation of
the pKa of the hydrogen-bonding atoms that alters the binding affinity of the system
(Figure 5.27).230
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Figure 5.26: The binding site can be sterically hindered by changing the conformation
of the azobenzene moieties, allowing interactions to be switched on and off.
Ka = 142± 13 M−1 Ka = 318± 30 M−1
Figure 5.27: The binding affinity of supramolecular heterodimers can be modulated by
changing the pKa of the hydrogen-bonding atoms using ring formation (R = CO2C6H13).
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The photolabile 2-nitrobenzyl group has been added to the UPy 19 moiety before to give
UPy* 122 (Figure 5.28).16,231–233 This group is removed using UV light (Scheme 5.12),221
firstly the nitro group forms a radical, which removes a hydrogen from the benzyl car-
bon and the resultant transition state can rearrange so that there is no longer a radical
present. An intramolecular cyclisation then gives a fused ring system, which reopens
to give the desired hydrogen-bonding motif along with the 2-nitrobenzaldehyde side
product. Since the 2-nitrosobenzaldehyde remains in the mixture once it has been re-
moved it is possible that it could compete with the desired interactions however, it does
not contain any hydrogen-bond arrays, so it is unlikely that it will be able to interact
strongly.
122
Figure 5.28: The 2-nitrobenzyl photolabile group has been appended to the end of the
quadruple hydrogen-bond array of UPy 19 to give UPy* 122.
Scheme 5.12: The mechanism for the photocleavage of the 2-nitrobenzyl protecting group
to reveal AIC 57, along with the 2-nitrosobenzaldehyde.
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Because the AIC 57 contains the same isocytosine functional group as UPy 19 it was
thought that a photolabile group could be appended to the AIC 57 molecule. Attempts
to append the 2-nitrophenyl group to the oxygen of AIC 57 to give AIC* 123 were all
unsuccessful (Scheme 5.13). An alternative synthesis was also attempted; alkylation of
2-nitrobenzyl to the isocytosine, followed by acylation however, no product was isolated
(Scheme 5.14). This was probably because, unlike UPy* 122, AIC* 123 cannot form a
stabilising intramolecular hydrogen bond and instead contains destabilising electrostatic
and steric interactions (Figure 5.29). For an intramolecular hydrogen bond to be present
57 123
Scheme 5.13: Synthesis of AIC* 123 was unsuccesful when O-alkylation of AIC 57 was
attempted.
123
Scheme 5.14: An alternative synthesis of AIC* 123 was attempted, but this was unsuc-
cessful.
122 123 124
Figure 5.29: UPy* 122 is stabilised by an intramolecular hydrogen bond, but AIC*
123 is destabilised by electrostatic interactions, preventing it from being synthesised.
Appending the 2-nitrobenzyl group to the amide allows a stabilising intramolecular
hydrogen bond to be formed.
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the 2-nitrophenyl group must be attached to the amide functional group to give AIC*
124 (Figure 5.29).
Attachment of the 2-nitrophenyl group to the amine group was first attempted via
reductive amination. This approach was never successful which was thought to be due
to the low reactivity of the amine, preventing the imine from being formed. The second
approach was via N-alkylation; in the presence of K2CO3 in DMF. This reaction was
first attempted with benzylbromide (Scheme 5.15) which resulted in both the N- and
O-alkylation products being obtained, which explains the low yield (28%) for this step.
These were separated by trituration (hexane) and 1H-1H NOESY confirmed that the
resultant solid was the desired N-alkylation product 125. Reaction with benzoyl chloride
in the presence of a catalytic amount of DMAP gave the AIC+ 126. These reactions were
then carried out with the 2-nitrophenyl group (Scheme 5.16) to give the 2-nitrophenyl
isocytosine 127, but in this case separation of the N- and O-alkylation products was not
possible. Both O- and N-alkylation products were taken onto the acylation step to give
the AIC* 124 in 27% yield over both steps. Confirmation that the desired product had
been synthesised was obtained by 1H-1H NOESY NMR (Figure 5.30). No correlations
were observed between the isocytosine proton and the CH2 of the 2-nitro benzyl group,
indicating that they are not positioned next to each other.
125 126
Scheme 5.15: Synthesis of AIC+ 126 via N-alkylation.
127 124
Scheme 5.16: Synthesis of AIC* 124 via N-alkylation.
Chapter 5 147
124
Figure 5.30: The 1H-1H NOESY spectra of AIC* 124 (25 mM, 500 MHz, CDCl3).
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To investigate the molecular interaction of substituted AIC molecules with UIM 17, UPy
80 and DAN 93, AIC+ 126 was used due to its ease of handling. Comparison of the
1H NMR spectra of the individual molecules with a 1:1 mixture was carried out to see if
there were any complexation induced shifts, which are indicative of interactions between
molecules. It was found that, as expected, there were negligible interactions between
AIC+ 126 and UIM 17 (Figure 5.31), UPy 80 (Figure 5.32) and DAN 93 (Figure 5.33)
because the hydrogen-bond array had been blocked. It was presumed that AIC* 124
would have the same recognition properties as AIC+ 126 because they both contain the
same hydrogen-bond array.
126 17
Figure 5.31: Comparison of the 1H NMR spectra of (a) AIC+ 126 and (b) UIM 17 with
(c) the 1:1 mixture of AIC+ 126 and UIM 17 shows that there are no complexation
induced interactions (300 MHz, CDCl3, 10 mM).
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126 80
Figure 5.32: Comparison of the 1H NMR spectra of (a) AIC+ 126 and (b) UPy 80 with
(c) the 1:1 mixture of AIC+ 126 and UPy 80 shows that there are no complexation
induced interactions (300 MHz, CDCl3, 10 mM).
126 93
Figure 5.33: Comparison of the 1H NMR spectra of (a) AIC+ 126 and (b) DAN 93 with
(c) the 1:1 mixture of AIC+ 126 and DAN 93 shows that there are no complexation
induced interactions (300 MHz, CDCl3, 10 mM).
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Removal of the 2-nitrobenzyl protecting group can be achieved using UV light. The
UV spectra of AIC* 124 showed that it’s maximum absorbance was 260-340 nm (Fig-
ure 5.34), so a lamp that emitted at 300 nm was used in the photocleavage experiments.
A 10 mM solution of AIC* 124 was irradiated for 4 hr and this gave evidence for the
removal of the protecting group (Figure 5.35). However, this reaction did not occur
efficiently which could easily be seen in the 1H NMR spectra, which was messy in the 8-
6 ppm region, the important region for studying the self-sorting mixture. It was thought
that using wet, degassed CDCl3 could aid the photocleavage by making protons more
easily available and reducing the amount of undesired radicals that were present in solu-
tion, but it was found that neither of these changes made any difference to the cleavage
yield.
Figure 5.34: The UV spectrum of AIC* 124 (1µM, CDCl3).
Currently only examples of self-complementary hydrogen bonding groups using the 2-
nitrobenzyl protecting group have appeared in the literature. It could be that the
cleavage yield could be increased by the presence of the complementary partner, UIM
17, allowing a dimer to form when the protecting group is removed. A 1:1 mixture of
AIC* 124 and UIM 17 was irradiated (Figure 5.36) and although this showed evidence
that UIM 17 was interacting, presumably with AIC 57, the cleavage yield was not
increased and the 1H NMR became increasingly more messy as the experiment was
continued.
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Figure 5.35: Irradiation of AIC* 124 with 300 nm for (a) 0 hr, (b) 0.5 hr, (c) 4 hr (10 mM,
300 MHz, CDCl3). There is evidence of a new species being present as shown in pink.
Figure 5.36: There is evidence of interactions being formed between UIM and AIC as
the photolabile group is removed. (a) AIC* 124, (b) UIM 17, (c) UIM ·AIC* 17 ·124,
(d) after irradiation for 1 hr, (e) after irradiation for 2 hrs.
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Although there are examples of the 2-nitrobenzyl group being appended to a tertiary
amide, there are no examples where there are two aromatic rings in conjugation with
the amide, as well as the 2-nitrobenzyl group. This however is the case in the AIC* 124,
which could lead to steric interactions in the transition state structure (Figure 5.37). It
seems that in order for the 2-nitrobenzyl group to be efficiently removed it must have
more space than it has been given in this last example.
Figure 5.37: The transition state is very sterically hindered, which could be the reason
for the poor cleavage yield.
5.7 Conclusions
Complementary hydrogen-bond arrays must be carefully designed in order to allow in-
teractions to occur. Subtle differences in shape complementarity or electrostatic interac-
tions can prevent the assembly of heterodimers. The dynamic nature of the reversibility
of hydrogen bonds can lead to broad 1H NMR spectra being obtained. Although a
broad spectrum can indicate that interactions are occurring it makes it difficult to in-
terpret the data, so association constants cannot be obtained. This can prevent some
complexes from being used in self-sorting systems even though they probably assemble
into heterodimers.
A self-sorting system was assembled using two different types of linear hydrogen-bond
arrays and even though many undesired complexes could be formed this system was
found to have high fidelity. As with all supramolecular systems these self-sorting systems
are under thermodynamic control and the thermodynamically favoured state is generally
the one that contains the most hydrogen bonds. In the case of the DAN 93, UPy 80, AIC
57, UIM 17 system this was achieved by pairing the quadruple (DAN ·UPy 93 ·80) and
triple (AIC ·UIM 57 ·17) hydrogen-bond arrays together. Another factor that aided the
orthogonal binding in this system was the fact that AIC 57 only forms complexes with
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UIM 17, removing UIM 17 from the system so that it cannot form undesired complexes
with DAN 93 or UPy 80. Undesired interactions could be exploited by the addition
of molecules in different orders to obtain a signalling cascade. The formation of the
UPy dimer could be switched on and off using three different cascades, all of which had
different fidelity profiles.
The signalling cascade could be made photosensitive by the addition of a photolabile
group to the AIC 124 molecule. Although it was shown that partial removal of the
2-nitrobenzyl group could be achieved, illustrated by the change in shift of the UIM 17
molecule, complete removal of the protecting group was never accomplished. Due to the
complexity of the resultant 1H NMR after partial cleavage of the protecting group the
photosensitive signalling cascade was never followed. In order to assemble a signalling
cascade using a photolabile protecting group it seems that it must be in a less sterically
hindered position, allowing the molecule to adopt any conformation that it requires for
the cleavage to be possible.

Chapter 6
Thesis Summary
This thesis began by investigating UIM 17 as a conformer independent array. Thorough
analysis, using both experimental and computational techniques, of UIM 17 alone and
bound to its complementary partner AIC 57 showed that UIM 17 could interact through
two possible conformations.159 This made it an ideal tool with which to probe some of
the factors that can affect the hydrogen bonding capabilities of molecules, including pre-
organisation using intramolecular hydrogen bonding and the remote substituent effect.
Firstly the effect that preorganisation using intramolecular hydrogen bonds was stud-
ied.159 The design and synthesis of two novel molecules (HAC 61 and ANT 62) that
both present AAD array without an intramolecular hydrogen bond was described. Con-
formational studies of the individual molecules indicated that both HAC 61 and ANT
62 preferentially presented the desired hydrogen-bonding array in solution, whereas AIC
57 could adopt an alternative conformation which did not present the desired AAD ar-
ray. It was found that although the binding affinity of AIC 57 was slightly stronger than
that of HAC 61, this was most likely due to inductive effects and not because of the
increase in preorganisation. The methyl group of ANT 62, which was appended to the
end of the hydrogen-bond array, was found that have a detrimental effect on binding.
These results indicated that preorganisation using intramolecular hydrogen bonds was
not essential in order to obtain high binding affinities, but consideration of the lowest
energy conformation and any detrimental steric interactions must be assessed.
Secondly, the UIM ·AIC 17 ·57 heterodimer60 was used to quantify the effects that
remote substituents can have on the binding affinity of hydrogen bonded complexes.177
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Because both of these molecules contained phenyl rings appended to the end of the
hydrogen-bond array it was possible to add electron withdrawing/donating groups as
required. This allowed the effects that changing the pKa of the hydrogen-bonding atoms
had on the binding affinity of the complex, without interference from sterics or different
conformer preferences. A small change in binding affinity was measured in the AIC
57 series, where a carbonyl group ‘blocked’ the hydrogen-bond array from the direct
effects of the substituent. Much larger differences were observed for the UIM 17 where
the substituent could directly affect the pKa of the hydrogen-bonding atoms. It was
proposed that this effect could be broadly applicable to many hydrogen-bonding motifs,
making it possible to modulate the strength of interaction without having to redesign
the motif.
It is important to be able to control the binding affinity of supramolecular polymers in
order to obtain the desired materials properties. Ditopic UPy molecules, one with an
electron donating linker 85 and the other with an electron withdrawing linker 86, were
designed in order to investigate whether differences in DP could be obtained simply
by changing the nature of the substituent. It was found that changes in the size of
the assembly could be measured by DOSY, showing that it is possible to alter the DP
by changing the electron donating/withdrawing nature of the substituent. This could
be important for applications where control over the DP is important, allowing subtle
changes in the materials properties to be obtained.
Although there are examples in the literature of molecules that present ADDA ar-
rays,40 they either have low affinity with DAN 21 due to an undesired conformer being
adopted152,197 or they can also assemble into strong homodimers,37,68,198,199 which can
result in a low fidelity being obtained. UDIM 91 was designed so that it contained two
intramolecular hydrogen bonds when the desired hydrogen-bond array was presented
and so that none of the possible conformers were self-complementary. However, a lower
than expected binding affinity of the UDIM ·DAN 91 ·93 complex (825±16 M−1) was
obtained.201 Thorough experimental and computational techniques were used in order
to explain this lack of binding affinity. It was found that, even though UDIM 91 did not
self-associate, it was most likely in an undesired conformation in solution which could
prevent it from interacting strongly with DAN 93. The low binding affinity could also
be due to subtle differences in shape complementarity between UDIM 91 and DAN 93,
preventing interactions using the desired quadruple hydrogen-bond array. Indeed, it was
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found that UIM 17, which can only interact through a triple hydrogen-bond array, had a
stronger association constant towards DAN 93 than UDIM 91 because it did not contain
an intramolecular hydrogen bond to the carbonyl oxygen, so could form stronger inter-
actions. In order to design molecules that present ADDA arrays that interact strongly
to DAN 21, shape complementarity, steric interactions and the preferred conformation
in solution must be carefully considered.
With the increased understanding of how molecules behaved in solution and the effect
that some factors had on binding affinity, a self-sorting system could be assembled.
Initially, molecules that interacted using entirely different hydrogen-bond arrays were
designed and synthesised. It was found that many of the desired heterodimers did not
form in solution, or the 1H NMR spectra were too broad to be used in the studies. The
assembly of a high fidelity self-sorting system using two different types of linear array
was then investigated. It was found that when all molecules were present in equimolar
amounts a high fidelity system (0.66 at 10 mM) was established, even though it was pos-
sible for many undesired complexes to be present. The high fidelity is achieved because
the maximum number of hydrogen bonds can be formed only when the desired com-
plexes are present, making it the thermodynamically favoured position of equilibrium.
Another reason for the interactions being so selective is that AIC 57 only interacts with
UIM 17, removing them both from the mixture, leaving only UPy 80 to interact with
DAN 93.
The undesired complexes could be exploited in a signalling cascade. It was possible
to assemble and disassemble the UPy 80 by carefully choosing the order of addition
of the molecules. The cascade could be carried out in many different ways, resulting
in different fidelities being established at each step. It was thought that addition of a
photolabile protecting group to one of the molecules could allow it to be present in the
self-sorting mixture without forming interactions. The hydrogen-bonding array would
only be revealed by removal of the photolabile protecting group, allowing control over
which complexes could be formed to be achieved. A photolabile protecting group was
added to AIC 57, to give AIC* 124. Although it was shown that some of the 2-nitro
benzyl group could be removed, revealing AIC 57 so that it could interact with UIM 17,
this cleavage was never achieved in quantitative yields, preventing it from being used in
a photolabile signalling cascade.
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In conclusion, the results represent a significant advancement in the understanding of the
behaviour of hydrogen-bonding motifs. A high fidelity self-sorting system was assembled
using extremely similar molecules, which had the potential to form strong interactions
with undesired motifs. These undesired interactions were exploited in a signalling cas-
cade, where the formation of the UPy 80 homodimer is switched on and off.
6.1 Future Directions
Several aspects of the research described in this thesis are ongoing within the Wilson
group. For example, assembly of the ditopic supramolecular polymers that use the
remote substituent effect (described in Chapter 3) to control polymerisation will be
investigated further using other techniques (e.g. rheology).
The self-sorting system described in Chapter 5 presents an area for significant future
research. The four molecules described could be appended to polymers, allowing a ABC
triple polymer blend to be made (Figure 6.1). This could enable the development of
many new materials, allowing new properties to be discovered.
Figure 6.1: A supramolecular polymer that blends three different polymers could be
synthesised using a four component self-sorting system.
Another area for future research is into the use of the signalling cascade, where the
formation of the UPy 80 homodimer could be switched on and off. If the UPy molecule
could be developed so that an output signal is released on binding then this could be
switched on and off by the addition of a new molecule (Figure 6.2).
Further research is required into different photolabile groups that could be used in order
to mask the hydrogen-bond array of AIC 57. Once a group is found that can be more
easily removed then a photosensitive signalling cascade can be realised.
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Figure 6.2: If UPy 80 were designed so that a signal was released when the homodimer
was present then the signal could be turned on and off as the signalling cascade was
carried out.

Chapter 7
Experimental
General
All reagents were purchased from Aldrich or Alfa-Aesar and used without further pu-
rification unless otherwise stated. Where anhydrous solvents were required, THF was
freshly distilled from sodium benzophenone ketyl radical and CH2Cl2 was freshly dis-
tilled from calcium hydride, or they were obtained using a solvent purification system
from Innovative Technology Inc. PureSolv R©. CHCl3 was freshly distilled from calcium
chloride under a nitrogen atmosphere. Anhydrous DMF was obtained “sure-sealed”
from Sigma-Aldrich. Triethylamine was distilled from calcium hydride and stored, un-
der nitrogen, over potassium hydroxide pellets. All non-aqueous reactions were carried
out under a nitrogen atmosphere. Analytical thin layer chromatography (TLC) was
conducted using Merck Kieslegel 0.25 mm silica gel pre-coated aluminium plates with
fluorescent indicator active at UV245. Purification by column chromatography was car-
ried out using Merck Kieselgel 60 silica gel. NMR spectra were obtained using Bruker
DMX500 or Bruker AMD300 spectrometers operating at 500 MHz or 300 MHz for 1H
spectra and 100 MHz or 75 MHz for 13C spectra as stated. Proton spectra are referenced
to TMS at 0.00 ppm, and carbon spectra to CDCl3 at 77.4 ppm, unless otherwise stated.
Melting points were determined using a Griffin D5 variable temperature apparatus and
are uncorrected. IR spectra were obtained using Perkin-Elmer FTIR spectrometer. Mi-
croanalysis was carried out on a Carlo Erba Elemental Analyser MOD 1106 instrument.
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High Resolution Mass Spectra (HRMS) were recorded on a Micromass GCT Premier us-
ing electron impact ionisation (EI) or a Bruker Daltonics micrOTOF using electrospray
ionisation (ESI).
7.1 Experimental for Chapter 2: Effects of Preorganisa-
tion
N-tert-Butoxycarbonylguanidine (58)
Synthesised following literature procedure.60 Di-tert-butyl dicarbonate (23.7 g, 109 mmol)
in acetone (250 mL) was added to a solution of guanidine hydrochloride (31.0 g, 326 mmol)
and sodium hydroxide (26.0 g, 652 mmol) in water (200 mL) stirring at 0 ◦C. The reac-
tion mixture was then allowed to warm to room temperature before being stirred for
20 hrs. The organics were evaporated, giving an aqueous suspension which was ex-
tracted into EtOAc (2 × 150 mL). The combined organics were dried (Na2SO4) and
concentrated in vacuo before being triturated (1:2 hexane–EtOAc, 200 mL). Filtration
gave N-tert-butoxycarbonylguanidine 58 (9.04 g, 52%) as a colourless powder; m.p. 165–
168 ◦C [Lit.60 decomposes> 350 ◦C] All other data is comparable to literature values
(Found: C, 45.0; H, 8.20; N, 26.7; C6H13N3O2 requires C, 45.3; H, 8.23; N, 26.4%);
Rf 0.00 (EtOAc); δH (300 MHz, DMSO-d6); 1.36 (9H, s, tBu); δC (75 MHz, DMSO-d6);
163.7, 163.0, 75.8, 28.58; νmax/cm−1 (neat); 2971-3402, 1666, 1600; ESI-HRMS found
m/z 160.1078 [M + H]+, C6H14N3O2 requires 160.1081.
Chapter 7 163
tert-Butyl 4-tert-butyl-1H-imidazol-2-ylcarbamate (59)
Synthesised following literature procedure.60 1-Bromopinacolone (0.56 mL, 4.19 mmol)
was added to a solution of N-tert-butoxy carbonylguanidine 58 (2.00 g, 12.56 mmol) in
dry DMF (14 mL) and was stirred at room temperature for 4 days. The reaction mixture
was then filtered to give crude product. Water (30 mL) was added to the filtrate which
was extracted into EtOAc (3 × 30 mL). The organics were washed with water (30 mL)
and dried (Na2SO4) before being removed in vacuo to give further crude product. The
combined crude material was purified by column chromatography (gradient elution: 0:1-
1:4 EtOAc–CH2Cl2 followed by EtOAc) to give tert-Butyl 4-tert-butyl-1H-imidazol-2-
ylcarbamate 59 (577 mg, 58%) as a colourless powder; m.p. decomposes> 173 ◦C [Lit.60
decomposes> 167 ◦C] (Found: C, 60.0; H, 8.85; N, 17.4; C12H21N3O2 requires C, 60.2;
H, 8.84; N, 17.6%); Rf 0.44 (1:9 MeOH–CH2Cl2); δH (300 MHz, DMSO-d6); 6.40 (1H, s,
ArCH), 1.53 (9H, s, tBu), 1.12 (9H, s, tBu); δC (75 MHz, DMSO-d6); 150.2, 149.4, 148.3,
103.2, 84.4, 31.6, 29.4, 27.9; νmax/cm−1 (neat); 2850-3500, 1720, 1630; ESI-HRMS found
m/z 240.1698 [M + H]+, C12H22N3O2 requires 240.1707.
1-(5-tert-Butyl-1H-imidazol-2-yl)-3-phenylurea (17a)
Synthesised following literature procedure.60 2-tert-Butoxyamido-4-tert-butylimidazole
(59) (1.40 g, 5.71 mmol) was dissolved in 1M HCl–EtOH (100 mL) before being stirred at
reflux for 17 hrs. It was then evaporated to dryness in vacuo to give the aminoimidazole ·
hydrochloride 60 as a yellow oil.
Phenyl isocyanate (0.68 mL, 6.28 mmol) in THF (20 mL) was added dropwise to a so-
lution of the aminoimidazole · hydrochloride 60 (1.00 g, 5.71 mmol) and triethylamine
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(1.19 mL, 8.57 mmol) in THF (60 mL) and the reaction mixture was heated at reflux for
24 hrs before the organics were evaporated in vacuo. The resultant solid was dissolved
in EtOAc (200 mL) and washed with water (2× 50 mL), 10% aqueous hydrochloric acid
(2× 50 mL), saturated aqueous sodium bicarbonate (2× 50 mL) and saturated aqueous
sodium chloride (2× 50 mL) before the organics were dried (Na2SO4) and removed in
vacuo. The resultant solid was triturated (CHCl3) and the solid removed by filtration.
The filtrate was evaporated in vacuo and crystallised (1:1 MeOH–MeCN) to give 1-(5-
tert-butyl-1H-imidazol-2-yl)-3-phenylurea 17a (188 mg, 16%) as colourless needles; m.p.
89–93 ◦C [Lit.60 decomposes> 147 ◦C] All other data is comparable to literature val-
ues; Rf 0.17 (1:19 MeOH–CH2Cl2); δH (300 MHz, CDCl3); 7.36 (2H, d, J= 9.9 Hz, 2×
ArCH), 7.26 (2H, t, J= 7.9 Hz, 2× ArCH), 7.04 (1H, t, J= 7.2 Hz, ArCH), 6.31 (1H, s,
ArCH), 1.27 (9H, s, tBu); δC (75 MHz, CDCl3); 155.1, 114.8, 138.3, 129.0, 123.3, 119.7,
30.6, 29.7; νmax/cm−1 (neat); 3292 (br), 2962, 1671, 1595, 1555; ESI-HRMS found m/z
259.1543 [M + H]+, C14H19N4O1 requires 259.1553.
N-(6-Methyl-4-oxo-1,4-dihydropyrimidin-2-yl)benzamide (57a)
Synthesised following literature procedure.60 Benzoic acid (500 mg, 4.1 mmol) was added
to a solution of 6-methylisocytosine (427 mg, 3.4 mmol) in CHCl3 before DMAP (625 mg,
5.1 mmol) and EDCI (1.20 g, 4.1 mmol) were added. The reaction mixture was heated
at reflux for 19 hrs before being cooled and washed with 10% aqueous hydrochloric
acid (2 × 50 mL), saturated aqueous sodium bicarbonate (2 × 50 mL) and saturated
aqueous sodium chloride (2×50 mL). The organics were dried (Na2SO4) and evaporated
in vacuo to give the crude material which was purified by column chromatography
(gradient elution: 0:1-1:19 MeOH–CH2Cl2) and crystallised (CH2Cl2–hexane) to give
N-(6-methyl-4-oxo-1,4-dihydropyrimidin-2-yl)benzamide 57a
(260 mg, 33%) as a colourless powder; m.p. 184–186 ◦C [Lit.60 189-192 ◦C] All other data
is comparable to literature values (Found: C, 62.7; H, 4.80; N, 18.1; C12H11N3O2 requires
C, 62.9; H, 4.80; N, 18.3%); Rf 0.35 (1:9 MeOH–CH2Cl2); δH (400 MHz, CHCl3); 7.92
(2H, d, J= 7.2 Hz, 2×ArCH), 7.65 (1H, t, J= 7.2 Hz, ArCH), 7.53 (2H, t, J= 7.2 Hz
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ArCH), 6.02 (1H, s, ArCH), 2.22 (3H, s, CH3); δC (125 MHz, CDCl3); 169.8, 162.3,
151.0, 133.6, 132.3, 128.9, 127.9 (× 2), 108.4, 22.9; νmax/cm−1 (neat); 3186, 1737, 1640;
ESI-HRMS found m/z 230.0934 [M + H]+, C12H12N3O2 requires 230.0930.
N-(1-Hexyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide (61)
Triethylamine (9.40 mL, 67.5 mmol) and benzoyl chloride (6.27 mL, 54.0 mmol) were
added to a solution of cytosine (5.00 g, 45.0 mmol) and DMAP (0.55 g, 4.50 mmol) in
CHCl3 and the reaction mixture was heated to reflux for 16 hrs before being allowed
to cool and filtered. The resultant solid was washed with CHCl3 (100 mL) and water
(100 mL) before being dried in vacuo to give benzamidocytosine 63 (10.3 g) as the crude
product.
Potassium carbonate (9.60 g, 69.7 mmol) and 1-bromohexane (4.90µL, 34.9 mmol) were
added to a suspension of benzamidocytosine 63 (5 g, 23.3 mmol) in DMF (400 mL) and
the mixture was heated to 80 ◦C for 20 hrs. The reaction mixture was then cooled to
room temperature before the solid was filtered. The filtrate was diluted with EtOAc
(200 mL) and washed with 10% aqueous hydrochloric acid (100 mL), water (100 mL)
and saturated aqueous sodium chloride (100 mL). The organics were dried (Na2SO4) and
evaporated in vacuo to give crude product which was purified by column chromatography
(EtOAc) to give N-(1-hexyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide 61 (377 mg, 5%)
as a colourless powder; m.p. 125–127 ◦C (Found: C, 67.9; H, 7.10; N, 14.2; C17H21N3O2
requires C, 68.2; H, 7.07; N, 14.0%); Rf 0.58 (EtOAc); δH (500 MHz, DMSO-d6); 11.17
(1H, s, NH), 8.19 (1H, d, J= 7.3 Hz, ArCH), 8.01 (2H, d, J= 8.1 Hz, 2×ArCH), 7.68
(1H, t, J= 8.1 Hz, ArCH), 7.57 (2H, t, J= 8.1 Hz, 2×ArCH), 7.32 (1H, d, J= 7.3 Hz,
ArCH), 3.85 (2H, t, J= 7.3 Hz, CH2), 1.66 (2H, m, CH2), 1.29 (6H, m, 3×CH2), 0.91
(3H, t, J= 7.3 Hz, CH3); δC (75 MHz, CDCl3); 162.0, 148.8, 133.2, 129.1, 127.5, 96.3,
51.1, 31.3, 28.9, 26.2, 22.5, 14.0; νmax/cm−1 (neat); 3381 (br), 2954, 1671, 1625; ESI-
HRMS found m/z 300.1695 [M + H]+, C17H22N3O2 requires 300.1707.
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2-Benzamido-7-methylnaphthyridine (62)
Synthesised following literature procedure.43 2,6-Diaminopyridine (2.99 g, 27.3 mmol)
and phosphoric acid (35.0 g) were heated to 90 ◦C until melted. 4,4-Dimethoxy-2-
butanone (3.75 mL, 28.1 mmol) was then added dropwise over 30 mins and the reac-
tion mixture was then heated to 115 ◦C for 3 hrs. After cooling to room temperature,
ammonuim hydroxide was added dropwise until pH> 10. The resultant mixture was
extracted with CHCl3 (3× 100 mL) and the combined organics were washed with satu-
rated aqueous sodium chloride (2× 100 mL), dried (Na2SO4) and concentrated in vacuo
to give 2-amino-7-methylnaphthyridine 64 (3.32 g, 82%) as a red-brown solid.
Benzoyl chloride (2.00 mL, 17.2 mmol) was added dropwise to a solution of 2-amino-7-
methylnaphthyridine 64 (2.10 g, 14.1 mmol) and NEt3 (2.96 mL, 21.1 mmol) in CH2Cl2
(50 mL) and stirred at room temperature for 16 hrs. The reaction mixture was then
diluted with CH2Cl2 (50 mL) and washed with saturated aqueous ammonium chloride
(3× 50 mL) and saturated aqueous sodium chloride (2× 50 mL). The organics were dried
(Na2SO4) and evaporated in vacuo. The resultant solid was purified by column chro-
matography (0:1–1:19 MeOH–EtOAc) and then crystallised (CH2Cl2–hexane) to give
2-benzamido-7-methylnaphthyridine 62 (1.66 g, 47%) as a colourless powder; m.p. 160–
162 ◦C; Rf 0.68 (1:9 MeOH–CH2Cl2); δH (500 MHz, CDCl3); 8.98 (1H, s, NH), 8.66 (1H,
d, J= 8.8 Hz, ArCH), 8.21 (1H, d, J= 8.8 Hz, ArCH), 8.05 (1H, d, J= 8.2 Hz, ArCH),
7.97 (2H, d, J= 7.0 Hz, 2×ArCH), 7.51-7.61 (3H, m, 3×ArCH), 7.31 (1H, d, J= 8.2 Hz,
ArCH), 2.79 (3H, s, CH3); δC (75 MHz, DMSO-d6); 166.7, 162.5, 154.5, 154.3, 139.1,
136.9, 133.9, 132.3, 128.5, 128.3, 121.6, 118.3, 115.0, 25.3; νmax/cm−1 (neat); 3225, 1677,
1610, 1579, 1505, 1437, 1391, 1322, 1272; ESI-HRMS found m/z 264.1131 [M + H]+,
C17H13N3O requires 264.1129.
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7.2 Experimental for Chapter 3: The Substituent Effect
Synthesis of 17a and 57a described in Section 7.1.
1-(5-tert-Butyl-1H-imidazol-2-yl)-3-p-tolylurea (17e)
Synthesised following literature procedure.60 2-tert-Butoxyamido-4-tert-butylimidazole
59 (685 mg, 2.86 mmol) was dissolved in 1M HCl–EtOH (10 mL) before being stirred at
reflux for 17 hrs. It was then evaporated to dryness in vacuo to give the aminoimidazole ·
hydrochloride 60 as a yellow oil.
4-Methylphenyl isocyanate (0.40 mL, 3.14 mmol) was added dropwise to a solution of
the aminoimidazole · hydrochloride 60 (500 mg, 2.86 mmol) and triethylamine (0.79 mL,
5.71 mmol) in THF (50 mL) and the reaction mixture was heated at reflux for 15 hrs be-
fore the organics were evaporated in vacuo. The resultant solid was dissolved in EtOAc
(50 mL) and washed with water (2× 50 mL), 10% aqueous hydrochloric acid (2× 50 mL),
saturated aqueous sodium bicarbonate (2× 50 mL) and saturated aqueous sodium chlo-
ride (2× 50 mL) before the organics were dried (Na2SO4) and removed in vacuo. The
crude product was purified by column chromatography (gradient elution: 0:1-3:7 EtOAc–
hexane followed by 1:4 MeOH–EtOAc) and crystallised (1:1 MeOH/MeCN–H2O) to give
1-(5-tert-Butyl-1H-imidazol-2-yl)-3-p-tolylurea 17e (361 mg, 46%) as colourless needles;
m.p. 185–188 ◦C; Rf 0.21 (1:9 MeOH–CH2Cl2); δH (300 MHz, CDCl3); 7.23 (2H, d,
J= 8.4 Hz, 2×ArCH), 7.07 (2H, d, J= 8.4 Hz, 2×ArCH), 6.29 (1H, s, ArCH), 2.30
(3H, s, CH3), 1.26 (9H, s,
tBu); δC (75 MHz, CDCl3); 155.5, 146.9, 144.9, 135.6, 133.2,
129.5, 121.7, 120.4, 30.6, 29.8, 20.8; νmax/cm−1 (neat); 3369 (br), 2963, 1667, 1598,
1552, 1515; ESI-HRMS found m/z 273.1713 [M + H]+, C15H21N4O requires 273.1710.
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4-tert-Butyl-N-(6-methyl-4-oxo-1,4-dihydropyrimidin-2-yl)benzamide
(57d)
Synthesised following literature procedure.60 2-Amino-6-methylpyrimidin-4-ol (0.29 g,
2.34 mmol), 4-tert-butylbenzoic acid (0.50 g, 2.81 mmol), DMAP (0.43 g, 3.51 mmol) and
EDCI (0.83 g, 2.81 mmol) were suspended in CHCl3 (100 mL) and heated to reflux for
18 hrs. The reaction mixture was cooled to room temperature and washed with 10%
aqueous hydrochloric acid (2 × 50 mL), saturated aqueous sodium bicarbonate (2 ×
50 mL) and saturated aqueous sodium chloride (2× 50 mL). The organic layer was then
dried (Na2SO4) and evaporated in vacuo and the resultant solid was purified by column
chromatography (1:1 EtOAc–hexane) followed by crystallisation (CH2Cl2–hexane) to
give 4-tert-butyl-N-(6-methyl-4-oxo-1,4-dihydropyrimidin-2-yl)benzamide 57d (552 mg,
83%) as a colourless floculent solid; m.p. 238–240 ◦C (Found: C, 67.6; H, 6.65; N,
14.7; C16H19N3O2 requires C, 67.4; H, 6.71; N, 14.7%); Rf 0.33 (EtOAc); δH (400 MHz,
CDCl3); 7.84 (2H, d, J= 8.6 Hz, 2×ArCH), 7.54 (2H, d, J= 8.6 Hz, 2×ArCH), 6.02
(1H, s, ArCH), 2.22 (3H, s, CH3), 1.36 (9H, s,
tBu); δC (75 MHz, CDCl3); 162.3, 158.1,
151.0, 129.5, 128.1, 126.4, 108.9, 35.6, 31.4, 23.6; νmax/cm−1 (neat); 3435 (br), 2079,
1650; ESI-HRMS found m/z 286.1546 [M + H]+, C16H20N3O2 requires 286.1550.
4-Chloro-N-(6-methyl-4-oxo-1,4-dihydropyrimidin-2-yl)benzamide (57e)
Synthesised following literature procedure.60 2-Amino-6-methylpyrimidin-4-ol (0.33 g,
2.65 mmol), 4-chlorobenzoic acid (0.50 g, 3.18 mmol), DMAP (0.49 g, 3.98 mmol) and
EDCI (0.95 g, 3.18 mmol) were suspended in CHCl3 (70 mL) and heated to reflux for
16 hrs. The reaction mixture was then allowed to cool to room temperature before being
washed with 10% aqueous hydrochloric acid (2 × 50 mL), saturated aqueous sodium
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bicarbonate (2×50 mL) and saturated aqueous sodium chloride (2×50 mL). The organic
layer was then dried (Na2SO4) and evaporated in vacuo. The crude product was purified
by column chromatography (1:9 MeOH–CH2Cl2) followed by crystallisation (CH2Cl2–
MeOH) to give 4-chloro-N-(6-methyl-4-oxo-1,4-dihydropyrimidin-2-yl)benzamide 57e
(278 mg, 40%) as colourless plates; m.p. 245–248 ◦C (Found: C, 54.9; H, 3.75; N, 16.0;
Cl, 12.3 C12H10ClN3O3 requires C, 54.7; H, 3.82; N, 16.0; Cl, 12.1%); Rf 0.61 (1:9
MeOH–CH2Cl2); δH (300 MHz, DMSO-d6); 8.08 (2H, d, J= 8.6 Hz, ArCH), 7.59 (2H,
d, J= 8.6 Hz, ArCH), 5.92 (1H, s, ArCH), 2.20 (3H, s, CH3); δC (75 MHz, DMSO-d6);
161.1, 153.0, 137.9, 133.4, 130.9, 128.8, 106.1, 31.0, 21.4; νmax/cm−1 (neat); 3435 (br),
2078, 1638; ESI-HRMS found m/z 264.0524 [M + H]+, C12H11ClN3O2 requires 264.0534.
Found m/z 286.0354 [M + Na]+, C12H10ClN3NaO2 requires 286.0354.
Hexane-1,6-diyl dibenzoate (72)
Benzoyl chloride (500µL, 4.29 mmol) was added dropwise to a solution of 1,6-hexanediol
(230 mg, 1.95 mmol) and triethylamine (543µL, 3.90 mmol) in THF (10 mL) and the
reaction mixture was stirred at room temperature for 18 hrs. The solvents were then
evaporated and the crude product was purified by column chromatography (gradient
elution: 1:0-0:1 hexane–CH2Cl2) to give hexane-1,6-diyl dibenzoate 72 (438 mg, 69%)
as a colourless powder; m.p. 44–46 ◦C (Found: C, 73.5; H, 6.80; C20H22O4 requires
C, 73.6; H, 6.79%); Rf 0.34 (CH2Cl2); δH (300 MHz, CDCl3); 8.04 (4H, d, J= 7.9 Hz,
4×ArCH), 7.55 (4H, t, J= 7.9 Hz, 2×ArCH), 7.43 (4H, t, J= 7.9 Hz, 4×ArCH), 4.34
(4H, t, J= 6.6 Hz, 2×CH2), 1.82 (4H, m, 2×CH2), 1.53 (4H, m, 2×CH2); δC (75 MHz,
CDCl3); 167.1, 138.2, 130.9, 129.9, 128.7, 65.3, 29.1, 26.2; νmax/cm
−1 (neat); 3064,
2979, 2936, 2868, 1715; ESI-HRMS found m/z 327.1602 [M + H]+, C20H23O4 requires
327.1591.
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Diphenyl octanedioate (73)
Suberoyl chloride (435µL, 2.40 mmol) was added to a refluxing solution of phenol (500 mg,
5.30 mmol) and triethylamine (673µL, 4.84 mmol) in THF (10 mL). The reaction mix-
ture was stirred at reflux for 15 hrs before being cooled and concentrated in vacuo. The
resultant solid was triturated (CH2Cl2), filtered and the filtrate concentrated to give the
crude product which was purified by column chromatography (CH2Cl2) to give diphenyl
octanedioate 73 (545 mg, 70%) as a colourless powder; m.p. 51–54 ◦C [Lit.234 73 ◦C] All
other data is comparable to literature values (Found: C, 73.4; H, 6.80; C20H22O4 requires
C, 73.6; H, 6.79%); Rf 0.61 (CH2Cl2); δH (500 MHz, CDCl3); 7.30 (4H, t, J= 7.9 Hz,
4×ArCH), 7.14 (2H, t, J= 7.9 Hz, 2×ArCH), 7.00 (4H, d, J= 7.9 Hz, 4×ArCH), 2.50
(4H, t, J= 7.5 Hz, 2×CH2), 1.72 (4H, m, 2×CH2), 1.42 (4H, m, 2×CH2); δC (75 MHz,
CDCl3); 172.2, 150.7, 129.5, 125.8, 121.6, 34.3, 28.8, 24.8; νmax/cm
−1 (neat); 2937,
2913, 2970, 2862, 1758; ESI-HRMS found m/z 349.1407 [M + Na]+, C20H25NaO4 re-
quires 349.1410.
Ethyl 4-(3-(6-methyl-4-oxo-1,4-dihydropyrimidin-2-yl)ureido)benzoate
(74)
Ethyl 4-isocyanatobenzoate (1.68 g, 8.8 mmol) was added to a solution of 2-amino-4-
hydroxy-6-methylpyrimidine (1.00 g, 8.0 mmol) and NEt3 (1.11 mL, 8.0 mmol) in THF
(50 mL) and the reaction mixture was heated to reflux for 17 hrs. After cooling to room
temperature the reaction mixture was filtered and the solid triturated with EtOAC.
The suspension was filtered to give ethyl 4-(3-(6-methyl-4-oxo-1,4-dihydropyrimidin-2-
yl)ureido)benzoate 74 (1.94 g, 77%) as a colourless solid; m.p. 274–276 ◦C; Rf 0.00 (1:4
MeOH–CH2Cl2); δH (300 MHz, DMSO-d6); 7.92 (2H, d, J= 9.0 Hz, 2×ArCH), 7.70 (2H,
d, J= 9.0 Hz, 2×ArCH), 5.76 (1H, s, ArCH), 4.29 (2H, q, J= 6.5 Hz, CH2), 2.20 (3H, s,
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CH3), 1.31 (3H, t, J= 6.5 Hz, CH3); Molecule was too insoluble to obtain δC; νmax/cm
−1
(neat); 3410 (br), 1698, 1660; Molecule was too insoluble to obtain MS.
1-(4-Methoxyphenyl)-3-(6-methyl-4-oxo-1,4-dihydropyrimidin-2-yl)urea
(75)
2-Amino-6-methylpyrimidin-4-ol (1.00 g, 8.0 mmol) was added to a solution of triethy-
lamine (1.11 mL, 8.0 mmol) in THF (50 mL). The reaction mixture was heated to reflux
before 4-methoxy phenylisocyanate (1.14 mL, 8.8 mmol) was added and the reaction mix-
ture was heated at reflux for a further 18 hrs before being cooled to room temperature
and filtered. The resultant crude solid was purified by repeated sonication in MeOH
(200 mL) followed by filtration to give the 1-(4-methoxyphenyl)-3-(6-methyl-4-oxo-1,4-
dihydropyrimidin-2-yl)urea 75 (1.56 g, 71%) as a cream coloured solid; m.p. 275–276 ◦C
(Found: C, 56.7; H, 5.05; N, 20.4; C13H14N4O3 requires C, 56.9; H, 5.14; N, 20.4%);
Rf 0.57 (1:9 MeOH–CH2Cl2); δH (300 MHz, DMSO-d6); 9.82 (1H, s, NH), 7.41 (2H, d,
J= 8.8 Hz, 2×ArCH), 6.91 (2H, d, J= 8.8 Hz, 2×ArCH), 5.82 (1H, s, ArCH), 3.73 (3H,
s, OCH3), 2.17 (3H, s, CH3); Molecule was too insoluble to obtain δC; νmax/cm
−1 (neat);
2987 (br), 1702, 1652, 1261; ESI-HRMS found m/z 275.1142 [M + H]+, C13H15N4O3 re-
quires 275.1139.
1-(4-Hydroxyphenyl)-3-(6-methyl-4-oxo-1,4-dihydropyrimidin-2-yl)urea
(77)
Synthesised following literature procedure.195 Boron tribromide (1M in CH2Cl2, 2.19 mL,
2.19 mmol) was added dropwise to a suspension of the methoxy ureidopyrimidine 75
(200 mg, 0.73 mmol) in CH2Cl2 (10 mL) stirring at -78
◦C. The reaction mixture was
then allowed to warm to room temperature and stirred for 19 hrs before being quenched
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with H2O (20 mL) and stirred for a further 2 hrs. The reaction mixture was filtered to
give 1-(4-hydroxyphenyl)-3-(6-methyl-4-oxo-1,4-dihydropyrimidin-2-yl)urea 77 (176 mg,
93%) as a colouless powder; m.p. 112–115 ◦C; Rf 0.36 (1:9 MeOH–CH2Cl2); δH (300 MHz,
DMSO-d6); 9.67 (1H, s, OH), 7.27 (2H, d, J= 8.8 Hz, 2×ArCH), 6.73 (2H, d, J= 8.8 Hz,
2×ArCH), 5.86 (1H, s, ArCH), 2.18 (3H, s, CH3); Molecule was too insoluble to ob-
tain δC; νmax/cm−1 (neat); 3655-2337, 1710, 1646, 1621, 1514, 1227; Molecule was too
insoluble to obtain MS.
2-Amino-6-tridecylpyrimidin-4-ol (78)
Synthesised following literature procedure.193 Triethylamine (50.0 mL, 360 mmol) was
added to a suspension of potassium ethyl malonate (40.8 g, 240 mmol) in MeCN (250 mL)
that was stirring at 0 ◦C. The reaction mixture was stirred for 15 mins before magne-
sium chloride (28.5 g, 300 mmol) in MeCN (80 mL) was added and allowed to warm to
10 ◦C. After stirring for 2 hrs the reaction mixture was cooled to 0 ◦C before myristoyl
chloride (32.6 mL, 120 mmol) was added dropwise. The reaction mixture was warmed to
room temperature and stirred for 16 hrs before the solvents were evaporated in vacuo.
The resultant solid was dissolved in Et2O (350 mL) and washed with 30% aqueous hy-
drochloric acid (250 mL) and saturated aqueous sodium bicarbonate (100 mL) before the
organics were dried (MgSO4) and evaporated in vacuo. The resultant solid was purified
by column chromatography (CHCl3) to give ethyl 3-oxohexadecanoate 79 (26.9 g, 75%)
as a colourless powder.
Guanidinium carbonate (12.8 g, 142.6 mmol) was added to a solution of 79 (25.0 g,
83.9 mmol) and potassium tert-butoxide (9.4 g, 83.9 mmol) in EtOH (300 mL) and the
reaction mixture was heated to reflux for 3 days. After cooling the reaction mixture was
filtered and the filtrate was evaporated in vacuo. The resultant solid was dissolved in
H2O (500 mL) and the solution was acidified to pH 6 (acetic acid). The resultant suspen-
sion was filtered and the solid washed with acetone and Et2O before being crystallised
(propan-2-ol) to give the 2-amino-6-tridecylpyrimidin-4-ol 78 as a cream coloured pow-
der; m.p. 162–165 ◦C; Rf 0.19 (1:9 MeOH–CH2Cl2); δH (300 MHz, DMSO-d6); 6.58 (2H,
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s, NH2), 5.33 (1H, s, ArCH), 2.20 (2H, t, J= 6.0 Hz, CH2), 1.51 (2H, m, CH2), 1.23
(20H, m, 10×CH2), 0.85 (3H, t, J= 6.0 Hz, CH3); Molecule was too insoluble to obtain
δC; νmax/cm−1 (neat); 3360, 3144, 2919, 2850, 2679 (br), 1637, 1468, 1401; ESI-HRMS
found m/z 294.2529 [M + H]+, C17H32N3O requires 294.2540.
Ethyl 4-(3-(4-oxo-6-tridecyl-1,4-dihydropyrimidin-2-yl)ureido)benzoate
(80)
Ethyl-4-isocyanatobenzoate (0.71 g, 3.75 mmol) was added to a refluxing solution of the
amine 78 (1.00 g, 3.41 mmol) and triethylamine (0.48 mL, 3.75 mmol) in THF (50 mL).
The reaction mixture was then stirred at reflux for 18 hrs before being allowed to cool and
the volatiles evaporated in vacuo. The resultant solid was suspended in EtOAc (50 mL)
and H2O (50 mL) was added. The suspension was filtered and sonicated in EtOAc
(50 mL) before being filtered and washed (Et2O) to give ethyl 4-(3-(4-oxo-6-tridecyl-
1,4-dihydropyrimidin-2-yl)ureido)benzoate 80 (1.22 g, 74%) as a colouless powder; m.p.
218–220 ◦C; Rf 0.38 (1:99 MeOH–CH2Cl2); δH (300 MHz, CDCl3); 12.95 (1H, s, NH),
12.52 (1H, s, NH), 12.32 (1H, s, NH), 8.07 (2H, d, J= 8.7 Hz, ArCH), 7.86 (2H, d,
J= 8.7 Hz, ArCH), 5.94 (1H, s, ArCH), 4.41 (2H, q, J= 7.2 Hz, CH2), 2.47 (2H, t,
J= 7.7 Hz, CH2), 1.65 (4H, m, 2×CH2), 1.44 (3H, t, J= 7.2 Hz, CH3), 1.32 (18H, m,
9×CH2), 0.92 (3H, t, J= 6.6 Hz, CH3); δC (75 MHz, CDCl3); 172.8, 166.2, 154.4, 154.3,
152.9, 142.8, 130.5, 125.3, 119.3, 105.9, 60.8, 32.4, 31.9, 29.6-29.2 (× 7), 28.9, 26.3, 22.7,
14.4, 14.1; νmax/cm−1 (neat); 3466-2850, 1698, 1650; Molecule was too insoluble to
obtain MS.
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4-(3-(4-Oxo-6-tridecyl-1,4-dihydropyrimidin-2-yl)ureido)benzoic acid (82)
Synthesised following literature procedure.194 1 M Aqueous sodium hydroxide (4.12 mL,
4.12 mmol) was added to a suspension of the ester ureidopyrimidine 80 (500 mg, 1.03 mmol)
in EtOH (50 mL) and the reaction mixture was heated to 70 ◦C for 18 hrs. The solvent
was then evaporated in vacuo and the resultant solid was dissolved in H2O (25 mL) and
acidified with 10% aqueous hydrochloric acid. The reaction mixture was then filtered
to give 4-(3-(4-oxo-6-tridecyl-1,4-dihydropyrimidin-2-yl)ureido)benzoic acid 82 (457 mg,
97%) as a colourless solid; m.p. 256–257 ◦C; Rf 0.39 (1:9 MeOH–CH2Cl2); δH (300 MHz,
DMSO-d6); 7.91 (2H, d, J= 9.0 Hz, 2×ArCH), 7.64 (2H, d, J= 9.0 Hz, 2×ArCH),
5.84 (1H, s, ArCH), 2.44 (2H, t, J= 7.5 Hz, CH2), 1.59 (2H, m, CH2), 1.21 (20H,
m, 10×CH2), 0.83 (3H, t, J= 6.0 Hz, CH3); Molecule was too insoluble to obtain δC;
νmax/cm−1 (neat); 3200-2343, 1689, 1656; ESI-HRMS found m/z 438.2747 [M - H2O]
−,
C25H34N4O3 requires 438.2631.
1-(4-Methoxyphenyl)-3-(4-oxo-6-tridecyl-1,4-dihydropyrimidin-2-yl)urea
(81)
4-Methoxyphenylisocyanate (0.24 mL, 1.90 mmol) was added to a refluxing mixture
of the amine 78 (0.50 g, 1.71 mmol) and triethylamine (0.24 mL, 1.71 mmol) in THF
(20 mL). The reaction mixture was then stirred at reflux for 18 hrs before being al-
lowed to cool and the volatiles evaporated in vacuo. The resultant solid was triturated
in hot CHCl3 (50 mL), filtered and the filtrate evaporated to give the crude product
which was crystallised (CHCl3–MeOH) to give 1-(4-methoxyphenyl)-3-(4-oxo-6-tridecyl-
1,4-dihydropyrimidin-2-yl)urea 81 (0.55 g, 73%) as colourless needles; m.p. 121–123 ◦C
(Found: C, 67.7; H, 8.65; N, 12.7; C25H38N4O3 requires C, 67.8; H, 8.65; N, 12.7%);
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Rf 0.57 (1:1 EtOAc–hexane); δH (300 MHz, CDCl3); 13.12 (1H, s, NH), 12.27 (1H, s,
NH), 12.10 (1H, s, NH), 7.61 (2H, d, J= 9.1 Hz, ArCH), 6.93 (2H, d, J= 9.1 Hz, ArCH),
5.94 (1H, s, ArCH), 3.84 (3H, s, OCH3), 2.50 (2H, t, J= 7.5 Hz, CH2), 1.68 (2H, m,
CH2), 1.60 (4H, m, 2×CH2), 1.32 (16H, m, 8×CH2), 0.92 (3H, t, J= 6.8 Hz, CH3); δC
(75 MHz, CDCl3); 173.1, 156.2, 154.7, 154.6, 152.7, 131.2, 122.4, 114.1, 105.9, 55.5, 32.6,
31.9, 29.7-29.2 (× 7), 28.9, 26.7, 22.7, 14.2; νmax/cm−1 (neat); 2916 (br), 1707, 1651,
1574, 1509; ESI-HRMS found m/z 443.3017 [M + H]+, C25H39N4O3 requires 443.3017.
1-(4-Hydroxyphenyl)-3-(4-oxo-6-tridecyl-1,4-dihydropyrimidin-2-yl)urea
(83)
Synthesised following literature procedure.195 BBr3 (3.4 mL, 1 M in CH2Cl2, 3.39 mmol)
was added dropwise to a suspension of 81 (500 mg, 1.13 mmol) in CH2Cl2 (10 mL) cooled
to −78 ◦C. The reaction mixture was then allowed to warm to room temperature and was
stirred for 20 hrs. H2O (10 mL) was then added dropwise before the reaction mixture was
filtered and the resultant solid was triturated with CHCl3 to give 1-(4-hydroxyphenyl)-3-
(4-oxo-6-tridecyl-1,4-dihydropyrimidin-2-yl)urea 83 (448 mg, 93%) as a colourless solid;
m.p. 175–176 ◦C; Rf 0.39 (1:9 MeOH–CH2Cl2); δH (300 MHz, DMSO-d6); 9.80 (1H, s,
OH), 7.25 (2H, d, J= 8.7 Hz, 2×ArCH), 6.73 (2H, d, J= 8.7 Hz, 2×ArCH), 5.84 (1H,
s, ArCH), 2.43 (2H, t, J= 7.4 Hz, CH2), 1.59 (2H, m, CH2), 1.22 (20H, m, 10×CH2),
0.85 (3H, t, J= 6.6 Hz, CH3); δC (75 MHz, DMSO-d6); 163.6, 163.4, 154.1, 153.5, 152.1,
129.5, 121.7, 115.7, 104.2, 36.1, 31.6, 29.4-29.1 (× 7), 28.7, 27.6, 22.4, 14.3; νmax/cm−1
(neat); 3234-2853 (br), 1695, 1646, 1627, 1562, 1505, 1447, 1222, 834; Molecule was too
insoluble to obtain MS.
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Undec-10-enyl benzoate (84)
Benzoic acid (1.00 g, 8.20 mmol), DMAP (1.36 g, 11.18 mmol), 10-undecen-1-ol (1.49 mL,
7.45 mmol) and EDCI (1.72 g, 8.94 mmol) were all dissolved in CHCl3 (50 mL) and the
reaction mixture was heated to reflux for 16 hrs. After being allowed to cool to room
temperature the solvent was evaporated in vacuo and the crude product was purified by
column chromatography (CH2Cl2) to give undec-10-enyl benzoate 84 (1.88 g, 92%) as a
yellow coloured oil; (Found: C, 78.9; H, 9.80; C18H26O2 requires C, 78.8; H, 9.60%); Rf
0.41 (1:1 CH2Cl2–hexane); δH (300 MHz, CDCl3); 7.98 (2H, d, J= 7.5 Hz, 2×ArCH),
7.49 (1H, t, J= 7.5 Hz, ArCH), 7.37 (2H, t, J= 7.5 Hz, 2×ArCH), 5.75 (1H, m, alkene-
CH), 4.90 (2H, m, 2× alkene-CH), 4.24 (2H, t, J= 7.5 Hz, CH2), 1.96 (2H, m, CH2),
1.70 (2H, m, CH2), 1.37-1.18 (12H, m, 6×CH2); δC (75 MHz, CDCl3); 166.7, 139.2,
132.8, 130.5, 129.5, 128.3, 114.1, 65.2, 33.8, 29.5, 29.4, 29.3, 29.1, 28.9, 28.7, 26.0;
νmax/cm−1 (neat); 3074, 2927, 2855, 1727, 1274, 1114, 711; ESI-HRMS found m/z
297.1823 [M + Na]+, C18H26NaO2 requires 297.1825.
Undec-10-enyl 4-(3-(4-oxo-6-tridecyl-1,4-dihydropyrimidin-2-yl)ureido)
benzoate (87)
10-Undecen-1-ol (358µL, 1.79 mmol) was added to a solution of acid 82 (900 mg,
1.97 mmol), DMAP (328 mg, 2.69 mmol) and EDCI (412 mg, 2.15 mmol) in CHCl3 (50 mL)
and the reaction mixture was heated to reflux for 3 days. It was then allowed to cool to
room temperature before the solvent was evaporated in vacuo and the resultant solid
was purified by column chromatography (gradient elution: 0:1-1:19 MeOH–CH2Cl2) to
give the undec-10-enyl 4-(3-(4-oxo-6-tridecyl-1,4-dihydropyrimidin-2-yl)ureido) benzoate
87 (740 mg, 68%) as a colourless powder; m.p. 122–125 ◦C; Rf 0.51 (1:19 Et2O–CHCl3);
Chapter 7 177
δH (500 MHz, CHCl3); 12.96 (1H, s, NH), 12.48 (1H, s, NH), 12.33 (1H, s, NH), 8.03
(2H, d, J= 8.3 Hz, ArCH), 7.82 (2H, d, J= 8.3 Hz, ArCH), 5.96 (1H, s, ArCH), 5.82
(1H, ddt, J= 11.0, 17.0, 6.6 Hz, CH), 4.97 (2H, ddd, J= 11.0, 17.0, 32.3 Hz, CH2), 4.30
(2H, t, J= 6.6 Hz, CH2), 2.52 (2H, t, J= 7.2 Hz, CH2), 2.05 (2H, q, J= 7.2 Hz, CH2),
1.79–1.26 (36H, m, alkyl), 0.87 (3H, t, J= 6.9 Hz, CH3); δC (75 MHz, CDCl3); 172.9,
166.3, 154.4, 154.3, 153.0, 142.8, 139.2, 130.6, 125.4, 119.4, 114.2, 106.0, 65.0, 33.9, 32.5,
32.0, 29.7-28.8 (× 14), 26.4, 26.1, 22.7, 14.2; νmax/cm−1 (neat); 3454, 2922, 2850, 1714,
1696, 1660; ESI-MS found m/z 609.4 [M + H]+, C36H56H4O4 requires 609.4.
4-(3-(4-Oxo-6-tridecyl-1,4-dihydropyrimidin-2-yl)ureido)phenyl undec-
10-enoate (88)
10-Undecenoic acid (473 mg, 2.57 mmol) was added to a solution of 83 (1.00 g, 2.34 mmol),
DMAP (428 mg, 3.50 mmol) and EDCI (538 mg, 2.80 mmol) in CHCl3 (50 mL) and
the reaction mixture was heated to reflux for 15 hrs before being allowed to cool to
room temperature. The volatiles were then removed in vacuo and the resultant solid
was purified by column chromatography (gradient elution: 0:1-1:9 MeOH–CH2Cl2) and
crystallisation (CHCl3–MeOH) to give the 4-(3-(4-oxo-6-tridecyl-1,4-dihydropyrimidin-
2-yl)ureido)phenyl undec-10-enoate 88 (758 mg, 54%) as a colourless powder; m.p. 128–
130 ◦C (Found: C, 70.5; H, 9.15; N, 9.5; C35H54N4O4 requires C, 70.7; H, 9.15; N, 9.4%);
Rf 0.28 (1:4 EtOAc–hexane); δH (300 MHz, CDCl3); 12.87 (1H, s, NH), 12.22 (1H, s, NH),
12.11 (1H, s, NH), 7.66 (2H, d, J= 9.0 Hz, 2×ArCH), 6.97 (2H, d, J= 9.0 Hz, 2×ArCH),
5.75 (1H, m, CH), 5.73 (1H, s, ArCH), 4.91 (2H, dd, J= 15.3, 22.2 Hz, CH2), 2.47 (2H, t,
J= 7.4 Hz, CH2), 2.24 (2H, t, J= 7.5 Hz, CH2), 1.98 (2H, q, J= 6.9 Hz, CH2), 1.68 (2H,
m, CH2), 1.48 (2H, m, CH2), 1.32-1.19 (30H, m, 15×CH2), 0.81 (3H, t, J= 6.6 Hz, CH3);
δC (75 MHz, CDCl3); 173.0, 172.2, 154.5 (× 2), 152.9, 146.7, 139.2, 135.9, 121.8, 121.2,
114.2, 106.0, 34.4, 33.8, 32.5, 31.9, 29.7-28.8 (× 13), 26.7, 24.9, 22.7, 14.1; νmax/cm−1
(neat); 3143, 2924, 281, 1749, 1697, 1580, 1505, 1201; ESI-HRMS found m/z 617.4018
[M + Na]+, C35H54N4NaO4 requires 617.4037.
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(E,Z)-Icos-10-ene-1,20-diyl bis(4-(3-(4-oxo-6-tridecyl-1,4-dihydropyrimidin-
2-yl)ureido)benzoate) (85)
Grubbs (I) (10 mg, 0.01 mmol) in degassed CH2Cl2 (2 mL) was added dropwise to a solu-
tion of 87 (150 mg, 0.25 mmol) in degassed CH2Cl2 (10 mL) and the reaction mixture was
stirred at room temperature for 2 days. It was then filtered through celite before the sol-
vent was evaporated and the resultant solid was crystallised (CHCl3–MeOH) to give
(E,Z)-icos-10-ene-1,20-diyl bis(4-(3-(4-oxo-6-tridecyl-1,4-dihydropyrimidin-2-yl)ureido)
benzoate) 85 (125 mg, 84%) as an off white powder; δH (300 MHz, CDCl3); 12.59 (2H, br,
NH) 12.40 (2H, br, NH), 11.90 (2H, br, NH), 7.91 (4H, br, ArCH), 7.75 (4H, br, ArCH)
5.60 (0.5H, br, CH), 5.45 (0.5H, br, CH), 5.35 (1H, br, CH), 4.18 (4H, br, CH2), 1.92
(4H, br, CH2), 1.68 (4H, br, CH2), 1.20 (72H, br, CH2), 0.85 (6H, br, CH3); Molecule
too insoluble to carry out MS.
(E,Z)-Bis(4-(3-(4-oxo-6-tridecyl-1,4-dihydropyrimidin-2-yl)ureido)phenyl)
icos-10-enedioate (86)
Grubbs (I) (10 mg, 0.01 mmol) in degassed CH2Cl2 (1 mL) was added dropwise to a so-
lution of 87 (150 mg, 0.25 mmol) in degassed CH2Cl2 (10 mL) and the reaction mixture
was stirred at room temperature for 2 days. It was then filtered through celite before the
solvent was evaporated and the resultant solid was crystallised (CHCl3–MeOH) to give
(E,Z)-bis(4-(3-(4-oxo-6-tridecyl-1,4-dihydropyrimidin-2-yl)ureido)phenyl) icos-10-enedioate
86 (140 mg, 93%) as an off white powder; δH (300 MHz, CDCl3); 12.80 (2H, br, NH),
12.30 (2H, br, NH), 11.95 (2H, br, NH), 7.70 (4H, br, ArCH), 6.95 (4H, br, ArCH), 5.60
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(2H, br, CH), 5.42 (2H, br, CH), 2.60 (4H, br, CH2), 1.90 (4H, br, CH2), 1.70 (4H, br,
CH2), 1.20 (68H, br, CH2), 0.75 (6H, br, CH3); Molecule too insoluble to carry out MS.
7.3 Experimental for Chapter 4: A Novel ADDA array
Synthesis of 17 described in Section 7.1.
1,3-Bis(5-tert-butyl-1H-imidazol-2-yl)urea (91)
2-tert-Butoxyamido-4-tert-butylimidazole 59 (1.36 g, 5.68 mmol) was dissolved in 1M
HCl–EtOH (100 mL) before being stirred at reflux for 17 hrs. It was then evaporated to
dryness in vacuo to give the aminoimidazole ·hydrochloride 60 as a yellow oil.
Triethylamine (1.98 mL, 14.20 mmol) was added to a solution of the aminoimidazole ·
hydrochloride 60 (1.00 g, 5.68 mmol) in THF (100 mL) and the reaction mixture was
stirred at room temperature for 2 hrs. It was then heated to reflux and carbonyl diim-
idazole (0.55 g, 3.41 mmol) was added. The reaction mixture was then heated at reflux
for a further 20 hrs before being cooled to room temperature and filtered. The filtrate
was evaporated in vacuo and the resultant solid was purified by column chromatography
(gradient elution: 0:1-1:19 MeOH–CH2Cl2) followed by trituration (MeOH) to give the
1,3-bis(5-tert-butyl-1H-imidazol-2-yl)urea 91 (150 mg, 17%) as a colourless solid; m.p.
decomposes> 280 ◦C (Found: C, 59.1; H, 7.95; N, 27.7; C15H24N6O requires C, 59.2;
H, 7.95; N, 27.6%); Rf 0.45 (1:9 MeOH–CH2Cl2); δH (300 MHz, CDCl3); 15.20 (1H, a,
NH), 12.40 (1H, s, NH), 11.16 (1H, s, NH), 10.96 (1H, s, NH), 6.30 and 6.26 (2H, 2× s,
2×ArCH), 1.33 (18H, s, tBu); δC (125 MHz, CDCl3); 162.9, 162.8 (× 2), 162.7 (× 2),
149.9, 149.1 (× 2), 149.0, 148.1, 141.3 (× 2), 140.1 (× 2), 136.7, 134.7, 111.8, 110.4 (× 2),
103.2, 30.9 (× 3), 30.8, 30.2 (× 2), 29.8 (× 2), 29.7; νmax/cm−1 (neat); 3372-2251 (br),
2140, 1916, 1674, 1538, 1480, 1446, 1397, 1173, 1073, 1037, 851, 808; ESI-HRMS found
m/z 305.2087 [M + H]+, C15H25N6O requires 305.2084.
Chapter 7 180
1,3-Di(1H-benzo[d]imidazol-2-yl)urea (128)
2-Aminobenzimidazole (100 mg, 0.75 mmol) was added to a solution of triethylamine
(262µL, 1.88 mmol) in THF (10 mL). The reaction mixture was then heated to reflux
and carbonyl diimidazole (73 mg, 0.45 mmol) was added. The reaction mixture was then
heated at reflux for a further 20 hrs, before being cooled to 0 ◦C and filtered. The resul-
tant solid was washed (Et2O) to give 1,3-di(1H-benzo[d]imidazol-2-yl)urea 128 (51 mg,
45%) as a colourless solid; m.p. > 350 ◦C Rf 0.00 (1:9 MeOH–EtOAc); δH (300 MHz,
DMSO-d6); 12.15 (2H, s, 2×NH), 7.47-7.44 (4H, m, 4×ArCH), 7.14-7.11 (4H, m,
4×ArCH); Molecule was too insoluble to obtain δC; νmax/cm−1 (neat); 3369-2681 (br),
1633, 1593, 1564, 1274, 752; ESI-HRMS found m/z 293.1142 [M + H]+, C15H13N6O
requires 293.1145.
7-Amino-1,8-naphthyridin-2-ol (94)
Synthesised following literature procedure.235 Concentrated sulphuric acid (10 mL) was
added dropwise to a ground mixture of 2,6-diaminopyridine (2.2 g, 20.0 mmol) and malic
acid (3.0 g, 22 mmol) cooled to 0 ◦C. The reaction mixture was then heated to 110 ◦C for
3 hrs before being cooled to 0 ◦C. Ammonium hydroxide solution was then added drop-
wise to pH 9 and the reaction mixture was filtered and washed with water and Et2O
to give 7-amino-1,8-naphthyridin-2-ol 94 (3.04 g, 95%) as an orange solid; m.p. decom-
poses> 350 ◦C [Lit.235 decomposes> 350 ◦C]; Rf 0.00 (EtOAc); δH (300 MHz, DMSO-
d6); 11.91 (1H, s, OH), 7.66 (1H, d, J= 9.5 Hz, ArCH), 7.65 (1H, d, J= 8.4 Hz, ArCH),
7.03 (2H, s, NH2), 6.36 (1H, d, J= 8.4 Hz, ArCH), 6.12 (1H, d, J= 9.5 Hz, ArCH); δC
(75 MHz, DMSO-d6); 164.1, 160.9, 150.7, 140.1, 137.7, 115.2, 105.6, 105.4; νmax/cm−1
(neat); 3600-2500 (br), 1616, 1511, 1370, 1140, 833; ESI found m/z 162.1 [M + H]+,
C8H8N3O requires 162.2.
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N-(7-Hydroxy-1,8-naphthyridin-2-yl)pentanamide (95)
Synthesised following literature procedure.191 Valeroyl chloride (3.70 mL, 31.7 mmol)
was added dropwise to a solution of 2-amino-7-hydroxy-1,8-naphthyridine 94 (3.00 g,
18.6 mmol) in pyridine (20 mL) and heated to 110 ◦C for 20 hrs before the reaction
mixture was allowed to cool to room temperature. The pyridine was evaporated and
then co-evaporated with toluene and the resultant black residue was dissolved in hot
CHCl3 (20 mL) and hexane (200 mL) was added. The solid was filtered and triturated
(MeOH) to give N-(7-hydroxy-1,8-naphthyridin-2-yl)pentanamide 95 (3.47 g, 76%) as
a pale yellow powder; m.p. 316–319 ◦C; Rf 0.39 (1:19 MeOH–CH2Cl2); δH (300 MHz,
DMSO-d6); 11.84 (1H, s, OH), 10.48 (1H, s, NH), 8.04 (1H, d, J= 8.5 Hz, ArCH), 7.94
(1H, d, J= 8.5 Hz, ArCH), 7.84 (1H, d, J= 9.4 Hz, ArCH), 6.42 (1H, d, J= 9.4 Hz,
ArCH), 2.45 (2H, t, J= 7.4 Hz, CH2), 1.55 (2H, m, CH2), 1.32 (2H, m, CH2), 0.89 (3H,
t, J= 7.3 Hz, CH3); νmax/cm
−1 (neat); 3170-2873, 1673, 1585; ESI-HRMS found m/z
246.1239 [M + H]+, C13H16N3O2 requires 246.1237.
N-(7-Chloro-1,8-naphthyridin-2-yl)pentanamide (96)
Synthesised following literature procedure.191 2-Pentanoylamino-7-hydroxy-1,8-naphthyri-
dine 95 (500 mg, 2.04 mmol) was dissolved in POCl3 (10 mL) and heated to 95
◦C for
3 hrs. The reaction mixture was then cooled and POCl3 was evaporated in vacuo. The
residue was poured onto iced water (25 mL) and neutralised with concentrated ammo-
nium hydroxide solution under vigorous stirring. The reaction mixture was extracted
into CH2Cl2 (3 × 20 mL) and then the organic phase was washed with saturated aque-
ous sodium bicarbonate (3× 20 mL), water (3× 20 mL) and saturated aqueous sodium
chloride (20 mL). The organic phase was dried (Na2SO4) and evaporated in vacuo be-
fore being crystallised (1:1 MeOH/MeCN–H2O) to give N-(7-chloro-1,8-naphthyridin-2-
yl)pentanamide 96 (380 mg, 71%) as yellow plates; m.p. 159–162 ◦C; Rf 0.60 (EtOAc);
δH (300 MHz, CDCl3); 8.57 (1H, d, J= 8.7 Hz, ArCH), 8.35 (1H, s, NH), 8.19 (1H, d,
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J= 8.7 Hz, ArCH), 8.07 (1H, d, J= 8.3 Hz, ArCH), 7.40 (1H, d, J= 8.3 Hz, ArCH), 2.48
(2H, t, J= 7.7 Hz, CH2), 1.75 (2H, m, CH2), 1.44 (2H, m, CH2), 0.96 (3H, t, J= 7.4 Hz,
CH3); δC (75 MHz, CDCl3); 172.7, 154.5, 154.4, 139.1, 138.8, 122.0, 119.2, 115.5, 37.7,
27.3, 22.3, 13.8; νmax/cm−1 (neat); 3183, 3129, 3056, 3015, 2951, 2870, 1711, 1490;
ESI-HRMS found m/z 264.0896 [M + H]+, C13H15ClN3O requires 264.0898. Found m/z
286.0713 [M + Na]+, C13H14ClN3NaO requires 286.0718.
N,N’-(1,8-Naphthyridine-2,7-diyl)dipentanamide (93)
Synthesised following literature procedure.202 2-Pentanoylamino-7-chloro-1,8-naphthyridine
96 (100 mg, 0.38 mmol), valeramide (46 mg, 0.46 mmol), potassium carbonate (73 mg,
0.53 mmol), palladium (II) acetate (4 mg, 0.02 mmol) and xantphos (18 mg, 0.04 mmol)
were suspended in 1,4-dioxane (10 mL) in a schlenck tube. The reaction mixture was
heated to 100 ◦C for 23 hrs before being cooled to room temperature and filtered through
celite. The solvent was evaporated in vacuo and the crude product was purified by
column chromatography (gradient elution: 0:1-1:19 MeOH–CH2Cl2) followed by crys-
tallisation (MeOH–H2O) to give N,N’-(1,8-naphthyridine-2,7-diyl)dipentanamide 93 as
colourless needles; m.p. 214–216 ◦C [Lit.61 216–217 ◦C] (Found: C, 65.6; H, 7.45; N,
17.0; C18H24N4O2 requires C, 65.8; H, 7.37; N, 17.1%); Rf 0.66 (1:9 MeOH–CH2Cl2); δH
(300 MHz, CDCl3); 8.44 (2H, d, J= 8.8 Hz, 2×ArCH), 8.35 (2H, s, 2×NH), 8.12 (2H,
d, J= 8.8 Hz, 2×ArCH), 2.46 (4H, t, J= 7.5 Hz, 2×CH2), 1.73 (4H, m, 2×CH2), 1.42
(4H, m, 2×CH2), 0.95 (6H, t, J= 7.3 Hz, 2×CH3); δC (75 MHz, CDCl3); 172.3, 153.9,
153.7, 139.0, 118.4, 113.4, 37.8, 27.3, 22.3, 13.8; νmax/cm−1 (neat); 3592, 3421, 3297,
2932, 2869, 1674, 1504; ESI-HRMS found m/z 329.1968 [M + H]+, C18H25N4O2 requires
329.1972.
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7.4 Experimental for Chapter 5: Self-Sorting of Hydrogen-
Bonding Motifs
Synthesis of 17 and 57 described in Section 7.1. Synthesis of 80 described in Section
7.2. Synthesis of 93 described in Section 7.3.
N,N’-(pyridine-2,6-diyl)dipentanamide (97)
Synthesised following literature procedure.63 Valeroyl chloride (4.0 mL, 33.7 mmol) was
added dropwise to a solution of 2,6-diaminopy-ridine (1.84 g, 9.5 mmol) and NEt3 (5.0 mL,
33.7 mmol) in THF (50 mL) stirring at 0 ◦C and the reaction mixture was then stirred
for a further 30 mins before the solvent was removed in vacuo. The resultant oil was
dissolved in CHCl3 (30 mL) and washed with H2O (5× 100 mL) before the organics
were dried (MgSO4) and removed in vacuo. Purification by column chromatography
(3:97 MeOH–CHCl3) followed by crystallisation (CHCl3–hexane) gave N,N’-(pyridine-
2,6-diyl)dipentanamide 97 (3.47 g, 74%) as a colourless powder; m.p. 123–124 ◦C (Found:
C, 64.8; H, 8.55; N, 15.2; C15H23N3O2 requires C, 65.0; H, 8.36; N, 15.2%); Rf 0.37 (3:97
MeOH–CHCl3); δH (300 MHz, CDCl3); 7.90 (2H, d, J= 7.8 Hz, 2×ArCH), 7.69 (1H,
t, J= 7.8 Hz, ArCH), 7.55 (2H, s, 2×NH), 2.38 (4H, t, J= 7.5 Hz, 2×CH2), 1.71 (4H,
m, 2×CH2), 1.41 (4H, m, 2×CH2), 0.95 (6H, t, J= 7.3 Hz, 2×CH3); δC (75 MHz,
CDCl3); 172.0, 149.9, 141.3, 109.8, 38.0, 27.8, 22.7, 14.2; νmax/cm
−1 (neat); 3400, 3255,
2958, 2874, 1981, 1754, 1662, 1591, 1463; ESI-HRMS found m/z 300.1682 [M + Na]+,
C15H23N3NaO2 requires 300.1688.
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3-(2-Phenylacetyl)oxazolidin-2-one (98a)
Synthesised following literature procedure.205 n-Butyl lithium (1.6 M in hexanes, 3.59 mL,
5.74 mmol) was added dropwise to a solution of 2-oxazolidinone (500 mg, 5.74 mmol)
in THF (25 mL) stirring at -78 ◦C. The reaction mixture was stirred for 10 mins be-
fore phenylacetyl chloride (837µL, 6.32 mmol) was added and it was then stirred for a
further 1 hr before being allowed to warm to room temperature. The reaction mix-
ture was quenched with saturated aqueous ammonium chloride (5 mL) and the or-
ganics were evaporated in vacuo. The resultant aqueous solution was then extracted
into CH2Cl2 (3× 20 mL) which was dried (Na2SO4) and removed in vacuo to give the
crude product which was purified by column chromatography (CH2Cl2) to give 3-(2-
phenylacetyl)oxazolidin-2-one 98a (422 mg, 36%) as a colourless powder; m.p. 54–56 ◦C
[Lit.205 67–68 ◦C] All other data is comparable to literature values Rf 0.38 (CH2Cl2);
δH (300 MHz, DMSO-d6); 7.37-7.21 (5H, m, 5×ArCH), 4.38 (2H, t, J= 7.8 Hz, CH2),
4.19 (2H, s, CH2), 3.91 (2H, t, J= 7.8 Hz, CH2); δC (75 MHz, CDCl3); 170.3, 152.5,
132.6, 128.7, 127.5, 126.2, 61.0, 41.7, 40.0; νmax/cm−1 (neat); 3396 (br), 1775, 1697;
ESI-HRMS found m/z 206.0819 [M + H]+, C11H12NO3 requires 206.0812. Found m/z
228.0623 [M + Na]+, C11H11NNaO3 requires 228.0631.
3-(2-(4-Nitrophenyl)acetyl)oxazolidin-2-one (98b)
Synthesised following literature procedure.205,206 Thionyl chloride (20.1 mL, 276 mmol)
was added to a suspension of 4-nitrophenylacetic acid (5.00 g, 27.6 mmol) in CH2Cl2
(200 mL) and refluxed for 3 hrs. The reaction mixture was then allowed to cool to room
temperature before the organics were evaporated in vacuo to give the acid chloride 103
as the crude material.
n-Butyl lithium (1.6 M in hexanes, 15.7 mL, 25.1 mmol) was added dropwise to a so-
lution of 2-oxazolidinone (2.18 g, 25.1 mmol) in THF (100 mL) stirring at -78 ◦C. The
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reaction mixture was stirred for 15 mins before acid chloride 103 (5.51 g, 27.6 mmol)
in THF (50 mL) was added and then stirred for a further 1 hr before being warmed
to room temperature. Saturated aqueous ammonium chloride (200 mL) was added
and the organics were removed in vacuo to give an aqueous solution which was ex-
tracted into CH2Cl2 (3 × 100 mL). The combined organics were dried (Na2SO4), re-
moved in vacuo and the crude material was purified by column chromatography (gradi-
ent elution: 3:7-2:3 EtOAc–hexane) and crystallisation (CH2Cl2–hexane) to give 3-(2-
(4-nitrophenyl)acetyl)oxazolidin-2-one 98b (505 mg, 8%) as a pale yellow powder; m.p.
139–142 ◦C (Found: C, 52.6; H, 4.00; N, 10.8; C11H10N2O5 requires C, 52.8; H, 4.03; N,
11.2%); Rf 0.44 (CH2Cl2); δH (300 MHz, CDCl3); 8.20 (2H, d, J= 8.9 Hz, ArCH), 7.49
(2H, d, J= 8.9 Hz, ArCH), 4.46 (2H, t, J= 8.1 Hz, CH2), 4.40 (2H, s, CH2), 4.06 (2H,
t, J= 8.1 Hz, CH2); δC (75 MHz, CDCl3); 169.8, 153.5, 147.3, 140.9, 130.8, 123.7, 62.2,
42.7, 41.0; νmax/cm−1 (neat); 3424 (br), 1776, 1696; ESI-HRMS found m/z 273.0476
[M + Na]+, C11H10N2NaO5 requires 273.0482.
Ethyl 5-formyl-1H-pyrrole-2-carboxylate (105)
Synthesised following literature procedure.208 Phosphoryl chloride (201µL, 2.16 mmol)
was added dropwise to DMF (167µL, 2.16 mmol) at 5 ◦C and stirred for 45 mins. The
Vilsmeier reagent was then added to ethyl-1H-pyrrole-2-carboxylate (200 mg, 1.44 mmol)
in CH2Cl2 (5 mL) at -20
◦C over 15 mins. The reaction mixture was stirred at -20 ◦C for
1 hr, 0 ◦C for 1 hr, room temperature for 1 hr and finally 40 ◦C for 30 mins before being
neutralised with saturated aqueous sodium bicarbonate and heated to reflux for 15 mins.
The reaction mixture was then allowed to cool before being diluted with CH2Cl2 (20 mL).
The layers were separated and the organic phase was washed with saturated aqueous
sodium chloride (2×20 mL) and dried (Na2SO4) before being evaporated in vacuo. The
crude material was purified by column chromatography (3.5:6.5 EtOAc–hexane) to give
ethyl 5-formyl-1H-pyrrole-2-carboxylate 105 (107 mg, 44%) as a yellow powder; m.p.
63–65 ◦C [Lit.236 72–73 ◦C] All other data is comparable to literature values; Rf 0.51
(3.5:6.5 EtOAc–hexane); δH (400 MHz, CDCl3); 10.03 (1H, s, NH) 9.67 (1H, s, CHO)
6.95 (1H, d, J= 6.8 Hz, ArCH) 6.94 (1H, d, J= 6.8 Hz, ArCH) 4.39 (2H, q, J= 7.2 Hz,
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CH2) 1.39 (3H, t, J= 7.2 Hz, CH3); δC (100 MHz, CDCl3); 180.3, 160.3, 134.3, 128.6,
119.7, 115.6, 61.4, 14.3; νmax/cm−1 (neat); 3435 (br), 2083, 1702, 1666; ES-HRMS found
m/z 167.0582 [M + H]+, C8H9NO3 requires 167.0582.
5-Formyl-N-propyl-1H-pyrrole-2-carboxamide (106)
Synthesised following literature procedure.208,237 Potassium hydroxide (219 mg, 3.91 mmol)
in H2O (1.2 mL) was added to a solution of ethyl-5-formylpyrrole-2-carboxylate 105
(594 mg, 3.56 mmol) in ethanol (4.8 mL) and the reaction mixture was heated to reflux
for 3 hrs. The reaction mixture was then allowed to cool to room temperature before
the solid was filtered. The yellow solid was dissolved in H2O (5 mL) and acidified with
conc. HCl. The resultant solid was filtered and washed with H2O to give the pyrrole
acid 129.
Propylamine (370µL, 4.51 mmol) was added to a solution of the pyrrole acid 129
(570 mg, 4.10 mmol) in CH2Cl2 (60 mL) and EDCI (1.18 g, 6.15 mmol) and HOBt (740 mg,
4.77 mmol) were added. The reaction mixture was stirred at room temperature for 20 hrs
before being diluted with CH2Cl2 (250 mL) and washed with saturated aqueous sodium
chloride (3 × 100 mL). The combined organics were dried (Na2SO4) and removed in
vacuo and the crude product was purified by column chromatography (EtOAc) followed
by cold trituration (CH2Cl2) to give 5-formyl-N-propyl-1H-pyrrole-2-carboxamide 106
(565 mg, 77%) as a yellow solid; m.p. 162–164 ◦C; Rf 0.39 (1:19 MeOH–CH2Cl2); δH
(300 MHz, DMSO-d6); 12.48 (1H, s, ArNH), 9.64 (1H, s, CHO), 8.36 (1H, s, NH), 6.95
(1H, d, J= 3.9 Hz, ArCH), 6.87 (1H, d, J= 3.9 Hz, ArCH), 3.21 (2H, t, J= 6.0 Hz, CH2),
1.53 (2H, m, CH2), 0.90 (3H, t, J= 7.5 Hz, CH3); δC (100 MHz, MeOD); 184.0, 181.5,
119.9, 116.5, 112.2 (× 2), 41.7, 23.1, 11.1; ESI-HRMS found m/z 181.0979 [M + H]+,
C9H13N2O2 requires 181.0972.
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1-tert-Butyl-2,5-dimethyl-1H-pyrrole-1,2,5-tri-carboxylate (110)
Synthesised following literature procedure.210 n-Butyl lithium (1.6 M in hexanes, 9.40 mL,
14.97 mmol) was added to a solution of 2,2,6,6-tetramethylpiperidine (2.50 mL, 14.97 mmol)
in THF (30 mL) stirring at -78 ◦C. N-Boc pyrrole (1.00 mL, 5.99 mmol) was then added
and the reaction mixture was stirred at -78 ◦C for 3 hrs. Methyl chloroformate (1.40 mL,
17.96 mmol) was then added and the reaction mixture was stirred for a further 1 h before
saturated aqueous ammonium chloride (5 mL) was added and allowed to warm to room
temperature. The reaction mixture was then diluted with ether (10 mL) and washed
with 10% aqueous hydrogen chloride (2× 20 mL) and saturated aqueous sodium chloride
(2× 20 mL). The organics were dried (Na2SO4) and evaporated in vacuo to give the crude
product which was purified by column chromatography (1:9 EtOAc–hexane) to give 1-
tert-butyl-2,5-dimethyl-1H-pyrrole-1,2,5-tricarboxylate 110 (240 mg, 14%) as a cream
coloured powder; m.p. 111–113 ◦C [Lit.238 112–114 ◦C]; Rf 0.35 (1:4 EtOAc–hexane);
δH (500 MHz, CDCl3); 6.84 (2H, s, 2×ArCH), 3.87 (6H, s, 2×Me), 1.66 (9H, s, tBu);
δC (75 MHz, CDCl3); 162.1, 160.3, 127.1, 116.2, 86.7, 52.4, 27.7; νmax/cm
−1 (neat);
2996, 1774, 1732, 1704, 1373, 1260, 745; ESI-HRMS found m/z 306.0957 [M + Na]+,
C13H17NNaO6 requires 306.0948.
1H-Pyrrole-2,5-dicarboxylic acid (108)
Synthesised following literature procedure.210 Sodium hydroxide (171 mg, 4.26 mmol)
was added to a suspension of the pyrrole 110 in H2O–MeOH (5:1, 7.2mL) and the
reaction mixture was heated to reflux for 22 hrs. Once cooled the reaction mixture was
acidified with 30% aqueous hydrochloric acid before being cooled to 0 ◦C. The resultant
solid was filtered and triturated (Et2O) and evaporation of the organics gave 1H-pyrrole-
2,5-dicarboxylic acid 108 (56 mg, 57%) as a white powder; m.p. decomposes> 250 ◦C
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[Lit.239 decomposes> 250 ◦C]; Rf 0.00 (1:4 MeOH–EtOAc); δH (300 MHz, DMSO-d6);
12.70 (2H, s, CO2H), 12.15 (1H, s, NH), 6.75 (2H, d, J= 3.0 Hz, 2×ArCH); δC (75 MHz,
DMSO-d6); 161.6, 127.7, 115.3; νmax/cm−1 (neat); 3432, 3127-2571, 1679; ESI-HRMS
found m/z 154.0166 [M - H]−, C6H4NO4 requires 154.0146.
N2,N5-Dipropyl-1H-pyrrole-2,5-dicarboxamide (99)
Synthesised following literature procedure.210 Pyrrole-2,5-dicarboxylic acid 108 (20 mg,
0.14 mmol) was dissolved in SOCl2 (7 mL) and the reaction mixture was heated at reflux
for 20 hrs. SOCl2 was then evaporated in vacuo to give the pyrrole-2,5-diacid chloride
130.
Pyridine (47µL, 0.59 mmol) and propyl amine (43µL, 0.53 mmol) were added to a so-
lution of pyrrole-2,5-diacid chloride 130 (27 mg, 0.14 mmol) in CH2Cl2 (5 mL) and the
reaction mixture was stirred at room temperature for 2 days. The reaction mixture was
then diluted with H2O (20 mL), the layers were separated and the aqueous phase was ex-
tracted into CH2Cl2 (2× 10 mL). The organic phase was combined and dried (Na2SO4)
before being evaporated in vacuo. The crude product was purified by column chromatog-
raphy (gradient elution: 0:1-1:49 MeOH–CH2Cl2) and crystallised (EtOAc–hexane) to
give the N2,N5-dipropyl-1H-pyrrole-2,5-dicarboxamide 99 (24 mg, 72%) as a colourless
solid; m.p. 193–195 ◦C; Rf 0.49 (1:9 MeOH–CH2Cl2); δH (300 MHz, CDCl3); 6.47 (2H,
d, J= 2.6 Hz, 2×ArCH), 3.39 (4H, t, J= 6.4 Hz, 2×CH2), 1.62 (4H, m, 2×CH2), 0.97
(6H, t, J= 7.4 Hz, 2×CH3); δC (125 MHz, CDCl3); 160.3, 128.6, 109.4, 41.3, 23.0, 11.4;
νmax/cm−1 (neat); 3241 (br), 2963, 2876, 1595, 1527; ESI-HRMS found m/z 238.1543
[M + H]+, C12H20N3O2 requires 238.1550.
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1-Benzoylpiperidin-2-one (100)
Synthesised following literature procedure.240 2-Piperidinone (2.00 g, 20.2 mmol) in THF
(20 mL) was added via cannula to a solution of n-butyl lithium (1.6 M in hexanes,
14.5 mL, 23.5 mmol) in THF (50 mL) and the solution was stirred at -78 ◦C for 20 mins.
Benzoyl chloride (2.35 mL, 20.2 mmol) was then added to the reaction mixture before
it was warmed to room temperature and stirred for 20 hrs. The reaction mixture was
then quenched with saturated aqueous ammonium chloride (30 mL) and extracted into
Et2O (3× 50 mL). The organics were combined and evaporated in vacuo and the crude
product was crystallised (toluene) to give 1-benzoylpiperidin-2-one 100 (1.20 g, 29%) as
a colourless powder; m.p. 98–101 ◦C [Lit.241 108–110 ◦C] All other data is comparable
to literature values; Rf 0.44 (CH2Cl2); δH (300 MHz, CDCl3); 7.54 (2H, d, J= 7.2 Hz,
2×ArCH), 7.46 (1H, d, J= 7.2 Hz, ArCH), 7.38 (2H, t, J= 7.2 Hz, 2×ArCH), 3.81 (2H,
t, J= 6.3 Hz, CH2), 2.57 (2H, t, J= 6.8 Hz, CH2), 1.97 (4H, m, 2×CH2); δC (75 MHz,
CDCl3); 175.1, 173.9, 136.6, 131.9, 128.5, 128.3, 46.5, 35.0, 23.2, 21.9; νmax/cm
−1 (neat);
2965, 1860, 1694, 1672; ESI-HRMS found m/z 204.1026 [M + H]+, C12H14NO2 requires
204.1019.
N-Benzylacetamide (113)
Benzylamine (3.00 mL, 27.50 mmol), methyl acetate (2.18 mL, 27.50 mmol) and TBD
(0.38 g, 2.75 mmol) were all charged in a schlenck tube and the reaction mixture was
stirred at room temperature for 17 hrs. The crude product was then purified by column
chromatography (gradient elution: 0:1-1:9 MeOH–CH2Cl2) to give N-benzylacetamide
113 (4.01 g, 98%) as a colourless powder; m.p. 53–54 ◦C [Lit.242 61 ◦C]; Rf 0.46 (1:9
MeOH–CH2Cl2); δH (300 MHz, CDCl3); 7.36–7.26 (5H, m, 5×ArCH), 5.79 (1H, s, NH),
4.43 (2H, d, J= 5.7 Hz, CH2), 2.02 (3H, s, CH3); δC (75 MHz, CDCl3); 169.8, 138.3,
128.7, 127.9, 127.6, 43.8, 23.3; νmax/cm−1 (neat); 3291, 3030, 2923, 2875, 1627, 1553;
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ESI-HRMS found m/z 150.0938 [M + H]+, C9H12NO requires 150.0913. Found m/z
172.0742 [M + Na]+, C9H11NNaO requires 172.0733.
N-Acetyl-N-benzylacetamide (114)
Synthesised following literature procedure.240 n-Butyl lithium (1.6 M in hexanes, 3.50 mL,
5.59 mmol) was added to a solution of 113 (1.00 g, 6.71 mL) in THF (30 mL) cooled
to -78 ◦C and the reaction mixture was stirred for 20 mins before being allowed to
warm to room temperature. Acetic anhydride (0.63 mL, 6.71 mmol) was then added
and the reaction mixture was stirred for a further 18 hrs. The reaction mixture was then
quenched with saturated aqueous ammonium chloride (30 mL) and extracted into Et2O
(3× 50 mL) before being dried (Na2SO4) and evaporated in vacuo. The resultant gel was
purified by coloum chromatography (CH2Cl2) to give N-acetyl-N-benzylacetamide 114
(480 mg, 45%) as a yellow liquid; Rf 0.41 (1:1 EtOAc–hexane); δH (300 MHz, CDCl3);
7.36-7.28 (3H, m, 3×ArCH), 7.15 (2H, d, J= 8.2 Hz, 2×ArCH), 4.97 (2H, s, CH2),
2.42 (6H, s, 2×CH3); δC (75 MHz, CDCl3); 173.6, 136.9, 128.9, 127.5, 126.1, 47.7,
26.6; νmax/cm−1 (neat); 3110-2941, 1704; ESI-HRMS found m/z 192.1027 [M + H]+,
C11H14NO2 requires 192.1019.
Benzene-1,3,5-triyltris(piperidin-1-ylmethanone) (102)
Synthesised following literature procedure.215 Piperidine (3.30 mL, 33.8 mmol) in THF
(100 mL) was added dropwise to a solution of benzene-1,3,5-tricarbonylchloride (2.00 mL,
11.3 mmol) and triethylamine (5.60 mL, 40.6 mmol) in THF (50 mL) and the reaction
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mixture was stirred for 22 hrs at room temperature. The volatiles were then evapo-
rated in vacuo and the resultant solid was dissolved in water (150 mL) and extracted
into CH2Cl2 (2× 100 mL). The organics were combined and dried (Na2SO4) before be-
ing evaporated in vacuo. The resultant crude product was purified by crystallisation
(EtOAc) to give benzene-1,3,5-triyltris(piperidin-1-ylmethanone 102 (3.74 g, 81%) as
yellow dendrites; m.p. 151–155 ◦C (Found: C, 69.8; H, 8.15; N, 10.3; C24H33N3O3 re-
quires C, 70.0; H, 8.08; N, 10.2%); Rf 0.59 (EtOH); δH (300 MHz, DMSO-d6); 7.38 (3H,
s, 3×ArCH), 3.58 (6H, br, 6×NCH), 3.26 (6H, br, 6×NCH), 1.99 (12H, br, 6×CH2),
1.47 (6H, br, 3×CH2); δC (75 MHz, CDCl3); 168.6, 137.1, 126.3, 48.9, 43.3, 26.6, 25.7,
24.5; νmax/cm−1 (neat); 3479 (br), 2937, 2856, 1626; ESI-HRMS found m/z 412.2598
[M + H]+, C24H34N3O3 requires 412.2595.
Benzene-1,3,5-triyltris(piperidin-1-ylmethanethione) (118)
Synthesised following literature procedure.217 Lawesson’s reagent (2.95 g, 7.30 mmol)
was added to a solution of 102 (1.00 g, 2.43 mmol) in toluene (100 mL) and the reaction
mixture was stirred at reflux for 18 hrs before being cooled. The volatiles were then
evaporated in vacuo and the resultant solid was triturated (MeOH) to give benzene-
1,3,5-triyltris(piperidin-1-ylmethanethione) 118 (574 mg, 51%) as a yellow powder; m.p.
241–243 ◦C; Rf 0.71 (EtOH); δH (500 MHz, CDCl3); 7.22 (3H, br, 3×ArCH), 4.34 (6H,
br, 6×NCH), 3.62 (6H, br, 6×NCH), 1.83 (6H, br, 3×CH2), 1.75 (6H, br, 3×CH2) 1.59
(6H, br, 3×CH2); δC (75 MHz, CDCl3); 197.8, 143.4, 123.9, 54.0, 51.3, 27.3, 25.9, 24.5;
νmax/cm−1 (neat); 2938, 2856, 2214, 1488; ESI-HRMS found m/z 460.1907 [M + H]+,
C24H34N3S3 requires 460.1909.
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N1,N3,N5-Trioctylbenzene-1,3,5-tricarboxamide (119)
Synthesised following literature procedure.215 Octylamine (5.60 mL, 33.8 mmol) in THF
(80 mL) was added dropwise to a solution of benzene-1,3,5-tricarbonylchloride (2.00 mL,
11.3 mmol) and triethylamine (5.60 mL, 40.6 mmol) in THF (50 mL) and the reaction
mixture was allowed to stir for 3 days at room temperature. The volatiles were then
evaporated in vacuo and the resultant solid was dissolved in CH2Cl2 (100 mL) which was
washed with water (3× 75 mL). The organics were then combined and dried (Na2SO4)
before being evaporated in vacuo to give the crude product which was purified by crys-
tallisation (EtOAc) to give N1,N3,N5-trioctylbenzene-1,3,5-tricarboxamide 119 (3.72 g,
61%) as brown plates; m.p. 178–182 ◦C [Lit.243 196 ◦C] All other data is comparable to
literature values (Found: C, 72.6; H, 10.55; N, 7.6; C33H57N3O3 requires C, 72.9; H,
10.60; N, 7.7%); Rf 0.68 (EtOAc); δH (400 MHz, CDCl3); 8.32 (3H, s, 3×ArCH), 6.65
(3H, s, 3×NH), 3.44 (6H, t, J= 7.2 Hz, 3×CH2), 1.61 (6H, m, 3×CH2), 1.32 (30H, m,
15×CH2), 0.88 (9H, t, J= 6.8 Hz, 3×CH3); δC (75 MHz, CDCl3); 166.1, 135.7, 128.3,
40.8, 32.2, 29.9, 29.7, 29.6, 27.4, 23.0, 14.4; νmax/cm−1 (neat); 3240, 3074, 2926, 2855,
1630; ESI-HRMS found m/z 544.4488 [M + H]+,
C33H58N3O3 requires 544.4473. Found m/z 566.4303 [M + Na]
+, C33H57N3NaO3 re-
quires 566.4292.
N1,N3,N5-Trioctylbenzene-1,3,5-tris(carbothioamide) (101)
Synthesised following literature procedure.217 Lawesson’s reagent (2.23 g, 5.52 mmol)
was added to a solution of 119 (1.00 g, 1.84 mmol) in toluene (100 mL) and the reaction
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mixture was stirred at reflux for 19 hrs before being cooled. The solvents were then
evaporated in vacuo and the resultant solid was triturated from MeOH to give N1,N3,N5-
trioctylbenzene-1,3,5-tris(carbothioamide) 101 (517 mg, 47%) as a sticky yellow solid;
(Found: C, 66.7; H, 9.70; N, 7.3; S, 16.4; C33H57N3S3 requires C, 67.0; H, 9.70; N, 7.1;
S, 16.3%); Rf 0.82 (EtOAc); δH (300 MHz, CDCl3); 9.01 (3H, br, 3×NH), 7.37 (3H, br,
3×ArCH), 3.64 (6H, br, 3×CH2), 1.72 (6H, br, 3×CH2), 1.34 (30H, br, 15×CH2),
0.91 (9H, t, J= 8.1 Hz, 3×CH3); δC (75 MHz, CDCl3); 195.4, 137.6, 130.2, 47.4, 32.3,
29.9, 27.9 (× 3), 23.2, 14.6; νmax/cm−1 (neat); 3176, 3040, 2925, 2854, 1542; ESI-HRMS
found m/z 592.3800 [M + H]+, C33H58N3S3 requires 295.3787.
2-(Benzylamino)-6-tridecylpyrimidin-4-ol (125)
Benzyl bromide (200µL, 1.7 mmol) was added dropwise to a solution of 78 (500 mg,
1.7 mmol) and K2CO3 (470 mg, 3.4 mmol) in DMF (20 mL) and the reaction mixture was
heated to 50 ◦C for 18 hrs. Once cooled the reaction mixture was filtered before the DMF
was removed by vacuum distillation. The resultant solid was triturated (hexane) to give
2-(benzylamino)-6-tridecylpyrimidin-4-ol 125 (184 mg, 28%) as a colourless powder; m.p.
108–110 ◦C; Rf 0.47 (1:19 MeOH–CH2Cl2); δH (500 MHz, CDCl3); 7.38 (2H, t, J= 7.8 Hz,
2×ArCH), 7.31 (1H, t, J= 7.8 Hz, ArCH), 7.27 (2H, d, J= 7.8 Hz, 2×ArCH), 5.92 (1H,
s, ArCH), 5.25 (2H, s, CH2), 4.74 (2H, s, OH/NH), 2.36 (2H, t, J= 7.8 Hz, CH2), 1.59
(4H, m, 2×CH2), 1.32 (18H, m, 9×CH2), 0.89 (3H, t, J= 6.8 Hz, CH3); δC (75 MHz,
CDCl3); 168.3, 163.0, 154.9, 134.6, 129.4, 128.3, 126.7, 101.8, 44.7, 37.5, 31.9, 29.7-29.4
(× 8), 28.0, 22.7, 14.2; νmax/cm−1 (neat); 3350, 3081, 2917, 2850, 1638; ESI-HRMS
found m/z 384.3017 [M + H]+, C24H38N3O requires 384.3009.
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N-Benzyl-N-(4-oxo-6-tridecyl-1,4-dihydropyrimidin-2-yl)benzamide (126)
Benzoyl chloride (45µL, 0.39 mmol) was added to a solution of 125 (100 mg, 0.26 mmol)
and DMAP (3 mg, 0.03 mmol) in CHCl3 (10 mL) and the reaction mixture was heated
to reflux for 20 hrs. It was then allowed to cool before the solvent was removed in vacuo
and the resultant solid was purified by column chromatography (gradient elution: 1:0-0:1
hexane–CH2Cl2) to give N-benzyl-N-(4-oxo-6-tridecyl-1,4-dihydropyrimidin-2-yl)benzamide
126 (90 mg, 71%) as a colourless powder; m.p. 65–68 ◦C; Rf 0.37 (CH2Cl2); δH (300 MHz,
CDCl3); 14.06 (1H, s, NH), 8.20 (2H, d, J= 7.5 Hz, 2×ArCH), 7.50 (3H, m, 3×ArCH),
7.39 (2H, t, J= 7.5 Hz, 2×ArCH), 7.20 (3H, m, 3×ArCH), 5.76 (1H, s, ArCH), 5.43 (2H,
s, CH2), 2.41 (2H, t, J= 7.5 Hz, CH2), 1.62 (2H, m, CH2), 1.23 (20H, m, 10×CH2), 0.81
(3H, t, J= 7.5 Hz, CH3); δC (75 MHz, CDCl3); 178.0, 160.5, 154.4, 151.6, 136.0, 135.6,
131.3, 128.5, 127.8, 127.4, 127.2, 126.7, 102.5, 43.7, 32.0, 30.9, 28.6-27.9 (× 8), 25.8,
21.7, 13.1; νmax/cm−1 (neat); 3088, 2920, 2853, 1697; ESI-HRMS found m/z 488.3281
[M + H]+, C31H42N3O2 requires 488.3272.
N-(2-Nitrobenzyl)-N-(4-oxo-6-tridecyl-1,4-dihydropyrimidin-2-yl) ben-
zamide (124)
2-Nitrobenzylbromide (369 mg, 1.71 mmol) was added to a solution of 78 (500 mg,
1.71 mmol) and K2CO3 (471 mg, 3.41 mmol) in DMF (20 mL) and the reaction mix-
ture was heated to 50 ◦C for 18 hrs. Once cooled the reaction mixture was filtered before
the DMF was removed by vacuum distillation. The resultant solid was purified by col-
umn chromatography (gradient elution: 0:1-1:9 MeOH–CH2Cl2) to give a mixture of
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the O- and N-alkylation products (506 mg, 77%). These could not be separated so were
both taken onto the next step.
Benzoyl chloride (140µL, 1.17 mmol) was added to a solution of the O- and N-alkylation
products (500 mg, 1.17 mmol) and DMAP (14 mg, 0.12 mmol) in CHCl3 (50 mL) and the
reaction mixture was heated to reflux for 20 hrs. It was then allowed to cool before the
solvent was removed in vacuo and the resultant solid was purified by column chromatog-
raphy (gradient elution: hexane–CH2Cl2) to give N-(2-Nitrobenzyl)-N-(4-oxo-6-tridecyl-
1,4-dihydropyrimidin-2-yl)benzamide 124 (170 mg, 27%) as a colourless sticky solid; Rf
0.42 (CH2Cl2); δH (300 MHz, CDCl3); 13.94 (1H, s, NH), 8.04 (1H, d, J= 9.0 Hz, ArCH),
7.92 (2H, d, J= 9.0 Hz, 2×ArCH), 7.44 (2H, m, 2×ArCH), 7.32 (3H, m, 3×ArCH),
7.12 (1H, d, J= 9.0 Hz, ArCH), 5.82 (1H, s, ArCH), 5.77 (2H, s, CH2), 2.48 (2H, t,
J= 7.5 Hz, CH2), 1.65 (2H, m, CH2), 1.25 (20H, m, 10×CH2), 0.81 (3H, t, J= 6.0 Hz,
CH3); δC (75 MHz, CDCl3); 179.2, 161.5, 155.0, 153.4, 148.5, 136.4, 133.7, 132.6, 132.4,
129.4, 128.2, 128.0, 127.3, 125.1, 103.1, 42.3, 33.2, 31.9, 29.7× 2, 29.6× 2, 29.4× 2, 29.2,
29.0, 26.9, 22.7, 14.2; νmax/cm−1 (neat); 3054, 2940, 2856, 1751, 1699, 1448, 1176, 917;
ESI-HRMS found m/z 555.2936 [M + Na]+, C31H40N4NaO4 requires 555.2942.
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7.5 NMR Titration/Dilution Experiments
Anhydrous CDCl3 was purchased from Aldrich and was distilled over CaCl2, to remove
residual H2O and other impurities, before being used immediately. For
1H NMR titration
experiments in Chapters 4 and 5 the CDCl3 was washed with K2CO3 prior to distilla-
tion in order to remove trace amounts of HCl. For titrations the 1H NMR spectrum
was recorded for a solution of host (2 – 10 mM) in CDCl3 upon sequential additions of
aliquots of a solution of guest (20 – 120 mM) containing host (2 – 10 mM) in CDCl3. The
change in chemical shift of key proton resonances was recorded at each titration point.
The data was analysed using the HypNMR program using the appropriate model.165
HypNMR uses data from multiple resonances for curve fitting. Representative data for
individual resonances is shown in Appendix B. Each titration was performed in triplicate
and the mean binding constant given with the standard deviation given as the error.
Dimerisation constants were calculated by taking 1H NMR spectra of a solution of the
desired molecule as it was diluted from ∼ 20 – 0.1 mM. The change in chemical shift
of the key resonansces was recorded at each dilution point and analysed in HypNMR
using the appropriate model.165 The self-dimerisation constants were sufficiently small
for most molecules that they were not included in the determination of the association
constants for heterodimer formation. Self-dimerisation of UPy 80 was assumed to be
1× 107 in the titration of UIM 17 into UPy 80 (Chapter 5) and was included in the
calculation for heterodimerisation.
7.6 Molecular Modelling
Ab initio density-functional calculations were carried out using the Gaussian 03 Package
and performed at the level of theory stated in the text. Where B3LYP/6-31G* was used
a standard desktop computer was used to carry out the calculation. Where the larger
basis set (B3LYP/C, 6-31G, N/O, 6-31G*, H, 6-31++G**) was used calculations were
carried out in parallel using eight nodes on a supercomputer.
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7.7 DOSY data aquisition
DOSY NMR measurements were made on a Varian Inova 500 MHz spectrometer. All
experiments were conducted at 20 ◦C on CDCl3 solutions and used a 5 mm ID probe.
The bipolar pulse pair simulated echo (BPPSTE) sequence244 was employed operating
in ONESHOT mode.245 Additional parameters: number of different gradient strengths,
20; gradient stabilisation delay, 0.002 s; gradient length, 0.002 s; diffusion delay, 0.03 s;
relaxation delay, 2.5 s (following measurement of T1); acquisition time, 2 s; kappa (un-
balancing factor), 0.2. Data were processed using a 3 Hz line broadening and exponential
multiplication. Data were zero-filled once. Spectra were phased and baseline-corrected
prior to production of the pseudo 2D DOSY plots. For measurement of diffusion coef-
ficients, a calibration curve was plotted (using the Stokes-Einstein relationship) for dif-
fusion coefficient (× 106 cm2 s−1) versus the reciprocal cube root of the molecular mass
(1/(molecular mass)
1
3 ). The compounds used for this calibration exercise were 4-amino-
pyrimidine (95.11 Da, 17.281× 106 cm2 s−1), dipyridyl (184.24 Da, 13.573), 4-(2’,6’,2”-
terpyridinyl)benzyl (323.4 Da, 10.197), benzene-1,3,5-tricarboxylic acid tris(6-methyl-2-
pyridinyl)amide (480.0 Da, 11.503), hexakis(2-pyridylmethyl)CTV (913.11 Da, 8.703),
tris[4-(2-pyridyl)benzyloxy]CTG (910.14 Da, 9.037). The straight line determined was
y= 73.275x+ 1.1263 (R2 = 0.93).
7.8 NOESY data acquisition
1H-1H NOESY data were recorded on a bruker Avance500 instrument operating at 300 K
at a frequency of 500 MHz. A pulse sequence of 8.2µs pulse, 2.0 s delay, 16.4µs pulse,
1.2 s delay was used.
7.9 ROESY data acquisition
1H-1H ROESY data were recorded on a Bruker Avance DRX500 instrument operating
at 300 K at a frequency of 500 MHz. A mix time of 350 ms was applied using a constant
wave spin lock mixing method. A pulse sequence repetition of 2.2 s was used.
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7.10 ITC experiments
Titrations were performed at 25 ◦C in a MicroCal VP-ITC with a cell volumne of
1.4109 mL. The concentration of receptor in the cell was 0.2 mM and the concentra-
tion of titrant in the syringe was 2.5 mM. For data fitting, the standard MicroCal Origin
software was used for initial data processing to calculate host and guest concentrations
and to integrate heat changes for each step in the titrations. For reverse titrations (57
in syringe and 17 in cell), the heat associated with diluting the host was subtracted from
the titration data prior to curve fitting. Dilution experiments with 57 in the syringe
gave non-linear curves that are indicative of significant self-association at the concentra-
tions used for the titrations. Therefore, rather than subtractiung the heat of 17 dilution
on a pont-by-point basis, several direct and reverse titrations, along with 17 dilution
experiments, were subjected to a global analysis in the SEDPHAT software167 using
a mixed association model that allows for 17 dimerisation coupled to 17 ·57 binding.
The model was constrained to exclude the possibility of 57 dimerisation or the forma-
tion of any ternary or quaternary complexes. For, 57 into 17 titration was for to a
simple 1:1 binding model to obtain an initial estimate for Ka and ∆Ha for the 17 ·57
interaction. These values were fixed while three dilution experiments for 17 were si-
multaneously fit to the mixed association model to provide initial estimates for Kdim
and ∆Hdim. A wide range of initial parameter values and repetitive switching between
simplex and Marquardt-Levenberg fitting methods were required to avoid local minima
at this stage in the fitting process. Then five titration experiments (three 17 into 57
titrations, and two 57 into 17 titrations) were fit to the global model, while keeping Kdim
and ∆Hdim fixed. Any apparent deviations from 1:1 binding were accommodated by us-
ing the “incompetent fraction” parameter for each experiment to estimate any errors in
concentrations of the 17 or 57.167 Finally, Ka, ∆Ha, Kdim and ∆Hdim were all allowed
to float freely in a global fit of eight datasets. Parameter errors (assuming Gaussian-
distributed errors) were estimated using Monte Carlo simulations246 as implemented in
the SEDPHAT software.167
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7.11 DSC experiments
Samples were run on a DSC Q200 V24.9 build 121 instrument and processed with TA
instruments Universal Analysis 2000 software. TZero pans and lids were used for all
samples. Analysis was performed over a temperature range -120 – 150 ◦C in a cyclic
manner (two cycles per sample) with an isothermal stage of 5 mins. The instrument was
modulated to FE type, with a cell constant of 0.9708 without correction.
7.12 Viscometry
Viscometry was performed in CHCl3 at 24.9
◦C using a water bath. A Cannon-Fenske
viscometer was used and all solutions allowed to equilibrate to the correct temperature
before experiments were run. The most concentrated samples were run first before being
diluted, mixed and allowed to equilibrate to the desired temperature.
7.13 HySS
All known binding constants were inputted to the HySS219 program operating in the
simulation mode. The concentration of each component was set to the appropriate
amount, 10 mM throughout if it was present from the beginning or 0-50 mM if it was
being added. The table of data was then accessed and the concentration of each possible
component at each possible concentration was obtained and converted to fidelity using
the appropriate calculation.
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Appendix A
Crystal Structures
Crystal Structure Determination for 61
Single crystals were grown by the slow evaporation of a solution of HAC 61 in CDCl3–
hexane. X-ray diffraction data were collected at the University of Leeds. Crystal data:
C17H21N3O2, M = 299.37, crystal size 0.34×0.32×0.08 mm, monoclinic, a = 34.9139(19),
b = 5.7312(3), c = 18.4423(10) A˚, α = γ = 90◦ β = 120.660(1)◦, U = 3174.4(3) A˚3,
T = 150 K, Z = 8 = 0.084 mm−1, λ = 0.71073A˚ [Mo-Kα], 17580 reflections measured, 3278
unique [R(int) = 0.0446], 2764 observed [I> 2σ(I)]. The final R1 was 0.0349 (observed
reflections 0.0439) and wR (F2) was 0.0930 (all data 0.3278) for 200 parameters.
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Crystal Structure Determination for 57e
Single crystals were grown by the slow evaporation of a solution of 57e in methanol. X-
ray diffraction data were collected at the University of Leeds. Crystal data: C16H19N3O2,
M = 285.34, crystal size 0.36×0.24×0.18 mm, orthorhombic, a = 17.2425(18), b = 10.2252(9),
c = 18.2845(19) A˚, α = γ = β = 90◦, U = 3223.7(6) A˚3, T = 150 K, Z = 8 = 0.079 mm−1,
λ = 0.71073A˚ [Mo-Kα], 48811 reflections measured, 4382 unique [R(int) = 0.0569], 3264
observed [I> 2σ(I)]. The final R1 was 0.0610 (observed reflections 0.0808) and wR (F2)
was 0.1814 (all data 0.2023) for 194 parameters.
Crystal Structure Determination for 98b
Single crystals were grown by the slow evaporation of a solution of the nitro oxazolidi-
none 131 in CH2Cl2–Et2O. X-ray diffraction data were collected at the University of
Leeds. Crystal data: C11H10N2O5, M = 250.21, crystal size 0.31× 0.19× 0.15 mm, mon-
oclinic, a = 12.1095(15), b = 5.5934(6), c = 16.9885(19) A˚, α = γ = 90◦ β = 104.914(5)◦,
U = 1111.9(2) A˚3, T = 150 K, Z = 4 = 0.120 mm−1, λ = 0.71073A˚ [Mo-Kα], 19416 reflec-
tions measured, 2563 unique [R(int) = 0.0363], 2123 observed [I> 2σ(I)]. The final R1
was 0.0362 (observed reflections 0.0450) and wR (F2) was 0.0921 (all data 0.0992) for
163 parameters.
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Crystal Structure Determination for 119
Single crystals were grown by the slow evaporation of a solution of the benzene-1,3,5-
tricarboxamide 119 in DMF–Et2O. X-ray diffraction data were collected at the Uni-
versity of Leeds. Crystal data: C33H57N3O3, M = 543.82, crystal size 0.29 × 0.26 ×
0.04 mm, monoclinic, a = 11.9302(5), b = 7.6632(4), c = 18.1674(10) A˚, α = γ = 90◦
β = 97.232(3)◦, U = 1647.71(14) A˚3, T = 150 K, Z = 2 = 0.069 mm−1, λ = 0.71073A˚ [Mo-
Kα], 24679 reflections measured, 3143 unique [R(int) = 0.0933], 2442 observed [I> 2σ(I)].
The final R1 was 0.0729 (observed reflections 0.0954) and wR (F2) was 0.1900 (all data
0.2097) for 355 parameters.
Crystal Structure Determination for 102
Single crystals were grown by the slow evaporation of a solution of the benzene-1,3,5-
tricarboxamide 102 in MeOH. X-ray diffraction data were collected at the University
of Leeds. Crystal data: C24H33N3O3, M = 411.53, crystal size 0.31 × 0.13 × 0.11 mm,
monoclinic, a = 6.6907(7), b = 11.4515(13), c = 29.715(3) A˚, α = γ = 90◦ β = 95.640(6)◦,
U = 2265.7(4) A˚3, T = 150 K, Z = 4 = 0.08 mm−1, λ = 0.71073A˚ [Mo-Kα], 42958 reflec-
tions measured, 5179 unique [R(int) = 0.0376], 4269 observed [I> 2σ(I)]. The final R1
was 0.0470 (observed reflections 0.0594) and wR (F2) was 0.1113 (all data 0.1192) for
271 parameters.
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Crystal Structure Determination for 118
Single crystals were grown by the slow evaporation of a solution of the benzene-1,3,5-
trithioamide 118 in DMSO–hexane. X-ray diffraction data were collected at the Univer-
sity of Leeds. Crystal data: C24H33N3S3, M = 459.71, crystal size 0.22×0.15×0.10 mm,
orthorhombic, a = 6.9235(5), b = 16.934(11), c = 22.2411(15) A˚, α = γ = β = 90◦,
U = 2478.2(3) A˚3, T = 150 K, Z = 4 = 0.315 mm−1, λ = 0.71073A˚ [Mo-Kα], 33002 reflec-
tions measured, 6190 unique [R(int) = 0.0612], 5498 observed [I> 2σ(I)]. The final R1
was 0.0320 (observed reflections 0.0398) and wR (F2) was 0.0714 (all data 0.0758) for
271 parameters.
Appendix B
1H NMR Titrations
Representative 1H NMR titration curves are included. The curves for just one resonance
is shown, however multiple resonances were followed in order to calculated the association
constant of each complex. Each titration was also carried out in triplicate, but just one
graph for each titration is shown. The black circle on the molecular structures indicate
which proton resonance is being followed.
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B.1 Preorganisation
UIM into AIC
57 ·17
[17]
UIM into HAC
61 ·17
[17]
Appendix B 219
UIM into ANT
62 ·17
[17]
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B.2 Substituent Effects
UIM into AIC-Cl
57e ·17a
[17]
Appendix B 221
UIM into AIC-CO2Me
57c ·17a
[17]
UIM into AIC-OMe
57b ·17a
[17]
Appendix B 222
UIM into AIC-tBu
57d ·17a
[17]
UIM-CF3 into AIC
57a ·17b
[17b]
Appendix B 223
UIM-Cl into AIC
57a ·17f
[17f]
UIM-CO2Et into AIC
57a ·17d
[17d]
Appendix B 224
UIM-F into AIC
57a ·17g
[17g]
UIM-Me into AIC
57a ·17e
[17e]
Appendix B 225
UIM-OMe into AIC
57a ·17c
[17c]
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B.3 UDIM
UDIM into DAN
21 ·91
[91]
UIM into DAN
21 ·17
[17]
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B.4 Self-Sorting
UIM into UPy
19 ·17
[17]

Appendix C
Molecular Modelling
Coordinates that were obtained for all of the calculations that were carried out. Ab
initio density-functional calculations were carried out using the Gaussian 03 Package
and performed at the B3LYP level of theory. The basis set that was used is stated for
each molecule. tBu groups have been removed from all of the UIM 17 calculations,
further simplifying the calculation and reducing the number of possible tautomers and
conformers that can be present in each complex. tBu groups were also been removed
from some of the UDIM 91 calculations for the same reasons.
229
Appendix C 230
C.1 Molecular Modelling for Chapter 2: Effects of Preor-
ganisation
AIC 57i C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 1.231291 1.275269 -4.214699
2 6 1.959403 1.355094 -3.020861
3 6 1.335652 1.083446 -1.799400
4 6 -0.025753 0.729808 -1.764594
5 6 -0.745766 0.633658 -2.968221
6 6 -0.121429 0.910332 -4.186130
7 1 1.716461 1.488972 -5.159813
8 1 3.009606 1.620056 -3.040139
9 1 1.927810 1.114091 -0.892060
10 1 -1.787337 0.343054 -2.925695
11 1 -0.685349 0.841731 -5.108596
12 6 -0.759260 0.423742 -0.500393
13 7 -0.201247 0.911899 0.663324
14 1 0.609255 1.516171 0.628613
15 8 -1.820813 -0.223513 -0.502518
16 6 -0.678607 0.756756 1.978507
17 6 -2.312773 -0.173829 3.432754
18 1 -2.248178 -0.361558 1.301770
19 6 -0.439686 1.208673 4.256485
20 6 -1.653329 0.405206 4.469473
21 1 -2.004370 0.293790 5.485581
22 7 -1.809141 0.004672 2.148763
23 7 0.004922 1.341627 2.914333
24 8 0.175871 1.747224 5.175577
25 6 -3.558269 -1.006840 3.545804
26 1 -4.381184 -0.569198 2.969245
27 1 -3.391658 -2.020927 3.165172
28 1 -3.872517 -1.080000 4.587445
Appendix C 231
AIC 57ii C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -1.408827 -2.840416 -0.389442
2 6 -0.338885 -2.012817 -0.025999
3 6 -0.571117 -0.678161 0.320492
4 6 -1.879599 -0.161354 0.304017
5 6 -2.951024 -1.002960 -0.042220
6 6 -2.715515 -2.333976 -0.392532
7 1 -1.226169 -3.873745 -0.659971
8 1 0.670379 -2.405938 -0.003817
9 1 0.265676 -0.066988 0.639296
10 1 -3.953331 -0.594876 -0.029865
11 1 -3.545748 -2.973954 -0.665850
12 6 -2.207639 1.250949 0.663234
13 8 -3.345878 1.592102 1.010877
14 7 -1.164253 2.158543 0.566740
15 1 -0.276612 1.868599 0.178763
16 6 -1.194948 3.527720 0.857641
17 6 -2.456104 5.457064 1.648682
18 1 -3.160777 3.464299 1.419532
19 6 -0.102454 5.537141 0.945993
20 6 -1.218969 6.175987 1.424541
21 1 -1.217582 7.233390 1.646646
22 7 -2.346153 4.073423 1.324357
23 7 -0.076595 4.184211 0.653605
24 8 -3.523273 5.904685 2.064559
25 6 1.195236 6.259227 0.698517
26 1 1.485842 6.166705 -0.353196
27 1 1.120198 7.318225 0.951239
28 1 1.997888 5.809722 1.292275
Appendix C 232
UIM 17i C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 0.114703 -3.794048 0.442554
2 6 0.765834 -3.014201 -0.521368
3 6 0.411720 -1.675988 -0.698807
4 6 -0.602140 -1.095040 0.087331
5 6 -1.259319 -1.874118 1.057016
6 6 -0.892359 -3.214216 1.222314
7 1 0.387671 -4.833093 0.582313
8 1 1.548558 -3.443896 -1.135773
9 1 0.920877 -1.077307 -1.448123
10 1 -2.035306 -1.430175 1.658989
11 1 -1.404342 -3.806623 1.971968
12 7 -0.897747 0.268003 -0.158707
13 1 -0.343399 0.697081 -0.885847
14 6 -1.837752 1.065424 0.467126
15 7 -1.865004 2.362154 -0.021811
16 1 -1.250123 2.670677 -0.761698
17 8 -2.592297 0.687587 1.374769
18 6 -2.723432 3.362610 0.441321
19 6 -4.288247 4.410930 1.594273
20 1 -3.769221 2.305751 1.911575
21 6 -3.705638 5.252830 0.674418
22 1 -5.068572 4.555795 2.319671
23 1 -3.928426 6.289235 0.485359
24 7 -2.723223 4.590226 -0.047654
25 7 -3.642574 3.188900 1.432864
Appendix C 233
UIM 17ii C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -3.282345 -2.708766 -1.836345
2 6 -2.127152 -1.998722 -2.188457
3 6 -1.441112 -1.249670 -1.231368
4 6 -1.901791 -1.198657 0.099457
5 6 -3.062009 -1.910576 0.457426
6 6 -3.738109 -2.656742 -0.514174
7 1 -3.815698 -3.290670 -2.578862
8 1 -1.758420 -2.026640 -3.207663
9 1 -0.546950 -0.701110 -1.507622
10 1 -3.413460 -1.870725 1.476035
11 1 -4.630793 -3.201417 -0.227766
12 7 -1.146390 -0.416193 1.002555
13 1 -0.317922 0.061078 0.636222
14 6 -1.400889 -0.221443 2.331125
15 7 -0.470336 0.616617 2.995392
16 1 -0.701880 0.728539 3.971664
17 8 -2.331434 -0.687416 2.992347
18 6 0.647988 1.256585 2.485611
19 6 2.480201 2.528085 2.444835
20 1 1.341998 2.237422 4.248560
21 6 2.225343 2.001826 1.205814
22 1 3.255068 3.174610 2.815142
23 1 2.782759 2.136433 0.294887
24 7 1.082860 1.210024 1.234985
25 7 1.458308 2.043033 3.265944
Appendix C 234
AIC · UIM 57 · 17i C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 6.987070 -1.341844 0.295437
2 6 5.600755 -1.495538 0.182107
3 6 4.772677 -0.356808 0.203252
4 6 5.356394 0.920240 0.338131
5 6 6.740854 1.054407 0.450356
6 6 7.568364 -0.076117 0.429986
7 1 7.614510 -2.226291 0.277187
8 1 5.156546 -2.471632 0.074390
9 1 4.717009 1.795166 0.351429
10 1 7.171787 2.044264 0.552977
11 1 8.643716 0.028697 0.516408
12 7 3.363105 -0.399587 0.108027
13 1 2.889279 0.509730 0.135369
14 6 2.577480 -1.501496 -0.103978
15 7 1.215735 -1.196935 -0.117621
16 1 0.871546 -0.235287 -0.014811
17 8 2.988994 -2.666590 -0.264954
18 6 0.237841 -2.126357 -0.418085
19 6 -1.675886 -3.050852 -0.823004
20 6 -0.735188 -4.035995 -0.991360
21 1 1.437263 -3.788609 -0.721997
22 1 -2.743588 -3.121436 -0.936495
23 1 -0.815758 -5.072731 -1.263914
24 7 -1.068009 -1.852832 -0.455961
25 7 0.487415 -3.428327 -0.727597
26 8 2.107931 2.235280 0.038696
27 6 0.897585 2.517817 -0.032621
28 6 0.416782 3.889618 -0.149467
29 6 -0.916477 4.148914 -0.226770
30 1 1.148074 4.684175 -0.174891
31 6 -1.331158 1.801781 -0.068717
32 1 -2.821788 3.167256 -0.256540
Appendix C 235
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
33 7 -0.058109 1.491315 0.005006
34 7 -1.798908 3.082024 -0.187174
35 6 -1.529525 5.514289 -0.355915
36 1 -2.115640 5.597129 -1.277881
37 1 -2.202418 5.725005 0.482550
38 1 -0.753389 6.279875 -0.373760
39 7 -2.266136 0.767921 -0.000977
40 1 -1.854946 -0.194280 -0.085244
41 6 -3.639602 0.949330 0.002177
42 6 -4.483531 -0.247832 0.272485
43 6 -5.814316 -0.223050 -0.184569
44 6 -4.026987 -1.344583 1.024129
45 6 -6.669716 -1.292239 0.084870
46 1 -6.156773 0.639222 -0.741751
47 6 -4.891824 -2.408303 1.302776
48 1 -3.011346 -1.368687 1.395289
49 6 -6.209742 -2.387208 0.830497
50 1 -7.690084 -1.272223 -0.278936
51 1 -4.536498 -3.247533 1.888527
52 1 -6.875894 -3.214597 1.046162
53 8 -4.170471 2.062396 -0.190029
AIC · UIM 57 · 17ii C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -0.613640 5.766778 0.038603
2 6 -1.531960 4.732072 -0.138330
3 6 -1.181216 3.406080 0.184209
4 6 0.098127 3.133969 0.700719
5 6 1.012756 4.176914 0.881622
6 6 0.662396 5.490943 0.550336
Appendix C 236
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
7 1 -0.889153 6.782560 -0.218893
8 1 -2.524716 4.926966 -0.521723
9 1 0.397048 2.126404 0.951641
10 1 1.996032 3.957986 1.279848
11 1 1.376100 6.294612 0.690908
12 6 -2.234923 2.370473 -0.000598
13 7 -1.855191 1.033566 0.010007
14 1 -0.856013 0.759111 -0.005030
15 6 -2.739128 -0.045793 -0.056689
16 6 -4.997454 -0.802550 -0.220262
17 1 -4.306581 1.229862 -0.212224
18 6 -3.115000 -2.358387 -0.052524
19 6 -4.542512 -2.083332 -0.165491
20 1 -5.219212 -2.924307 -0.204307
21 8 -3.427484 2.709168 -0.150827
22 7 -4.073787 0.227461 -0.164524
23 7 -2.241322 -1.260505 -0.002463
24 6 -6.438874 -0.396611 -0.339140
25 1 -6.747443 0.215153 0.515707
26 1 -6.607440 0.195023 -1.245704
27 1 -7.080582 -1.277138 -0.380273
28 8 -2.666306 -3.519311 0.002701
29 6 3.672194 1.167145 -0.558172
30 6 3.851750 -0.182673 -0.200478
31 6 5.157025 -0.668801 0.018264
32 6 6.259771 0.175681 -0.117171
33 6 6.083404 1.520162 -0.469546
34 6 4.787622 2.002131 -0.687076
35 1 2.675552 1.539033 -0.731985
36 1 5.296977 -1.707696 0.296337
37 1 7.255452 -0.217655 0.054245
38 1 6.939152 2.176798 -0.574372
39 1 4.636385 3.038696 -0.967999
40 7 2.799314 -1.113342 -0.064658
41 1 3.050390 -2.103874 0.050812
42 6 1.456186 -0.862998 -0.055678
43 7 0.635606 -1.967513 0.071331
44 1 -0.367487 -1.747528 0.050684
45 8 0.932698 0.274589 -0.149254
46 6 1.009637 -3.303487 0.167338
47 6 2.087475 -5.164436 0.315801
48 6 0.752810 -5.492967 0.307640
49 1 -0.945972 -4.120777 0.156317
50 1 2.939619 -5.819561 0.378668
51 1 0.242881 -6.438220 0.359308
52 7 2.246127 -3.786567 0.228439
53 7 0.067693 -4.287799 0.212843
Appendix C 237
HAC 61i C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -2.893744 -3.153882 -0.899827
2 6 -1.384050 -2.276872 0.662109
3 6 -2.250001 -1.205796 1.036906
4 6 -3.455435 -1.161072 0.388142
5 1 -1.965548 -0.492463 1.789350
6 1 -4.189170 -0.392467 0.594077
7 7 -1.680349 -3.193080 -0.245051
8 7 -3.791460 -2.085595 -0.550084
9 7 -0.114462 -2.452564 1.221010
10 1 0.348522 -3.273936 0.851781
11 6 0.500394 -1.737989 2.241861
12 6 -5.079989 -2.055249 -1.255476
13 1 -4.908991 -1.979412 -2.330362
14 1 -5.623162 -2.983330 -1.070725
15 1 -5.658794 -1.201421 -0.903147
16 8 -0.053954 -0.820974 2.850962
17 8 -3.252192 -3.962963 -1.753294
18 6 1.896431 -2.174834 2.572329
19 6 2.725851 -2.866601 1.671020
20 6 2.390802 -1.838346 3.844333
21 6 4.022674 -3.232295 2.047165
22 1 2.389043 -3.091105 0.665395
23 6 3.683523 -2.209550 4.219921
24 1 1.746921 -1.287085 4.517428
25 6 4.501170 -2.910837 3.323336
26 1 4.657414 -3.758578 1.344251
27 1 4.053110 -1.953235 5.205700
28 1 5.505102 -3.197923 3.613698
Appendix C 238
HAC 61ii C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -0.800254 -3.080016 -2.282303
2 6 -0.699786 -3.267274 -0.897232
3 6 -0.870606 -2.184336 -0.028645
4 6 -1.151956 -0.906090 -0.544079
5 6 -1.280861 -0.729718 -1.932469
6 6 -1.091500 -1.809605 -2.798794
7 1 -0.662966 -3.919781 -2.953665
8 1 -0.495486 -4.252517 -0.495116
9 1 -0.803793 -2.331269 1.041989
10 1 -1.537001 0.251785 -2.310850
11 1 -1.180185 -1.664952 -3.868915
12 6 -1.449930 0.260739 0.341338
13 7 -0.799030 0.379660 1.577625
14 1 -1.274920 1.006508 2.219998
15 6 0.494162 0.065544 2.005585
16 6 1.511109 -0.416610 1.120998
17 6 2.740634 -0.643102 1.679565
18 1 1.342503 -0.577282 0.070852
19 6 1.933661 0.092411 3.857098
20 1 3.578293 -1.000186 1.094330
21 8 -2.318299 1.081061 0.049574
22 7 0.697506 0.315465 3.287828
23 7 2.971431 -0.418363 2.998591
24 8 2.203771 0.293685 5.038458
25 6 4.282200 -0.654112 3.619385
26 1 4.647339 0.271375 4.066763
27 1 4.185781 -1.392816 4.416682
28 1 4.978580 -1.008312 2.859068
Appendix C 239
HAC 61iii C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -2.266700 3.356918 5.885846
2 6 -1.454902 2.223273 5.748426
3 6 -1.435813 1.516193 4.544060
4 6 -2.239827 1.933260 3.470255
5 6 -3.070644 3.057384 3.620985
6 6 -3.075155 3.773218 4.819821
7 1 -2.269919 3.910727 6.817746
8 1 -0.832898 1.896898 6.573306
9 1 -0.801461 0.647555 4.438357
10 1 -3.701568 3.351998 2.792386
11 1 -3.706048 4.648009 4.923963
12 6 -2.342998 1.175279 2.196800
13 7 -1.294938 0.319110 1.769591
14 1 -1.639142 -0.279052 1.026040
15 6 0.088206 0.520358 1.749429
16 6 0.861185 -0.464067 1.045815
17 6 2.213472 -0.267739 1.008072
18 1 0.404687 -1.323151 0.576914
19 6 1.976027 1.765939 2.332781
20 1 2.884544 -0.949083 0.500811
21 8 -3.366383 1.178890 1.513154
22 7 0.608771 1.571433 2.343958
23 7 2.779800 0.806170 1.619549
24 8 2.547598 2.703824 2.882686
25 6 4.229327 1.045798 1.601821
26 1 4.435829 2.018978 1.154017
27 1 4.613347 1.062087 2.622985
28 1 4.714290 0.255710 1.028069
Appendix C 240
HAC 61iv C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -6.766831 1.003679 1.812065
2 6 -5.803122 1.009895 0.796265
3 6 -4.443987 1.092618 1.119880
4 6 -4.040074 1.168184 2.465056
5 6 -5.014055 1.183825 3.477663
6 6 -6.369581 1.095964 3.153408
7 1 -7.819068 0.938208 1.560405
8 1 -6.107485 0.962407 -0.242751
9 1 -3.710057 1.143855 0.323175
10 1 -4.685049 1.270889 4.505435
11 1 -7.113905 1.101207 3.940856
12 6 -2.601000 1.274355 2.888276
13 7 -1.696136 0.724672 1.958578
14 1 -2.099364 0.088668 1.285919
15 6 -0.297780 0.774352 1.976059
16 6 0.382850 -0.185516 1.151515
17 6 1.748446 -0.124118 1.141498
18 1 -0.147388 -0.930882 0.576601
19 6 1.689149 1.758744 2.693031
20 1 2.356865 -0.803677 0.558245
21 8 -2.268800 1.760233 3.957420
22 7 0.308938 1.691935 2.692345
23 7 2.407089 0.805291 1.881933
24 8 2.344585 2.578209 3.330398
25 6 3.872620 0.901693 1.897719
26 1 4.180394 1.891757 1.557757
27 1 4.238772 0.773090 2.917468
28 1 4.288305 0.132067 1.246645
Appendix C 241
ANT 62i C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -4.549589 -2.389591 -0.994584
2 6 -2.959022 -1.113396 0.099405
3 6 -3.938243 -0.151057 0.508854
4 6 -5.284248 -0.368025 0.117586
5 6 -5.591624 -1.481456 -0.631207
6 6 -3.497161 0.955680 1.280752
7 1 -6.049752 0.342407 0.411751
8 1 -6.607886 -1.680730 -0.948850
9 6 -2.167657 1.080566 1.611813
10 6 -1.274984 0.066136 1.150205
11 1 -4.215094 1.699891 1.608123
12 1 -1.783088 1.895476 2.202575
13 6 -4.874271 -3.616258 -1.815666
14 1 -5.592596 -4.262118 -1.297770
15 1 -5.320518 -3.343182 -2.778745
16 1 -3.960883 -4.182233 -1.998623
17 7 0.105775 0.089194 1.410395
18 1 0.573736 -0.721384 1.025064
19 6 0.836362 0.973578 2.184862
20 6 2.314340 0.712591 2.227380
21 6 3.005403 -0.001004 1.231536
22 6 3.029075 1.242347 3.315245
23 6 4.386343 -0.198904 1.336879
24 1 2.487542 -0.372369 0.354580
25 6 4.406730 1.039582 3.421479
26 1 2.485138 1.808272 4.060485
27 6 5.088127 0.314490 2.434473
28 1 4.911492 -0.744163 0.561560
29 1 4.947655 1.444937 4.268438
30 1 6.157525 0.157708 2.515594
31 8 0.326825 1.904957 2.814949
32 7 -1.643754 -0.985009 0.428451
33 7 -3.282059 -2.214955 -0.644445
Appendix C 242
ANT 62ii C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -5.093818 -0.350378 0.136919
2 6 -3.277291 0.772179 1.029734
3 6 -4.081254 1.352340 2.063419
4 6 -5.462394 1.032652 2.089689
5 6 -5.969947 0.185568 1.130341
6 6 -3.435860 2.195351 3.006199
7 1 -6.097605 1.455454 2.861109
8 1 -7.019361 -0.082357 1.117145
9 6 -2.087287 2.439332 2.897093
10 6 -1.380732 1.839904 1.807532
11 1 -4.008242 2.627988 3.819569
12 1 -1.569601 3.051083 3.619146
13 7 -3.797551 -0.070410 0.087139
14 7 -1.943373 1.030796 0.920369
15 7 0.005037 1.997498 1.625392
16 1 0.426028 1.233193 1.106879
17 6 -5.636784 -1.283693 -0.920294
18 1 -4.827706 -1.589388 -1.583483
19 1 -6.082384 -2.177844 -0.469623
20 1 -6.418206 -0.797779 -1.515720
21 6 0.941823 2.864649 2.186725
22 6 0.517815 4.235020 2.615169
23 6 -0.439274 4.979431 1.902471
24 6 1.193633 4.827588 3.695228
25 6 -0.730092 6.293668 2.282814
26 1 -0.938583 4.540321 1.047770
27 6 0.888405 6.134783 4.084456
28 1 1.956865 4.255696 4.207723
29 6 -0.074757 6.869596 3.379291
30 1 -1.460214 6.866634 1.723405
31 1 1.404799 6.581605 4.925821
32 1 -0.305407 7.886383 3.675716
33 8 2.121240 2.514662 2.249020
Appendix C 243
ANT 62iii C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -4.885527 0.253676 -0.859818
2 6 -3.005969 1.316628 -0.024592
3 6 -3.802435 2.209435 0.763316
4 6 -5.212050 2.075706 0.699323
5 6 -5.755133 1.102157 -0.109379
6 6 -3.126225 3.173936 1.559377
7 1 -5.842093 2.737554 1.284539
8 1 -6.827495 0.969478 -0.184777
9 6 -1.754252 3.212861 1.549819
10 6 -1.050489 2.279169 0.720744
11 1 -3.698144 3.863535 2.170842
12 1 -1.202371 3.919308 2.157540
13 7 -3.562411 0.355019 -0.819821
14 7 -1.641848 1.378647 -0.041270
15 7 0.354334 2.366971 0.729189
16 1 0.717211 3.295825 0.914921
17 6 -5.464564 -0.818186 -1.753918
18 1 -4.653552 -1.393032 -2.200940
19 1 -6.115679 -1.497510 -1.192445
20 1 -6.068945 -0.379928 -2.556647
21 6 1.308876 1.622403 0.006769
22 6 1.166292 0.146806 -0.132976
23 6 0.483352 -0.643622 0.806080
24 6 1.839904 -0.471485 -1.199577
25 6 0.465248 -2.033940 0.670950
26 1 -0.025564 -0.175335 1.637679
27 6 1.806588 -1.860425 -1.343284
28 1 2.382033 0.149551 -1.900900
29 6 1.118883 -2.644397 -0.407786
30 1 -0.060136 -2.638673 1.400791
31 1 2.316383 -2.329195 -2.176813
32 1 1.094580 -3.722839 -0.516067
33 8 2.303443 2.220799 -0.406692
Appendix C 244
ANT 62iv C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -4.657492 -0.164523 -0.103801
2 6 -2.659928 0.979458 0.150020
3 6 -3.333416 2.244472 0.168505
4 6 -4.745318 2.250292 0.035648
5 6 -5.407924 1.051647 -0.101569
6 6 -2.542732 3.414265 0.321750
7 1 -5.282233 3.193355 0.043315
8 1 -6.485445 1.014847 -0.206727
9 6 -1.179407 3.292438 0.433267
10 6 -0.605903 1.980527 0.400464
11 1 -3.019261 4.388579 0.340023
12 1 -0.542024 4.163227 0.531528
13 7 -3.337229 -0.201100 0.017463
14 7 -1.305878 0.869042 0.278052
15 7 0.790613 1.888694 0.557458
16 1 1.248301 2.723679 0.893573
17 6 -5.370703 -1.489031 -0.249204
18 1 -4.638558 -2.296230 -0.234621
19 1 -6.087750 -1.645960 0.564858
20 1 -5.932204 -1.536891 -1.189251
21 6 1.640100 0.905995 0.026627
22 6 3.070863 1.036164 0.471966
23 6 3.445675 1.645205 1.682955
24 6 4.061645 0.488763 -0.360163
25 6 4.796076 1.726402 2.042119
26 1 2.688662 2.015498 2.365349
27 6 5.409078 0.574546 -0.002733
28 1 3.750706 -0.001020 -1.274276
29 6 5.779699 1.198416 1.196876
30 1 5.076822 2.188900 2.981209
31 1 6.167639 0.156196 -0.653822
32 1 6.825319 1.262751 1.475334
33 8 1.275905 0.039312 -0.755233
Appendix C 245
HAC · UIM 61 · 17i C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 6.736628 -1.826606 0.245908
2 6 5.341996 -1.872739 0.141008
3 6 4.603605 -0.673928 0.172974
4 6 5.286036 0.552978 0.310761
5 6 6.677395 0.580172 0.414360
6 6 7.415198 -0.610426 0.382603
7 1 7.293697 -2.756716 0.219458
8 1 4.823036 -2.811068 0.032371
9 1 4.716088 1.474576 0.334452
10 1 7.184138 1.533226 0.519697
11 1 8.495870 -0.589471 0.462524
12 7 3.195379 -0.607359 0.084634
13 1 2.792521 0.332174 0.122521
14 6 2.322792 -1.646608 -0.117085
15 7 0.990790 -1.238597 -0.134467
16 1 0.717287 -0.255948 -0.036320
17 8 2.645645 -2.840128 -0.267361
18 6 -0.061071 -2.102461 -0.391089
19 6 -2.045680 -2.887799 -0.724809
20 6 -1.186829 -3.946682 -0.888068
21 1 1.002303 -3.861438 -0.676308
22 1 -3.118365 -2.879256 -0.808269
23 1 -1.352282 -4.981284 -1.128752
24 7 -1.340300 -1.731266 -0.406877
25 7 0.084707 -3.427254 -0.670776
26 8 2.104703 2.112107 0.073587
27 6 0.914829 2.466978 -0.008550
28 6 -0.652471 4.291609 -0.184974
29 6 -1.392476 2.024945 -0.106120
30 7 -0.133117 1.585508 -0.018420
31 7 -2.361372 1.038372 -0.059739
32 1 -1.999209 0.061272 -0.079482
33 6 -3.743267 1.238113 -0.172195
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Center Atomic Coordinates (Angstroms)
Number Number X Y Z
34 6 -4.602549 0.072055 0.199271
35 6 -5.897989 0.020333 -0.347068
36 6 -4.201661 -0.905742 1.125677
37 6 -6.771221 -1.009032 0.007860
38 1 -6.199022 0.796075 -1.039355
39 6 -5.084516 -1.928383 1.490421
40 1 -3.213852 -0.868436 1.564859
41 6 -6.365833 -1.985715 0.929156
42 1 -7.763640 -1.049086 -0.425464
43 1 -4.771223 -2.675536 2.209853
44 1 -7.045993 -2.781503 1.210638
45 8 -4.246062 2.303727 -0.536846
46 1 -0.793018 5.362168 -0.250908
47 6 -1.704774 3.420212 -0.198734
48 1 -2.722192 3.751944 -0.295136
49 7 0.635031 3.854108 -0.091463
50 6 1.781397 4.775779 -0.078917
51 1 2.347722 4.647126 0.844465
52 1 2.444255 4.550413 -0.915339
53 1 1.412546 5.798232 -0.155129
HAC · UIM 61 · 17ii C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 2.269140 5.322613 -0.114903
2 6 0.976219 4.880540 -0.396064
3 6 0.516306 3.652436 0.116553
4 6 1.364104 2.882421 0.931140
5 6 2.657150 3.333339 1.217984
6 6 3.113115 4.548845 0.694773
7 1 2.618060 6.264741 -0.521086
8 1 0.303523 5.469949 -1.005419
9 1 1.033732 1.936441 1.335090
10 1 3.304416 2.733147 1.846000
Appendix C 247
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
11 1 4.116908 4.892585 0.917252
12 6 -0.899372 3.282484 -0.187517
13 7 -1.241829 1.927980 -0.043021
14 1 -0.486993 1.224888 0.005664
15 6 -2.521346 1.402129 -0.092410
16 6 -4.898008 1.568961 -0.205632
17 1 -3.616842 3.281912 -0.312159
18 6 -3.802304 -0.569918 0.006275
19 8 -1.715534 4.138169 -0.538390
20 7 -2.590770 0.069699 0.008159
21 8 -3.933267 -1.804912 0.095101
22 6 3.825464 -0.390700 -0.421741
23 6 3.382824 -1.707719 -0.194205
24 6 4.332147 -2.745533 -0.092951
25 6 5.695216 -2.473704 -0.216785
26 6 6.138585 -1.163789 -0.441745
27 6 5.195833 -0.134358 -0.542086
28 1 3.101181 0.403499 -0.501634
29 1 3.992867 -3.760428 0.083938
30 1 6.409314 -3.285671 -0.136744
31 1 7.197025 -0.951648 -0.538019
32 1 5.523598 0.883893 -0.720485
33 7 2.026797 -2.079558 -0.071551
34 1 1.814454 -3.082248 0.002597
35 6 0.933957 -1.259742 -0.031296
36 7 -0.294038 -1.896464 0.078042
37 1 -1.093035 -1.254335 0.077043
38 8 0.962944 -0.009670 -0.080963
39 6 -0.545182 -3.262191 0.138138
40 6 -0.392536 -5.412568 0.220741
41 6 -1.735397 -5.123406 0.248363
42 1 -2.658785 -3.144116 0.180399
43 1 0.087124 -6.376206 0.245716
44 1 -2.607277 -5.750670 0.299277
45 7 0.352802 -4.241772 0.152300
46 7 -1.822688 -3.736761 0.195587
47 7 -4.979583 0.213002 -0.099562
48 6 -3.694313 2.215499 -0.209179
49 1 -5.835421 2.102354 -0.288489
50 6 -6.266384 -0.499960 -0.098044
51 1 -6.301187 -1.200195 -0.933684
52 1 -6.369421 -1.071755 0.825061
53 1 -7.072526 0.228208 -0.182425
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ANT · UIM 62 · 17i C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 3.089877 2.667847 0.860199
2 6 0.838101 2.439887 0.327816
3 6 0.679305 3.854229 0.199315
4 6 1.810717 4.675384 0.424265
5 6 3.008428 4.088122 0.767841
6 6 -0.612264 4.339461 -0.133727
7 1 1.717277 5.752485 0.335664
8 1 3.890116 4.684312 0.966428
9 6 -1.658226 3.464408 -0.288745
10 6 -1.413309 2.063429 -0.103778
11 1 -0.769629 5.405980 -0.251293
12 1 -2.657686 3.787533 -0.523946
13 6 4.400823 2.020605 1.240939
14 1 5.141485 2.115203 0.439102
15 1 4.825072 2.496967 2.130727
16 1 4.256448 0.960889 1.448084
17 7 -2.425235 1.105151 -0.202387
18 1 -2.190057 0.187694 0.215149
19 6 -3.751627 1.330447 -0.563388
20 6 -4.591124 0.103610 -0.753005
21 6 -4.059909 -1.136649 -1.145316
22 6 -5.982697 0.243011 -0.602463
23 6 -4.910289 -2.225156 -1.369330
24 1 -2.994036 -1.252442 -1.287712
25 6 -6.828055 -0.847520 -0.814325
26 1 -6.377717 1.212469 -0.327226
27 6 -6.292676 -2.085297 -1.198534
28 1 -4.493154 -3.176737 -1.676819
29 1 -7.898264 -0.734190 -0.686296
30 1 -6.948773 -2.931234 -1.369588
31 8 -4.236255 2.453368 -0.740209
32 7 -0.200868 1.571362 0.172560
33 7 2.049332 1.870227 0.625844
34 6 -2.621654 -2.384528 1.888402
35 6 -0.600674 -1.980158 1.250589
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Center Atomic Coordinates (Angstroms)
Number Number X Y Z
36 6 -1.909214 -3.532239 2.138945
37 1 -3.665736 -2.193734 2.067534
38 1 0.208902 -3.852060 1.657045
39 1 -2.191312 -4.482562 2.555068
40 7 -1.801264 -1.414707 1.323732
41 7 -0.607696 -3.255638 1.730376
42 7 0.519678 -1.330731 0.756816
43 1 0.372987 -0.340696 0.525022
44 6 1.706212 -1.987532 0.463290
45 7 2.661088 -1.143099 -0.059735
46 1 2.453376 -0.144087 -0.006945
47 8 1.857238 -3.206373 0.659330
48 6 3.900715 -1.509707 -0.629895
49 6 4.495310 -2.775758 -0.464263
50 6 4.563206 -0.535364 -1.404086
51 6 5.729557 -3.042868 -1.066506
52 1 3.985784 -3.525679 0.118852
53 6 5.799053 -0.813851 -1.990452
54 1 4.094391 0.430731 -1.554671
55 6 6.392350 -2.072040 -1.826313
56 1 6.175423 -4.022258 -0.933238
57 1 6.291381 -0.051268 -2.583744
58 1 7.348991 -2.291873 -2.285475
ANT · UIM 62 · 17ii C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 3.849086 -1.443542 -1.434568
2 6 3.283920 -2.384799 -0.553142
3 6 4.077853 -3.449274 -0.080638
4 6 5.410141 -3.570184 -0.478741
5 6 5.976500 -2.632048 -1.351537
6 6 5.187171 -1.576105 -1.821629
7 1 3.241775 -0.631952 -1.802132
8 1 3.644481 -4.174091 0.599975
9 1 6.004480 -4.396238 -0.104718
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Center Atomic Coordinates (Angstroms)
Number Number X Y Z
10 1 7.011316 -2.724241 -1.659842
11 1 5.610033 -0.846429 -2.503385
12 7 1.940062 -2.353116 -0.120608
13 1 1.586904 -3.166074 0.396776
14 6 1.047352 -1.326772 -0.260767
15 7 -0.227173 -1.560823 0.235700
16 1 -0.877391 -0.777506 0.104736
17 8 1.285705 -0.219586 -0.788385
18 6 -0.708920 -2.714603 0.836572
19 6 -0.951607 -4.653368 1.747642
20 6 -2.205701 -4.093771 1.704621
21 1 -2.743315 -2.164883 0.810700
22 1 -0.659807 -5.614190 2.136300
23 1 -3.164364 -4.451666 2.034928
24 7 -0.012910 -3.784811 1.203517
25 7 -2.037055 -2.841246 1.120764
26 6 -1.656594 2.078436 -0.284643
27 6 -3.409643 0.553582 -0.345263
28 6 -4.340218 1.565479 -0.740098
29 6 -3.846237 2.887869 -0.896145
30 6 -2.521869 3.157124 -0.666913
31 6 -5.687204 1.191298 -0.952386
32 1 -4.522258 3.678828 -1.201143
33 1 -2.112501 4.147906 -0.755491
34 6 -6.057650 -0.124116 -0.768329
35 6 -5.079550 -1.068697 -0.352211
36 1 -6.409042 1.940209 -1.259818
37 1 -7.077661 -0.448352 -0.928968
38 6 -5.476323 -2.506688 -0.103849
39 1 -6.388137 -2.768980 -0.645148
40 1 -4.679798 -3.185504 -0.415121
41 1 -5.666196 -2.677523 0.962848
42 7 -3.803538 -0.743133 -0.143293
43 7 -2.086367 0.822266 -0.137483
44 7 -0.287405 2.277717 -0.076221
45 1 0.280935 1.428146 -0.139320
46 6 0.300297 3.495143 0.278739
47 6 1.781105 3.515540 0.512621
48 6 2.302689 4.696226 1.076556
49 6 2.654229 2.459920 0.198257
50 6 3.669013 4.816539 1.331618
51 1 1.616906 5.501529 1.304228
52 6 4.024840 2.585705 0.455115
53 1 2.294446 1.542249 -0.246315
54 6 4.535443 3.758644 1.022286
55 1 4.057668 5.728587 1.769635
56 1 4.687333 1.763790 0.210556
57 1 5.597489 3.849147 1.220850
58 8 -0.370870 4.522590 0.425163
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C.2 Molecular Modelling for Chapter 3: The Substituent
Effect
UIM-H 17ai 6-31G*
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -3.843967 1.399328 -0.000002
2 6 -2.496944 1.036434 -0.000002
3 6 -2.153102 -0.323883 0.000000
4 6 -3.169331 -1.292443 0.000002
5 6 -4.508502 -0.912450 0.000002
6 6 -4.856367 0.439077 0.000000
7 1 -4.099506 2.455657 -0.000003
8 1 -1.718191 1.785307 -0.000003
9 1 -2.907574 -2.349296 0.000003
10 1 -5.279007 -1.678560 0.000003
11 1 -5.900205 0.738708 0.000000
12 7 -0.821992 -0.796922 0.000000
13 1 -0.736748 -1.804167 0.000002
14 6 0.349552 -0.067665 -0.000002
15 7 1.483621 -0.859298 0.000000
16 1 1.434465 -1.869151 0.000002
17 8 0.408582 1.161311 -0.000004
18 6 2.792764 -0.376237 0.000000
19 1 2.421812 1.680631 0.000010
20 6 4.501273 1.004398 0.000005
21 6 4.920438 -0.299203 -0.000007
22 1 5.026304 1.946989 0.000009
23 1 5.935084 -0.672688 -0.000014
24 7 3.114527 0.942411 0.000006
25 7 3.843850 -1.167340 0.000000
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UIM-CF3 17bi 6-31G*
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 3.298507 0.029197 -0.038341
2 6 2.858026 1.354854 -0.025518
3 6 1.498383 1.636416 -0.016716
4 6 0.551107 0.598484 -0.018382
5 6 0.992258 -0.734650 -0.032737
6 6 2.357949 -1.003346 -0.041783
7 1 3.577489 2.166731 -0.030821
8 1 1.165981 2.672507 -0.011810
9 1 0.270140 -1.537857 -0.039639
10 1 2.693177 -2.035392 -0.059791
11 7 -0.804739 0.973718 -0.009380
12 1 -0.963596 1.972161 -0.000754
13 6 -1.921980 0.156284 -0.008093
14 7 -3.108929 0.858967 0.003495
15 1 -3.136729 1.869866 0.010169
16 8 -1.882687 -1.072751 -0.016216
17 6 -4.379434 0.279440 0.008027
18 6 -6.495272 0.045967 0.020324
19 6 -5.980267 -1.223214 0.008962
20 1 -3.859568 -1.746598 -0.008177
21 1 -7.534353 0.344345 0.028998
22 1 -6.436587 -2.200937 0.005760
23 7 -5.485065 0.990437 0.019763
24 7 -4.602883 -1.059769 0.000972
25 6 4.766432 -0.281439 0.012110
26 9 5.508812 0.701127 -0.548357
27 9 5.060978 -1.432466 -0.633455
28 9 5.210499 -0.425800 1.284559
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UIM-OMe 17ci 6-31G*
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -2.967629 1.299157 -0.000196
2 6 -1.622690 0.952583 -0.000231
3 6 -1.251675 -0.402951 -0.000082
4 6 -2.255141 -1.376883 0.000092
5 6 -3.606349 -1.027409 0.000119
6 6 -3.971934 0.322106 -0.000019
7 1 -3.263708 2.343597 -0.000305
8 1 -0.858196 1.716173 -0.000363
9 1 -1.985858 -2.431817 0.000198
10 1 -4.352771 -1.813347 0.000248
11 7 0.090605 -0.853106 -0.000142
12 1 0.193742 -1.858545 0.000003
13 6 1.244620 -0.102029 -0.000087
14 8 1.278124 1.129109 -0.000067
15 7 2.396977 -0.868820 -0.000065
16 1 2.369631 -1.879473 -0.000154
17 6 3.694809 -0.357759 0.000020
18 6 5.820482 -0.230261 -0.000009
19 6 5.370110 1.063074 0.000187
20 1 3.274079 1.688512 0.000481
21 1 6.843477 -0.580360 -0.000088
22 1 5.875046 2.016647 0.000326
23 7 4.764276 -1.123554 -0.000148
24 7 3.985955 0.968547 0.000286
25 8 -5.258780 0.784311 0.000003
26 6 -6.308405 -0.167743 0.000192
27 1 -7.236157 0.407476 0.000245
28 1 -6.278050 -0.804575 -0.894484
29 1 -6.277865 -0.804425 0.894966
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UIM-CO2Me 17di 6-31G*
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 2.374321 -0.815155 -0.000072
2 6 0.998947 -0.604394 -0.000056
3 6 0.501486 0.709374 0.000013
4 6 1.403386 1.789283 0.000066
5 6 2.770920 1.564904 0.000059
6 6 3.275776 0.257428 -0.000015
7 1 2.754530 -1.830629 -0.000121
8 1 0.310729 -1.436980 -0.000092
9 1 1.024576 2.809608 0.000123
10 1 3.469569 2.394886 0.000110
11 7 -0.868304 1.027492 0.000016
12 1 -1.067342 2.018866 0.000083
13 6 -1.952603 0.167095 0.000077
14 7 -3.166275 0.824074 0.000040
15 1 -3.232694 1.833177 -0.000069
16 8 -1.867171 -1.059518 0.000063
17 6 -4.413036 0.195740 0.000000
18 6 -6.518150 -0.121284 -0.000104
19 6 -5.953344 -1.369151 0.000002
20 1 -3.813084 -1.807720 0.000182
21 1 -7.568299 0.135643 -0.000178
22 1 -6.370523 -2.364224 0.000047
23 7 -5.546163 0.862459 -0.000129
24 7 -4.583573 -1.151351 0.000100
25 6 4.749941 0.077706 -0.000018
26 8 5.113538 -1.227247 0.000046
27 8 5.556358 0.988862 -0.000078
28 6 6.528237 -1.466934 -0.000022
29 1 6.992413 -1.032598 0.889574
30 1 6.640725 -2.551656 -0.000644
31 1 6.992520 -1.031531 -0.889030
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UIM-Me 17ei 6-31G*
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 4.427495 -0.235706 -0.006687
2 6 4.015367 1.102314 -0.003123
3 6 2.666248 1.442623 -0.000421
4 6 1.678411 0.447094 -0.003638
5 6 2.070381 -0.899004 -0.011807
6 6 3.427969 -1.215881 -0.014220
7 1 4.759644 1.895392 -0.004028
8 1 2.376887 2.492419 -0.000574
9 1 1.319681 -1.676070 -0.019990
10 1 3.713255 -2.265705 -0.024063
11 7 0.332156 0.877452 -0.004398
12 1 0.215116 1.881511 -0.002307
13 6 -0.813300 0.110218 -0.002005
14 7 -1.974359 0.862428 -0.001148
15 1 -1.959650 1.873386 -0.002558
16 8 -0.830405 -1.120638 -0.000967
17 6 -3.265858 0.334846 0.001302
18 6 -4.922627 -1.107230 0.004899
19 1 -2.818898 -1.705894 0.002402
20 6 -5.389567 0.180301 0.004741
21 1 -5.415379 -2.067147 0.006349
22 1 -6.416942 0.517253 0.006085
23 7 -3.539946 -0.995132 0.002857
24 7 -4.344849 1.086895 0.002386
25 6 5.891664 -0.606794 0.022135
26 1 6.248828 -0.755605 1.050291
27 1 6.079654 -1.538559 -0.522417
28 1 6.512939 0.175927 -0.426387
Appendix C 256
UIM-Cl 17gi 6-31G*
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -3.035936 -1.126357 -0.000014
2 6 -1.675884 -0.820147 -0.000012
3 6 -1.263813 0.521114 0.000003
4 6 -2.234470 1.535168 0.000016
5 6 -3.591079 1.227379 0.000014
6 6 -3.986995 -0.108682 -0.000001
7 1 -3.353003 -2.163889 -0.000026
8 1 -0.936876 -1.608243 -0.000023
9 1 -1.928430 2.579530 0.000028
10 1 -4.332400 2.019113 0.000024
11 7 0.086734 0.926833 0.000005
12 1 0.224008 1.928322 0.000017
13 6 1.218394 0.134018 -0.000006
14 7 2.392750 0.860026 0.000001
15 1 2.400504 1.871215 0.000009
16 8 1.204996 -1.096374 -0.000021
17 6 3.673913 0.305489 -0.000001
18 6 5.303049 -1.166889 0.000033
19 1 3.191459 -1.729124 0.000079
20 6 5.793968 0.111752 -0.000053
21 1 5.777801 -2.135818 0.000059
22 1 6.827298 0.429700 -0.000108
23 7 4.766195 1.037253 -0.000005
24 7 3.922701 -1.029281 0.000042
25 17 -5.699757 -0.509453 -0.000003
Appendix C 257
UIM-H 17aii 6-31G*
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -4.054940 0.565695 0.000008
2 6 -4.448697 -0.772775 0.000012
3 6 -3.469168 -1.767902 0.000009
4 6 -2.119841 -1.427052 0.000003
5 6 -1.726112 -0.078506 -0.000001
6 6 -2.706866 0.925508 0.000002
7 1 -4.805983 1.351680 0.000010
8 1 -3.753451 -2.817013 0.000012
9 1 -1.360622 -2.205921 0.000000
10 1 -2.405587 1.963623 -0.000002
11 7 -0.339537 0.174891 -0.000009
12 1 0.281121 -0.639032 -0.000010
13 6 0.280836 1.389750 -0.000014
14 7 1.693782 1.327469 -0.000017
15 1 2.098880 2.252905 -0.000015
16 8 -0.246864 2.494574 -0.000010
17 6 2.532777 0.228171 -0.000017
18 6 4.422554 -0.934357 0.000045
19 1 4.421550 1.215170 0.000068
20 6 3.341414 -1.765235 -0.000054
21 1 5.486453 -1.112225 0.000081
22 1 3.326036 -2.845722 -0.000108
23 7 3.893390 0.355092 0.000036
24 7 2.163364 -1.037744 -0.000001
25 1 -5.502228 -1.037792 0.000018
Appendix C 258
UIM-CF3 17bii 6-31G*
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -2.467335 1.145635 -0.029763
2 6 -3.007931 -0.142242 -0.041440
3 6 -2.148446 -1.244829 -0.043587
4 6 -0.773221 -1.056782 -0.034857
5 6 -0.227119 0.239082 -0.021674
6 6 -1.090070 1.347651 -0.021045
7 1 -3.128983 2.005926 -0.035378
8 1 -2.556002 -2.250274 -0.060234
9 1 -0.109626 -1.917798 -0.041508
10 1 -0.676133 2.345808 -0.016684
11 7 1.173055 0.333439 -0.013438
12 1 1.701769 -0.544537 -0.014935
13 6 1.926309 1.475513 -0.001064
14 7 3.320228 1.255225 0.007716
15 1 3.829041 2.128061 0.017213
16 8 1.518954 2.629025 0.003023
17 6 4.027033 0.064996 0.007674
18 6 5.765417 -1.311829 0.016658
19 1 6.018563 0.822296 0.031474
20 6 4.594359 -2.010024 0.001400
21 1 6.800931 -1.613653 0.024885
22 1 4.451756 -3.081045 -0.006018
23 7 5.392079 0.030901 0.020622
24 7 3.510715 -1.148253 -0.004243
25 6 -4.493244 -0.344761 0.011527
26 9 -4.869377 -1.491219 -0.603066
27 9 -5.166131 0.669937 -0.578285
28 9 -4.952270 -0.423232 1.285731
Appendix C 259
UIM-OMe 17cii 6-31G*
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -3.194134 0.783473 0.000073
2 6 -3.640738 -0.540474 -0.000065
3 6 -2.698041 -1.577701 -0.000901
4 6 -1.341720 -1.289751 -0.001637
5 6 -0.885221 0.040152 -0.001494
6 6 -1.826386 1.075102 -0.000595
7 1 -3.897590 1.608570 0.000781
8 1 -3.050693 -2.604335 -0.000846
9 1 -0.621310 -2.104567 -0.002208
10 1 -1.488780 2.102176 -0.000353
11 7 0.513476 0.235040 -0.002472
12 1 1.099586 -0.603669 -0.003135
13 6 1.179895 1.421984 -0.000785
14 7 2.590942 1.305843 -0.002874
15 1 3.031246 2.214931 0.001996
16 8 0.695572 2.547632 0.001883
17 6 3.385632 0.174863 -0.000431
18 6 5.227931 -1.062319 0.002385
19 1 5.312188 1.085719 0.000215
20 6 4.114575 -1.849363 0.001187
21 1 6.283974 -1.282104 0.004174
22 1 4.056394 -2.928426 0.001612
23 7 4.750306 0.247337 0.001500
24 7 2.966228 -1.075761 -0.000550
25 8 -4.954555 -0.927904 0.000451
26 6 -5.945052 0.084453 0.002440
27 1 -6.905901 -0.434278 0.003274
28 1 -5.875992 0.718596 0.896935
29 1 -5.878366 0.719833 -0.891396
Appendix C 260
UIM-CO2Me 17dii 6-31G*
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -2.446113 1.005108 0.000076
2 6 -2.952748 -0.301687 -0.000062
3 6 -2.051465 -1.376307 -0.000197
4 6 -0.684872 -1.147713 -0.000193
5 6 -0.179646 0.166513 -0.000050
6 6 -1.076523 1.248917 0.000092
7 1 -3.134665 1.842827 0.000162
8 1 -2.444638 -2.387571 -0.000310
9 1 0.007086 -1.986467 -0.000312
10 1 -0.692673 2.259103 0.000202
11 7 1.216274 0.302971 -0.000066
12 1 1.769333 -0.559758 -0.000256
13 6 1.937895 1.465733 -0.000032
14 7 3.337634 1.283916 -0.000088
15 1 3.821663 2.170776 -0.000166
16 8 1.499962 2.607828 -0.000014
17 6 4.078314 0.114564 -0.000038
18 6 5.856314 -1.210817 -0.000061
19 1 6.047099 0.929875 -0.000520
20 6 4.705963 -1.942905 0.000356
21 1 6.900225 -1.482338 -0.000229
22 1 4.594477 -3.017639 0.000617
23 7 5.444028 0.120454 -0.000218
24 7 3.597651 -1.113128 0.000510
25 6 -4.404546 -0.605771 -0.000127
26 8 -4.879229 -1.726679 -0.000268
27 8 -5.170996 0.513899 0.000108
28 6 -6.585810 0.283444 0.000289
29 1 -7.043799 1.273409 0.000730
30 1 -6.885988 -0.277909 -0.888913
31 1 -6.885707 -0.278651 0.889096
Appendix C 261
UIM-Me 17eii 6-31G*
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -3.583174 0.841583 -0.006802
2 6 -4.071314 -0.469995 -0.007658
3 6 -3.129525 -1.507024 -0.011888
4 6 -1.763797 -1.243887 -0.008447
5 6 -1.291123 0.077831 -0.003099
6 6 -2.218578 1.129658 -0.003512
7 1 -4.287815 1.670790 -0.010442
8 1 -3.468014 -2.541000 -0.019630
9 1 -1.053325 -2.067607 -0.014841
10 1 -1.866993 2.151947 -0.005571
11 7 0.107949 0.253799 -0.002875
12 1 0.682262 -0.593285 -0.003440
13 6 0.793385 1.431982 -0.000286
14 7 2.201739 1.292687 0.000256
15 1 2.656700 2.194606 0.002798
16 8 0.327282 2.564394 0.001335
17 6 2.978860 0.149171 0.001338
18 6 4.801692 -1.116111 0.004551
19 1 4.919207 1.030262 0.006202
20 6 3.676330 -1.885954 0.001584
21 1 5.854206 -1.352221 0.006720
22 1 3.601451 -2.963975 0.000779
23 7 4.344379 0.200672 0.004358
24 7 2.540160 -1.094664 -0.000466
25 6 -5.554282 -0.758339 0.020999
26 1 -5.922915 -0.876712 1.049320
27 1 -6.128928 0.054250 -0.436641
28 1 -5.794512 -1.683149 -0.515528
Appendix C 262
UIM-Cl 17gii 6-31G*
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 3.169337 0.999477 -0.000003
2 6 3.657958 -0.304556 -0.000002
3 6 2.782085 -1.388686 0.000002
4 6 1.410754 -1.155943 0.000005
5 6 0.900512 0.152791 0.000003
6 6 1.794974 1.234640 -0.000001
7 1 3.859316 1.836792 -0.000007
8 1 3.166195 -2.403124 0.000003
9 1 0.725503 -2.000082 0.000008
10 1 1.410856 2.244954 -0.000001
11 7 -0.499516 0.288356 0.000008
12 1 -1.053195 -0.573427 0.000011
13 6 -1.216452 1.450926 0.000009
14 7 -2.617621 1.275054 0.000008
15 1 -3.098062 2.163803 0.000006
16 8 -0.774790 2.592615 0.000004
17 6 -3.362014 0.108689 0.000008
18 6 -5.145140 -1.210381 -0.000022
19 1 -5.327878 0.931055 -0.000033
20 6 -3.997457 -1.946600 0.000023
21 1 -6.189985 -1.478305 -0.000039
22 1 -3.890123 -3.021788 0.000048
23 7 -4.727932 0.119330 -0.000018
24 7 -2.885877 -1.121030 -0.000004
25 17 5.396763 -0.589112 -0.000006
Appendix C 263
AIC-H 57a 6-31G*
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 1.316013 -0.377024 -0.042106
2 6 3.236517 1.008522 0.086737
3 6 3.993986 -0.109156 -0.005953
4 6 3.385390 -1.442725 -0.127862
5 1 1.207304 1.656049 0.110404
6 1 5.075980 -0.049440 0.004980
7 7 1.971540 -1.487238 -0.135913
8 7 1.856770 0.870036 0.068755
9 7 -0.084429 -0.466962 -0.052381
10 1 -0.392171 -1.422185 -0.181414
11 8 4.047056 -2.467190 -0.217509
12 6 -1.008109 0.553005 0.022853
13 8 -0.673994 1.739836 0.073111
14 6 -2.445373 0.142233 0.023286
15 6 -2.884234 -1.144283 0.371569
16 6 -3.388567 1.119855 -0.325509
17 6 -4.244217 -1.449414 0.354224
18 1 -2.181506 -1.907739 0.694524
19 6 -4.745311 0.809652 -0.350014
20 1 -3.035963 2.114738 -0.575252
21 6 -5.175549 -0.476098 -0.012643
22 1 -4.575536 -2.445175 0.633963
23 1 -5.468251 1.570356 -0.630386
24 1 -6.234713 -0.717567 -0.028871
25 6 3.752776 2.411589 0.211029
26 1 4.844729 2.417573 0.211560
27 1 3.404513 3.035530 -0.621843
28 1 3.404025 2.878899 1.140623
Appendix C 264
AIC-OMe 57c 6-31G*
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -4.356402 -0.370776 -0.047075
2 6 -3.426097 -1.390374 -0.312278
3 6 -2.069072 -1.112944 -0.312324
4 6 -1.599277 0.188006 -0.050003
5 6 -2.537956 1.198048 0.196678
6 6 -3.903566 0.932478 0.206196
7 1 -3.796526 -2.388259 -0.522472
8 1 -1.384682 -1.921890 -0.553161
9 1 -2.175611 2.203028 0.384471
10 1 -4.601255 1.736573 0.408526
11 6 -0.163321 0.576137 -0.034390
12 7 0.752257 -0.454948 0.032982
13 1 0.437637 -1.410264 0.139879
14 8 0.190936 1.759691 -0.067806
15 6 2.151948 -0.378067 0.034608
16 6 4.211091 -1.464047 0.119022
17 6 4.086428 0.991366 -0.055847
18 1 2.061736 1.656637 -0.086967
19 6 4.833275 -0.134406 0.024289
20 1 5.915845 -0.084509 0.022952
21 7 2.705880 0.865406 -0.051170
22 7 2.797734 -1.495926 0.115245
23 8 4.863696 -2.495775 0.196745
24 6 4.616409 2.391610 -0.152234
25 1 5.708394 2.387451 -0.147184
26 1 4.276649 2.878930 -1.074864
27 1 4.269480 3.003677 0.689981
28 8 -5.658944 -0.746754 -0.065046
29 6 -6.657006 0.236358 0.184854
30 1 -7.611500 -0.287403 0.117228
31 1 -6.549320 0.669950 1.186886
32 1 -6.626160 1.036752 -0.564793
Appendix C 265
AIC-CO2Me 57d 6-31G*
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -2.853410 0.884730 0.308525
2 6 -1.470868 0.724552 0.335325
3 6 -0.895065 -0.516080 0.021760
4 6 -1.725801 -1.598597 -0.303154
5 6 -3.105021 -1.437262 -0.338628
6 6 -3.677125 -0.194593 -0.035410
7 1 -3.296973 1.841236 0.559167
8 1 -0.855989 1.567513 0.638611
9 1 -1.269063 -2.556759 -0.525398
10 1 -3.759527 -2.262575 -0.597742
11 6 0.580228 -0.769659 0.040177
12 7 1.386895 0.339885 -0.074108
13 1 0.978240 1.250613 -0.240548
14 6 -5.166378 -0.080249 -0.087432
15 8 -5.597395 1.159036 0.228921
16 8 -5.909695 -0.994784 -0.380681
17 8 1.035988 -1.911194 0.139871
18 6 2.789780 0.403577 -0.057008
19 6 4.729969 1.686811 -0.177462
20 6 4.849774 -0.756530 0.128434
21 1 2.905738 -1.622988 0.174412
22 6 5.480199 0.433658 -0.003967
23 1 6.562089 0.493659 0.012100
24 8 5.274594 2.773993 -0.303621
25 7 3.462895 -0.771662 0.101640
26 7 3.319288 1.574625 -0.190950
27 6 5.516298 -2.088740 0.305668
28 1 6.602095 -1.973504 0.315109
29 1 5.210412 -2.560175 1.248131
30 1 5.249011 -2.774974 -0.507900
31 6 -7.023521 1.340409 0.198191
32 1 -7.509367 0.667111 0.908987
33 1 -7.190458 2.380953 0.476801
34 1 -7.412038 1.141391 -0.803841
Appendix C 266
AIC-Me 57e 6-31G*
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 4.287139 1.006494 -0.302555
2 6 2.922771 1.271238 -0.287470
3 6 2.004882 0.258696 0.027252
4 6 2.491042 -1.016892 0.350021
5 6 3.859947 -1.271192 0.340146
6 6 4.781501 -0.269891 0.004927
7 1 4.983424 1.802909 -0.553898
8 1 2.544154 2.261685 -0.516168
9 1 1.818400 -1.815679 0.651461
10 1 4.218968 -2.262398 0.605265
11 6 0.557824 0.622456 0.022754
12 7 -0.334505 -0.426748 -0.046556
13 1 0.002886 -1.373029 -0.166084
14 6 -1.736285 -0.380551 -0.038624
15 6 -3.699195 0.945880 0.075790
16 1 -1.690629 1.655776 0.098060
17 6 -3.771744 -1.510317 -0.118603
18 6 -4.421752 -0.195319 -0.008731
19 1 -5.505096 -0.169000 0.000156
20 8 0.184190 1.798341 0.065015
21 8 -4.401748 -2.555426 -0.200630
22 7 -2.357575 -1.511353 -0.124224
23 7 -2.316029 0.850001 0.061211
24 6 -4.258815 2.333350 0.187211
25 1 -5.350429 2.305123 0.190505
26 1 -3.922649 2.820884 1.111014
27 1 -3.932111 2.959290 -0.652896
28 6 6.261816 -0.560352 -0.040893
29 1 6.530519 -1.384742 0.627257
30 1 6.573592 -0.846197 -1.054312
31 1 6.851415 0.317145 0.244179
Appendix C 267
AIC-Cl 57f 6-31G*
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -3.884566 1.119602 -0.317872
2 6 -2.513060 1.347712 -0.299497
3 6 -1.617755 0.317688 0.022541
4 6 -2.124672 -0.948092 0.352105
5 6 -3.496624 -1.187140 0.345267
6 6 -4.366158 -0.150881 0.003358
7 1 -4.576124 1.914134 -0.575908
8 1 -2.114167 2.328247 -0.535353
9 1 -1.466133 -1.757902 0.653614
10 1 -3.889017 -2.162988 0.609012
11 17 -6.092480 -0.447978 -0.013580
12 6 -0.162178 0.657318 0.018001
13 7 0.711542 -0.404282 -0.053565
14 1 0.362060 -1.345507 -0.179298
15 8 0.224693 1.827926 0.063923
16 6 2.115747 -0.380469 -0.042441
17 6 4.130591 -1.546799 -0.120473
18 6 4.101523 0.909962 0.081950
19 1 2.108340 1.657468 0.101146
20 6 4.803277 -0.243990 -0.003853
21 1 5.886837 -0.237195 0.008752
22 8 4.740378 -2.602982 -0.204576
23 7 2.715589 -1.521641 -0.129749
24 7 2.716202 0.839320 0.062205
25 6 4.685694 2.286646 0.199518
26 1 5.776509 2.238278 0.208456
27 1 4.375175 2.920274 -0.640956
28 1 4.353856 2.778159 1.122761
Appendix C 268
C.3 Molecular Modelling for Chapter 4: A Novel ADDA
array
UDIM 1 C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -1.970823 5.312410 1.843401
2 6 -2.813798 3.396679 1.101217
3 6 -2.997127 5.522188 0.943444
4 1 -1.241815 3.343749 2.479987
5 1 -3.393443 6.460652 0.597036
6 7 -3.024543 2.026079 0.914424
7 1 -3.767650 1.813853 0.262963
8 6 -2.309749 1.029969 1.539797
9 7 -2.693768 -0.247636 1.201424
10 1 -3.442006 -0.417647 0.543481
11 8 -1.388181 1.266112 2.348476
12 6 -2.113109 -1.415603 1.707924
13 6 -0.793123 -2.777178 2.863433
14 1 -0.669511 -0.589917 2.976492
15 6 -1.685833 -3.478913 2.077379
16 1 -1.789725 -4.545742 1.983238
17 7 -2.508599 -2.622533 1.357277
18 7 -1.087845 -1.434907 2.608636
19 7 -1.866934 3.921443 1.932420
20 7 -3.520443 4.320983 0.482872
21 6 -1.079085 6.250398 2.626759
22 6 -1.261330 6.010541 4.152113
23 1 -0.998609 4.984577 4.431114
24 1 -0.617762 6.687912 4.723658
25 1 -2.299110 6.185641 4.451040
26 6 -1.458218 7.712532 2.295971
27 1 -0.819261 8.401175 2.857210
28 1 -1.329413 7.922511 1.229751
29 1 -2.498799 7.920890 2.562954
30 6 0.297320 -3.207329 3.819753
31 6 0.355786 -4.751778 3.867981
32 1 0.576223 -5.169761 2.880977
33 1 1.141848 -5.075381 4.557087
34 1 -0.593340 -5.172428 4.214010
35 6 0.000526 -2.664922 5.246355
Appendix C 269
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
36 1 -0.045434 -1.570751 5.257936
37 1 -0.956452 -3.046153 5.614958
38 1 0.787387 -2.974205 5.942673
39 6 1.672341 -2.661147 3.341814
40 1 1.914599 -3.039671 2.344311
41 1 1.675799 -1.566846 3.297274
42 1 2.465400 -2.970385 4.031121
43 6 0.409804 6.012794 2.246953
44 1 0.721743 4.986839 2.469616
45 1 0.570702 6.189543 1.179305
46 1 1.059616 6.690108 2.811469
UDIM 2 C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -1.740102 5.179481 1.727844
2 6 -2.369143 3.226485 0.878466
3 6 -2.484640 5.340939 0.576009
4 1 -1.226344 3.247269 2.630266
5 1 -2.764963 6.259803 0.091394
6 7 -2.534133 1.847523 0.707046
7 1 -3.075666 1.601235 -0.110119
8 6 -2.022605 0.886723 1.548732
9 7 -2.312738 -0.408667 1.180539
10 1 -2.859963 -0.612902 0.355800
11 8 -1.350865 1.164875 2.562708
12 6 -1.900459 -1.546280 1.881789
13 6 -0.962879 -2.845782 3.397465
14 1 -0.839508 -0.661200 3.454131
15 6 -1.613902 -3.606278 2.446709
16 7 -2.200574 -2.772424 1.497074
17 7 -1.155633 -1.518915 3.020681
18 7 -1.676329 3.794941 1.907819
19 7 -2.875165 4.116626 0.049418
20 6 -1.083973 6.157713 2.676893
21 6 -1.672424 5.990305 4.106283
22 1 -1.499447 4.981325 4.495609
23 1 -1.204649 6.699865 4.797276
24 1 -2.751648 6.170100 4.104842
25 6 -1.347487 7.600744 2.187186
Appendix C 270
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
26 1 -0.877351 8.318618 2.866157
27 1 -0.934750 7.759413 1.186208
28 1 -2.419757 7.816636 2.153931
29 6 0.450047 5.908542 2.723239
30 1 0.681717 4.897284 3.074278
31 1 0.892765 6.029749 1.730080
32 1 0.931606 6.617538 3.405283
33 6 -1.743238 -5.112961 2.340553
34 6 -3.246162 -5.501896 2.375339
35 1 -3.788124 -4.999906 1.569921
36 1 -3.364450 -6.584732 2.256645
37 1 -3.702093 -5.208538 3.326827
38 6 -1.007363 -5.801767 3.512015
39 1 0.060763 -5.558957 3.509125
40 1 -1.426338 -5.499831 4.478013
41 1 -1.103888 -6.889024 3.430191
42 6 -1.128476 -5.586396 0.995412
43 1 -1.618157 -5.086247 0.156086
44 1 -0.059127 -5.354109 0.953258
45 1 -1.250185 -6.669060 0.878631
46 1 -0.401051 -3.110154 4.274355
UDIM 3 C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -2.327559 5.351656 2.345681
2 6 -2.438553 3.464441 1.209702
3 6 -2.632698 5.602575 1.022717
4 1 -1.990208 3.388389 3.252833
5 7 -2.409543 2.102496 0.891782
6 1 -2.606628 1.905339 -0.079633
7 6 -2.143195 1.094793 1.792099
8 7 -2.168797 -0.173137 1.254811
9 1 -2.370227 -0.329124 0.276826
10 8 -1.898428 1.312591 2.995045
11 6 -1.929562 -1.346874 1.977246
12 6 -1.472853 -2.728398 3.634702
13 1 -1.573206 -0.555873 3.882111
14 6 -1.676920 -3.431027 2.463817
15 7 -1.964169 -2.545703 1.426995
Appendix C 271
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
16 7 -1.638698 -1.385169 3.306346
17 7 -2.204912 3.968476 2.452253
18 7 -2.699197 4.402100 0.318622
19 6 -1.625230 -4.925485 2.215077
20 6 -3.003514 -5.404680 1.683582
21 1 -3.273797 -4.859037 0.775966
22 1 -2.973603 -6.475549 1.453204
23 1 -3.788089 -5.235292 2.428633
24 6 -1.288974 -5.678456 3.521776
25 1 -0.314177 -5.372810 3.916654
26 1 -2.045959 -5.495149 4.291807
27 1 -1.252920 -6.756566 3.336629
28 6 -0.537404 -5.230440 1.149442
29 1 -0.740886 -4.680075 0.227362
30 1 0.453771 -4.935548 1.509927
31 1 -0.515365 -6.301871 0.920796
32 1 -1.234071 -3.042671 4.634078
33 1 -2.190559 6.000041 3.191473
34 6 -2.879230 6.925365 0.324582
35 6 -2.746502 8.095912 1.324432
36 1 -1.743202 8.132447 1.762191
37 1 -2.925358 9.048174 0.815405
38 1 -3.474743 8.007988 2.137766
39 6 -4.308299 6.925663 -0.283320
40 1 -4.431797 6.084079 -0.969637
41 1 -5.065553 6.837343 0.502885
42 1 -4.490230 7.856020 -0.832927
43 6 -1.842540 7.102927 -0.818083
44 1 -1.899247 6.266145 -1.518882
45 1 -2.032344 8.032733 -1.365956
46 1 -0.824290 7.142224 -0.416884
UDIM alt 1 C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -1.924840 4.739878 1.691793
2 6 -2.663226 2.709269 1.168283
3 6 -2.839701 4.780039 0.656953
4 1 -1.265741 2.909628 2.709691
5 1 -3.198120 5.643329 0.123423
Appendix C 272
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
6 7 -2.829431 1.322563 1.190823
7 1 -3.483360 0.906626 0.518683
8 6 -2.170035 0.502797 2.056648
9 7 -2.455525 -0.866053 1.941992
10 1 -1.940736 -1.423937 2.607322
11 8 -1.354405 0.873796 2.918188
12 6 -3.328730 -1.484489 1.055231
13 6 -4.455023 -3.134887 0.040060
14 1 -3.071876 -3.515261 1.651434
15 6 -4.767207 -1.908014 -0.496754
16 1 -5.450180 -1.686416 -1.297676
17 7 -4.065464 -0.887405 0.136920
18 7 -3.519628 -2.843797 1.046864
19 7 -1.823754 3.385092 2.010188
20 7 -3.297402 3.510626 0.334029
21 6 -1.138289 5.810613 2.414692
22 6 -1.497610 5.807760 3.927443
23 1 -1.265339 4.844065 4.392826
24 1 -0.929924 6.581156 4.456576
25 1 -2.564644 6.002093 4.072029
26 6 -1.484476 7.193745 1.816231
27 1 -0.920815 7.977572 2.331763
28 1 -1.232367 7.236938 0.752230
29 1 -2.550891 7.414130 1.924458
30 6 -4.916219 -4.543170 -0.264550
31 6 -5.941308 -4.504097 -1.422207
32 1 -5.498104 -4.081393 -2.328831
33 1 -6.282789 -5.517716 -1.652189
34 1 -6.816161 -3.903527 -1.155708
35 6 -5.591062 -5.168669 0.988934
36 1 -4.896995 -5.229320 1.834657
37 1 -6.453493 -4.573905 1.303403
38 1 -5.933644 -6.185165 0.769185
39 6 -3.706298 -5.423026 -0.688611
40 1 -3.218142 -5.010549 -1.576300
41 1 -2.956429 -5.491152 0.107443
42 1 -4.038051 -6.440988 -0.917969
43 6 0.386700 5.554584 2.252296
44 1 0.676465 4.583176 2.666594
45 1 0.670820 5.567372 1.195723
46 1 0.961711 6.327001 2.774911
Appendix C 273
UDIM alt 2 C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -2.192658 4.760225 2.183841
2 6 -2.824129 2.748817 1.524627
3 6 -3.069301 4.852118 1.120361
4 1 -1.489889 2.912602 3.127428
5 7 -2.941156 1.359412 1.454638
6 1 -3.554479 0.963167 0.733960
7 6 -2.282669 0.509451 2.293621
8 7 -2.514719 -0.858163 2.083715
9 1 -2.002954 -1.439446 2.731151
10 8 -1.513068 0.853698 3.205368
11 6 -3.332046 -1.448583 1.127303
12 6 -4.360529 -3.068762 -0.030120
13 1 -3.024898 -3.502847 1.607348
14 6 -4.697098 -1.821766 -0.502044
15 7 -4.055954 -0.819964 0.219853
16 7 -3.473391 -2.810198 1.027768
17 7 -2.043660 3.400229 2.433820
18 7 -3.458531 3.578905 0.715711
19 6 -3.601013 6.084141 0.415062
20 6 -3.018856 7.365885 1.052265
21 1 -3.293050 7.443323 2.109976
22 1 -1.926135 7.385168 0.978047
23 1 -3.406339 8.251839 0.538882
24 6 -5.149709 6.109902 0.526930
25 1 -5.559831 6.969031 -0.016226
26 1 -5.575464 5.193885 0.109893
27 1 -5.462075 6.183759 1.574092
28 6 -3.203347 6.027197 -1.084993
29 1 -2.114099 6.041662 -1.198658
30 1 -3.579836 5.109020 -1.542673
31 1 -3.617378 6.886409 -1.625042
32 1 -1.680001 5.504676 2.764986
33 1 -5.358002 -1.573366 -1.313518
34 6 -4.759469 -4.469786 -0.438582
35 6 -3.504250 -5.280391 -0.869235
Appendix C 274
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
36 1 -2.782290 -5.373992 -0.050284
37 1 -3.791340 -6.292198 -1.173623
38 1 -2.998674 -4.796898 -1.710120
39 6 -5.456145 -5.195804 0.747038
40 1 -6.350058 -4.651577 1.065160
41 1 -5.753808 -6.207096 0.451230
42 1 -4.790892 -5.287129 1.612932
43 6 -5.742617 -4.391548 -1.629948
44 1 -6.647298 -3.838481 -1.360158
45 1 -5.281947 -3.897697 -2.490767
46 1 -6.040037 -5.398863 -1.936364
UDIM alt 3 C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -2.191932 4.718608 2.105145
2 6 -2.818757 2.688171 1.503364
3 6 -3.142962 4.782048 1.105368
4 1 -1.380351 2.894728 3.007556
5 7 -2.906842 1.296013 1.449398
6 1 -3.559200 0.878776 0.776583
7 6 -2.171903 0.466595 2.244272
8 7 -2.387678 -0.907276 2.055912
9 1 -1.819445 -1.474059 2.668304
10 8 -1.349062 0.833748 3.098066
11 6 -3.256151 -1.520797 1.161649
12 6 -4.326875 -3.145871 0.083227
13 1 -2.875610 -3.569120 1.617419
14 6 -4.736693 -1.918359 -0.381066
15 7 -4.056458 -0.909852 0.304744
16 7 -3.375194 -2.881598 1.074702
17 7 -1.992601 3.364285 2.351535
18 7 -3.528448 3.496605 0.736273
19 1 -4.605367 -4.149177 -0.180984
20 6 -5.750401 -1.578149 -1.454400
21 6 -6.352297 -2.871057 -2.050113
22 1 -6.864597 -3.462263 -1.283384
Appendix C 275
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
23 1 -7.083844 -2.622250 -2.824832
24 1 -5.578626 -3.496383 -2.508642
25 6 -6.885247 -0.717719 -0.834539
26 1 -7.414574 -1.274201 -0.054061
27 1 -6.479978 0.193569 -0.387677
28 1 -7.609673 -0.433147 -1.605192
29 6 -5.053252 -0.766285 -2.580149
30 1 -4.601171 0.143766 -2.177900
31 1 -4.264083 -1.357719 -3.055985
32 1 -5.780137 -0.481655 -3.348462
33 6 -3.753223 5.995457 0.431670
34 6 -3.159372 7.295792 1.018594
35 1 -3.360162 7.374678 2.092534
36 1 -2.075366 7.340815 0.867586
37 1 -3.603109 8.168664 0.529026
38 6 -5.290237 5.983813 0.652398
39 1 -5.759940 6.827934 0.134547
40 1 -5.720949 5.054362 0.271671
41 1 -5.530018 6.057553 1.718478
42 6 -3.460419 5.935572 -1.092123
43 1 -2.382560 5.974523 -1.282271
44 1 -3.845893 5.004952 -1.516035
45 1 -3.931925 6.779767 -1.608217
46 1 -1.657602 5.479045 2.644539
UDIM alt 4 C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 0.636149 -1.975271 0.387535
2 8 0.998252 -2.756814 -0.507789
3 7 0.724022 -2.213636 1.726101
4 1 0.391849 -1.491418 2.374857
5 7 0.086678 -0.735473 0.024425
6 1 0.044376 -0.609609 -0.976279
7 6 1.243532 -3.391524 2.266896
8 6 1.895926 -4.892028 3.646914
9 6 2.148529 -5.418009 2.394475
10 1 1.718419 -4.398108 0.498010
11 1 2.085043 -5.344143 4.605116
Appendix C 276
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
12 6 -0.374821 0.270389 0.864388
13 6 -1.252652 2.214072 1.499114
14 1 -0.998285 1.710793 -0.579720
15 6 -0.929822 1.457198 2.600571
16 1 -1.687750 3.190686 1.394499
17 7 -0.892754 1.444119 0.387008
18 7 -0.380855 0.242310 2.186237
19 7 1.717435 -4.427404 1.510937
20 7 1.331073 -3.627137 3.562204
21 6 -1.090588 1.770399 4.074019
22 6 -1.718928 3.170470 4.257904
23 1 -2.710449 3.226052 3.795695
24 1 -1.833255 3.392660 5.323139
25 1 -1.088389 3.951013 3.818570
26 6 -2.008087 0.702067 4.729301
27 1 -3.006802 0.716877 4.280534
28 1 -1.590476 -0.299421 4.598841
29 1 -2.110234 0.897402 5.802251
30 6 0.301543 1.734315 4.761913
31 1 0.966960 2.492875 4.336648
32 1 0.198894 1.929426 5.834856
33 1 0.772202 0.756536 4.632208
34 6 2.741362 -6.728646 1.926512
35 6 1.709709 -7.499237 1.055179
36 1 1.425241 -6.921735 0.169369
37 1 2.132192 -8.450865 0.714446
38 1 0.800404 -7.708953 1.626429
39 6 3.112070 -7.592579 3.154386
40 1 3.542467 -8.544481 2.827800
41 1 3.848208 -7.085655 3.785916
42 1 2.230101 -7.810042 3.764751
43 6 4.021932 -6.464156 1.085373
44 1 4.771294 -5.931052 1.678165
45 1 4.457841 -7.409863 0.745075
46 1 3.799941 -5.858954 0.200189
UDIM no tbu C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -1.412563 -0.691433 -0.514208
2 7 -0.676646 -0.675362 0.649083
Appendix C 277
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
3 1 -0.998902 -1.140678 1.486421
4 7 -2.599313 -1.384015 -0.431018
5 1 -2.889232 -1.837413 0.424489
6 6 0.558029 -0.035152 0.798638
7 6 2.379883 0.692060 1.658382
8 6 2.377411 1.134244 0.354876
9 1 0.806851 0.757923 -1.122696
10 1 3.128542 0.853628 2.415064
11 1 3.076044 1.719445 -0.215661
12 6 -3.507006 -1.533523 -1.484733
13 6 -4.444811 -1.380370 -3.477508
14 1 -2.516560 -0.467032 -2.989737
15 6 -5.230295 -2.112927 -2.616568
16 1 -4.565157 -1.097181 -4.507750
17 1 -6.181041 -2.577689 -2.814548
18 7 1.190559 0.655945 -0.191836
19 7 1.234934 -0.042007 1.932249
20 7 -4.636750 -2.206244 -1.366103
21 7 -3.330323 -1.010377 -2.731531
22 8 -1.034559 -0.124301 -1.559039
UDIM alt no tbu C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -1.142493 -0.554832 -0.471677
2 7 -0.238164 -0.410921 0.593230
3 1 0.573776 0.130957 0.336201
4 7 -2.267404 -1.275427 -0.204425
5 1 -2.393328 -1.665683 0.735360
6 6 -0.350792 -0.912774 1.883276
7 6 -1.027609 -1.902959 3.680886
8 6 0.178332 -1.338401 4.005028
9 1 1.467944 -0.182088 2.727290
10 1 -1.684731 -2.483069 4.305307
11 1 0.755291 -1.324021 4.911905
12 6 -3.267434 -1.513502 -1.150006
13 6 -4.384649 -1.489957 -3.057146
14 1 -2.450073 -0.498740 -2.787151
15 6 -5.065139 -2.199270 -2.092396
Appendix C 278
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
16 1 -4.606608 -1.264467 -4.084913
17 1 -6.014112 -2.700596 -2.180505
18 7 0.609885 -0.700082 2.838477
19 7 -1.353317 -1.634853 2.356836
20 7 -4.361093 -2.211403 -0.898334
21 7 -3.222592 -1.051175 -2.434760
22 8 -0.868069 -0.029970 -1.563083
DAN C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -2.164319 5.205780 -5.629096
2 6 -0.573289 3.743762 -4.820588
3 6 0.385321 4.195073 -5.786591
4 6 -0.017017 5.208797 -6.693382
5 6 -1.290459 5.727457 -6.629820
6 6 1.671517 3.597390 -5.770611
7 1 0.685711 5.571166 -7.435614
8 1 -1.646188 6.497866 -7.294061
9 6 1.967447 2.618362 -4.849399
10 6 0.938905 2.244302 -3.933207
11 1 2.418342 3.917677 -6.488744
12 1 2.927877 2.132731 -4.794369
13 7 -1.832708 4.258663 -4.759736
14 7 -0.277937 2.774910 -3.910065
15 7 -3.486142 5.657086 -5.467391
16 1 -3.961741 5.179629 -4.711638
17 7 1.123514 1.257987 -2.948249
18 1 0.292103 1.120089 -2.386944
19 6 -4.181281 6.614777 -6.185202
20 6 2.240067 0.486739 -2.675983
21 8 3.301800 0.571187 -3.290408
22 8 -3.703756 7.256728 -7.118902
23 6 2.040754 -0.518573 -1.549790
24 1 1.193783 -0.281920 -0.901639
25 1 1.883982 -1.513729 -1.978284
26 1 2.952401 -0.556402 -0.951851
27 6 -5.625776 6.797745 -5.739503
28 1 -6.288340 6.285282 -6.444422
29 1 -5.822251 6.413608 -4.735860
30 1 -5.867871 7.860944 -5.772073
Appendix C 279
DAN · UDIM C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -0.000013 2.484629 -0.000274
2 7 1.124098 1.736466 0.251648
3 1 1.106954 0.708195 0.155492
4 7 -1.124090 1.736429 -0.252259
5 1 -1.106889 0.708178 -0.155974
6 6 2.352753 2.309510 0.556009
7 6 4.445903 2.545296 1.015994
8 6 3.905007 3.807480 1.059996
9 1 1.815421 4.321165 0.645510
10 1 5.465996 2.250737 1.192850
11 1 4.334062 4.771457 1.265709
12 6 -2.352885 2.309388 -0.556174
13 6 -3.905375 3.807250 -1.059759
14 1 -1.815761 4.321126 -0.645799
15 6 -4.446194 2.545044 -1.015519
16 1 -4.334560 4.771186 -1.265404
17 1 -5.466330 2.250422 -1.192003
18 7 2.556706 3.641029 0.766033
19 7 3.470198 1.609410 0.696369
20 7 -3.470321 1.609221 -0.696188
21 7 -2.556957 3.640889 -0.766263
22 8 -0.000067 3.737715 -0.000169
23 6 -2.315458 -1.968304 0.241566
24 6 0.000049 -2.014295 -0.000091
25 6 0.000080 -3.445136 -0.000103
26 6 -1.234574 -4.114823 0.171182
27 6 -2.392960 -3.394263 0.308902
28 6 1.234759 -4.114782 -0.171435
29 1 -1.254540 -5.198821 0.189619
30 1 -3.353557 -3.855739 0.460146
31 6 2.393115 -3.394179 -0.309102
32 6 2.315554 -1.968214 -0.241641
33 1 1.254730 -5.198779 -0.189939
34 1 3.353755 -3.855551 -0.460397
35 7 -1.163442 -1.296022 0.098000
Appendix C 280
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
36 7 1.163523 -1.295974 -0.098150
37 7 -3.473842 -1.187588 0.296612
38 1 -3.392807 -0.209297 -0.019251
39 7 3.473938 -1.187466 -0.296539
40 1 3.392862 -0.209241 0.019431
41 6 -4.753222 -1.605850 0.647121
42 6 4.753392 -1.605705 -0.646832
43 8 5.045640 -2.744792 -1.009679
44 8 -5.045391 -2.744949 1.009998
45 6 5.807510 -0.514456 -0.533888
46 1 5.450200 0.442702 -0.917855
47 1 6.081752 -0.370087 0.516739
48 1 6.690210 -0.836022 -1.084927
49 6 -5.807397 -0.514625 0.534415
50 1 -5.449982 0.442594 0.918128
51 1 -6.082011 -0.370420 -0.516136
52 1 -6.689890 -0.836158 1.085806
DAN · UDIM alt C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -2.432729 -0.634982 -0.163251
2 7 -1.100665 -0.884334 0.104532
3 1 -0.473043 -0.077763 -0.002506
4 7 -3.294245 -1.680056 -0.017028
5 1 -2.918655 -2.572591 0.328093
6 6 -0.555238 -2.066727 0.588500
7 6 -0.217761 -4.063537 1.325462
8 6 1.013065 -3.452540 1.309865
9 1 1.459187 -1.428234 0.602459
10 1 -0.466236 -5.063763 1.636431
11 1 1.988905 -3.793246 1.607313
12 6 -4.664529 -1.606850 -0.270916
13 6 -6.637957 -0.816778 -0.884617
14 1 -4.797025 0.366925 -0.949086
15 6 -6.735085 -2.125900 -0.467915
Appendix C 281
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
16 1 -7.366703 -0.113283 -1.245941
17 1 -7.614943 -2.744869 -0.418824
18 7 0.783744 -2.162035 0.836116
19 7 -1.198514 -3.191532 0.871764
20 7 -5.497036 -2.616785 -0.084929
21 7 -5.293037 -0.492724 -0.752486
22 8 -2.783421 0.516613 -0.529360
23 6 0.275750 2.765188 0.112040
24 6 2.110168 1.350439 -0.044716
25 6 3.023190 2.445957 0.062228
26 6 2.474153 3.744712 0.220386
27 6 1.112577 3.919674 0.248008
28 6 4.409793 2.164625 0.000765
29 1 3.137685 4.597181 0.312524
30 1 0.648986 4.884740 0.364942
31 6 4.850750 0.871627 -0.175627
32 6 3.865590 -0.151746 -0.275112
33 1 5.122339 2.977463 0.084699
34 1 5.893779 0.609716 -0.237300
35 7 0.757668 1.522636 -0.014044
36 7 2.552194 0.064865 -0.187192
37 7 -1.114722 2.856891 0.086133
38 1 -1.615839 1.984515 -0.124758
39 7 4.196215 -1.499934 -0.489421
40 1 3.391516 -2.089441 -0.659678
41 6 -1.897321 3.994555 0.271657
42 6 5.452898 -2.088074 -0.588902
43 8 6.506289 -1.477384 -0.436587
44 8 -1.447380 5.111887 0.518915
45 6 5.415546 -3.569437 -0.933000
46 1 4.459217 -4.044918 -0.703141
47 1 5.617223 -3.696971 -2.001578
48 1 6.211090 -4.074608 -0.384080
49 6 -3.388060 3.744311 0.115592
50 1 -3.677987 3.930262 -0.924670
51 1 -3.668562 2.721205 0.367958
52 1 -3.924848 4.452698 0.746598
Appendix C 282
DAN · UIM C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -1.809594 -2.241089 -0.596593
2 6 0.438838 -2.040333 -0.063112
3 6 0.553930 -3.452613 0.128236
4 6 -0.602884 -4.245408 -0.070985
5 6 -1.790362 -3.658843 -0.446728
6 6 1.824103 -3.962125 0.500751
7 1 -0.543168 -5.319376 0.065967
8 1 -2.693159 -4.219378 -0.623234
9 6 2.895293 -3.113255 0.634007
10 6 2.695257 -1.718126 0.377795
11 1 1.943965 -5.026424 0.670075
12 1 3.877654 -3.451968 0.916796
13 7 3.745799 -0.802005 0.409481
14 1 3.544513 0.126729 0.001856
15 7 -2.962881 -1.543863 -0.980732
16 1 -2.820993 -0.545099 -1.067489
17 6 5.048857 -1.028357 0.837837
18 6 -4.243337 -2.028396 -1.230971
19 6 -5.228952 -0.941265 -1.630500
20 1 -5.268128 -0.147754 -0.877843
21 1 -4.941010 -0.487871 -2.585020
22 1 -6.215009 -1.390482 -1.735551
23 6 5.968602 0.169362 0.660020
24 1 6.374191 0.171308 -0.357904
25 1 5.450841 1.116881 0.816795
26 1 6.798571 0.071848 1.359144
27 8 5.454451 -2.091424 1.306958
28 8 -4.554089 -3.213047 -1.145394
29 7 -0.750994 -1.454979 -0.390896
30 7 1.502809 -1.196785 0.065041
31 6 -5.109878 2.413739 1.776122
32 6 -4.503098 1.171425 2.001201
33 6 -3.216085 0.917601 1.521089
34 6 -2.516071 1.902146 0.793479
35 6 -3.124465 3.152510 0.567249
Appendix C 283
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
36 6 -4.409449 3.395131 1.064299
37 1 -6.104696 2.614926 2.155468
38 1 -5.022565 0.403141 2.562812
39 1 -2.737812 -0.033616 1.725723
40 1 -2.584783 3.911732 0.024612
41 1 -4.864580 4.363177 0.887749
42 7 -1.230965 1.557629 0.314871
43 1 -1.008853 0.561771 0.272193
44 6 -0.240866 2.426178 -0.093784
45 8 -0.382361 3.655069 -0.219388
46 7 0.959173 1.783303 -0.357349
47 1 1.077803 0.772180 -0.209124
48 6 2.109016 2.462355 -0.732942
49 6 3.472947 4.085806 -1.377132
50 1 1.337393 4.380165 -0.960396
51 6 4.158627 2.903028 -1.242071
52 1 3.784483 5.073738 -1.664570
53 1 5.205204 2.716807 -1.413202
54 7 3.302950 1.886852 -0.832204
55 7 2.154617 3.786413 -1.051908
DAN · UIM alt C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 4.072755 -0.356424 -0.253839
2 6 2.424384 1.264589 -0.031278
3 6 3.412250 2.289226 0.110486
4 6 4.775641 1.909715 0.071360
5 6 5.126575 0.590876 -0.117733
6 6 2.954913 3.622118 0.278128
7 1 5.542745 2.667862 0.182498
8 1 6.149179 0.255632 -0.163830
9 6 1.609485 3.894185 0.282305
10 6 0.693376 2.805080 0.113275
Appendix C 284
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
11 1 3.676227 4.422988 0.396027
12 1 1.213247 4.888125 0.405102
13 7 -0.684580 2.998235 0.063548
14 1 -1.246404 2.163504 -0.153860
15 7 4.309663 -1.722069 -0.486355
16 1 3.467994 -2.248254 -0.682857
17 6 -1.385408 4.190544 0.238001
18 6 5.521658 -2.397092 -0.576386
19 6 5.384883 -3.865805 -0.949924
20 1 4.386883 -4.270650 -0.766812
21 1 5.619615 -3.990450 -2.011983
22 1 6.117204 -4.439757 -0.380726
23 6 -2.885701 4.054102 0.043741
24 1 -3.139110 4.332013 -0.985437
25 1 -3.243922 3.039332 0.217114
26 1 -3.385820 4.756198 0.711615
27 8 -0.858288 5.269942 0.503756
28 8 6.614039 -1.868077 -0.394363
29 7 2.776871 -0.047273 -0.187669
30 7 1.087723 1.532450 -0.023013
31 6 -7.418745 -1.210154 -0.488932
32 6 -6.773194 -2.336663 0.037281
33 6 -5.384646 -2.353029 0.175959
34 6 -4.614182 -1.238767 -0.213361
35 6 -5.259601 -0.106879 -0.745571
36 6 -6.652760 -0.104670 -0.875670
37 1 -8.497069 -1.195717 -0.595296
38 1 -7.348963 -3.203244 0.342119
39 1 -4.888699 -3.225109 0.588237
40 1 -4.670798 0.744515 -1.045874
41 1 -7.138979 0.772824 -1.287192
42 7 -3.214557 -1.350764 -0.053155
43 1 -2.846998 -2.253402 0.267873
44 6 -2.277949 -0.369298 -0.207925
45 8 -2.510284 0.814229 -0.533942
46 7 -0.957947 -0.752541 0.013853
47 1 -0.273891 0.007452 -0.073163
48 6 -0.496659 -1.968811 0.495779
49 6 0.977731 -3.458750 1.213878
50 1 1.555675 -1.460799 0.527322
51 6 -0.289477 -3.988836 1.225160
52 1 1.929057 -3.863281 1.510886
53 1 -0.601150 -4.972924 1.531264
54 7 -1.211732 -3.053198 0.772959
55 7 0.832883 -2.154436 0.744827
Appendix C 285
UDIM · UDIM C, 6-31G; N/O, 6-31G*; H, 6-31++G**
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
1 6 -1.684491 -0.174824 -1.386715
2 7 -1.141975 -0.456679 -0.147674
3 1 -1.653179 -1.143576 0.425253
4 7 -0.969000 0.649758 -2.197318
5 1 -0.076861 1.019666 -1.842965
6 6 0.041002 0.048419 0.374592
7 6 1.909139 1.077493 0.709330
8 6 1.644499 0.400068 1.873059
9 1 -0.078329 -0.835851 2.298316
10 1 2.750644 1.707059 0.477517
11 1 2.176526 0.323832 2.804023
12 6 -1.356136 1.018545 -3.486910
13 6 -1.386226 1.934905 -5.424435
14 6 -2.484891 1.105135 -5.388184
15 1 -3.071978 -0.159017 -3.701618
16 1 -1.058062 2.569255 -6.230270
17 1 -3.254128 0.886724 -6.107280
18 8 -2.793954 -0.683950 -1.708655
19 7 -0.682974 1.877287 -4.232114
20 7 -2.454791 0.518312 -4.128588
21 7 0.437899 -0.261849 1.647640
22 7 0.904559 0.853569 -0.224396
23 6 -3.720626 -2.311242 1.524828
24 7 -4.346975 -1.763625 0.421749
25 1 -3.727953 -1.416838 -0.325263
26 7 -4.521247 -2.868508 2.472161
27 1 -5.538244 -2.844975 2.319139
28 6 -5.714801 -1.686982 0.196986
29 6 -7.865898 -1.825552 0.317399
30 6 -7.601997 -1.144520 -0.844392
31 1 -5.659327 -0.599647 -1.622741
32 1 -8.821083 -2.097805 0.731803
33 1 -8.241611 -0.728795 -1.601774
34 6 -4.055722 -3.485559 3.634691
35 6 -3.995089 -4.500268 5.521841
Appendix C 286
Center Atomic Coordinates (Angstroms)
Number Number X Y Z
36 6 -2.680950 -4.348744 5.138454
37 1 -1.993835 -3.397820 3.291586
38 1 -4.378140 -4.962706 6.415646
39 1 -1.752268 -4.633078 5.600222
40 8 -2.461272 -2.274635 1.605070
41 7 -4.851759 -3.958350 4.577412
42 7 -2.733503 -3.689785 3.915810
43 7 -6.211710 -1.060622 -0.914412
44 7 -6.683094 -2.163268 0.964008
